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3 Summary
Staphylococcus aureus cell-surface proteins have been proposed to play important 
roles in bacterial virulence. The immunoglobulin (Ig)-binding protein A (SpA) has 
been well characterised and it is known to bind most mammalian IgG Fc and Fab 
fragments, thereby inhibiting phagocytosis and acting as a B cell superantigen. 
Recently, a second S. aureus Ig-binding protein has been discovered, Sbi, which also 
binds a second serum protein (^-glycoprotein 1 (P2GPI). In this thesis the Ig-binding 
characteristics of Sbi are analysed and compared to those of SpA. Both Sbi and SpA 
were found to bind all mammalian IgGs tested, but significant differences were found 
between the two proteins in their ability to form high molecular weight complexes 
with some mammalian IgGs. Sbi has one functional Ig-binding domain and sequence 
alignment predicts a second putative Ig-binding domain. Here we show that both Ig- 
binding domains of Sbi bind IgG with high affinity and with specificity for the Fc 
fragment only. Homology modelling of the two Ig-binding domains, based on the 
structure of domain D of SpA, supports our observation that Sbi has conserved Fc 
binding characteristics but does not bind Fab fragments. Structural models of Sbi also 
reveal that the variation in the affinity values of Sbi and SpA for IgG is mainly due to 
small variations in IgG sequence on certain loops at the IgG-ligand interface and at 
the Ch2-Ch3 interface. Multidomain models of Sbi and SpA are used to explain why 
SpA forms large soluble complexes with Fc and insoluble complexes with intact IgG, 
while Sbi forms insoluble complexes with both. Structural studies using small angle 
X-ray scattering, reveal that the N-terminal region of Sbi is composed of 4 globular 
domains, the two Ig-binding domains and two other three-helix bundle domains with 
novel functions.
4 Abbreviations
P2G P I (^-glycoprotein 1
BLAST Basic Local Alignment Search Tool
C na Collagen-binding protein
Ch the constant region of the Ig heavy chain
Cl the constant region of the Ig light chain
ClfA/B Clumping factor A and B
co d  coagulase negative mutant of S. aureus
Ebps Elastin-binding protein
EC M  Extracellular matrix
FnBPA/B Fibronectin binding proteins A and B
GISA glycopeptide intermediately susceptible S. aureus, also referred to as
VISA, vancomycin intermediately susceptible S. aureus








M O E Molecular Operating Environment
MRSA Methicillin resistant S. aureus
M SCRAM M  Microbial surface components recognising adhesive matrix molecules
MSSA Methicillin susceptible S. aureus
NM R Nuclear Magnetic Resonance Spectroscopy
PDB Protein Database
SAXS Small-angle X-ray scattering
Sbi S. aureus Ig-binding protein Sbi
SCCmec staphylococcal cassette chromosome mec
SpA S. aureus Ig-binding protein SpA
TEV Tobacco Etch Virus
TNFR1 tumour-necrosis factor-a receptor 1
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V h the variable region of the Ig heavy chain
Vl the variable region of the Ig light chain
vW F von Willebrand factor
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5 Chapter 1
5.1 Cell adhesion properties of proteins from Staphylococcus aureus 
and their role in virulence
In 1884 Rosenbach described the isolation of two species of Staphylococcus: 
Staphylococcus aureus and what is now termed Staphylococcus epidermidis. This 
genus of bacteria is spherical and forms typical grape shaped clusters as the bacteria 
divides on two planes. Currently, more than 20 species and subspecies of this genus 
have been described, of which S. aureus is the most common. S. aureus derives its 
name from the fact that under certain conditions, the colonies are a gold colour 
(aureus = gold). The bacterium is non-sporing, non-motile, and generally a capsule- 
less cell of ljim  in diameter. It is generally found on the skin and in the nasal 
passages of its host. It does however cause a large range of infections in its host. 
These range from harmless infections, such as pimples, impetigo, boils, to serious 
wound infections and abscesses, septicaemia, osteomyelitis, endocarditis, food 
poisoning and pneumonia (Todar 2005, Prescott, Harley and Klein 2002 Ch 39, 
Greenwood et al 1997 Ch 15). It has been determined that 20% of individuals are 
always colonised, 60% are intermittent carriers, and 20% are never carriers (Foster 
2004).
S. aureus has hit the headlines in the last few years due to the increase in infections by 
MRSA -  methicillin resistant Staphylococcus aureus. The first antibiotic, penicillin, 
was introduced in the early 1940’s, with the first cases of resistance recorded in 1942 
(Lowy 2003). Methicillin, the first of the semi synthetic penicillinase-resistant 
penicillins, was introduced in 1959 to treat infections caused by the penicillin resistant 
staphylococci. However by 1961, there were reports of resistance to this antibiotic, in 
what are now known as MRSA strains (Enright et al 2002). Since the 1960’s, other 
antibiotics have been developed, although there is a lack of novel drugs currently in 
development (Foster 2004). Today, the drug used to treat MRSA infections is the 
glycopeptide antibiotic vancomycin, however in 1997 the first cases of vancomycin 
resistance were reported. These Staphylococci strains with decreased susceptibility to 
this drug (glycopeptide intermediately susceptible S. aureus GISA) are all MRSA
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strains, and are of great concern as there are no drugs currently available that can 
target such strains (Enright et al 2002, Lowy 2003).
How have antibiotic resistant strains arisen?
S. aureus resistance to methicillin occurs when the S. aureus genome contains the 
mecA gene. Katayama, Ito and Hiramatsu (2000) determined that this gene is carried 
on a novel genetic element: the staphylococcal cassette chromosome mec (SCCraec); 
currently five different cassettes have been identified (Foster 2004). The resistance 
was thought to have occurred once, with a single strain acquiring the SCCmec cassette 
(Kreiswirth et al 1993), however it has now been established that the different MRSA 
strains have evolved from MSSA (methicillin-susceptible S. aureus) strains (Enright 
et al., 2002). According to this study, the major MRSA clones have all evolved from 
the successful MSSA strains and the GISA strains are arising from the major MRSA 
strains. In order to tackle this resistance problem it is necessary to develop novel 
drugs that will be effective to those strains that are already resistant to the currently 
available drugs.
5.1.1 How does S. aureus interact with its host?
One step toward the development of novel drugs against S. aureus is to understand 
how the bacterium interacts with its host, in the case of normal carriage as well as 
infection. It has been determined that S. aureus can interact with a number of host 
proteins though cell-surface adhesion molecules, these include components of the 
host’s extracellular matrix (ECM), host serum proteins, or proteins that are present on 
the surface of the host’s cells (i.e. receptors). S. aureus binds to the ECM protein 
elastin via an elastin-binding protein (EbpS) and fibronectin binding proteins (FnBPA 
and FnBPB). Examples of S. aureus proteins that interact with serum proteins include 
fibrinogen, via clumping factors A and B (ClfA and ClfB), and immunoglobulin G, 
via by S. aureus Ig-binding protein A (SpA) and a recently discovered second Ig- 
binding protein Sbi. The adhesion proteins involved are often referred to as microbial 
surface components recognising adhesive matrix molecules (MSCRAMM) (Foster 
and Hook 1998, O ’Brien et al 2002, Zhang et al 1998). Adhesion proteins are not 
exclusive to S. aureus, there are other known examples in the same genus, and also in 
other infective bacteria. For example the adhesion protein SdrX found in 
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*/* both interactions are required for activation o f platelets (Loughman et al 2005)
Figure 1 Interactions between S. aureus and platelet cells mediated by (A) SpA and (B) clumping 
factors ClfA and ClfB (adapted from O’Brien et al 2002).
lugdunensis contains a fibrinogen-binding protein (Nilsson et al 2004). Streptococcal 
protein G (SpG) and Peptostreptococcal protein L both bind immunoglobulins
(Tashiro and Montelione 1995). Binding to receptor proteins on host cells generally 
occurs through bridging between the bacterium and the host cell utilising the host 












Figure 2 Interactions between S. aureus, platelet cells and the extracellular matrix by adhesion
proteins: fibronectin binding proteins FnBPA and FnBPB; Elastin binding protein EpbS, collagen 
binding protein Cna, and SdrE (references in text).
identified that can bind directly to host cells. Examples of S. aureus interactions with 
host ECM and serum proteins are shown in Figure 1 and Figure 2, (also see Appendix 
1), and are described in more detail below.
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Figure 3 Structural arrangement of the serine-aspartate repeat proteins of S. aureus showing their 
relative arrangement of the (S) signal domain, the A domain, the B repeats, the (R) serine-aspartate 
repeat region, the (W) cell-wall spanning region, and the (M) membrane spanning region, which 
contains the LPXTG motif. The lengths of the A domain, the R region, and the total length of the 
protein is indicated (Josefsson et al 1998).
5.1.1.1 MSCRAMM adhesion proteins of S. aureus
The mechanism of attachment by S. aureus to its host is very complex. There are at 
least nine different adhesion proteins with a known ligand or function, most of which 
are known to bind more than one ligand. It has also been found that a number of S.
aureus ligands interact with more than one adhesion protein. A feature common to 
most S. aureus adhesion proteins is the LPXTG sequence motif. This sequence is 
located in the C-terminal of the immature protein, and is cleaved between amino acids 
threonine and glycine by the enzyme sortase. The threonine is then amine-linked to 
the cell wall via the carboxyl of the threonine to the free amino group of the 
pentaglycine crossbridge in the staphylococcal cell wall (Schneewind, Fowler and 
Foull 1995). I will now describe some examples of adhesion proteins of the 
MSCRAMM family.
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5.1.1.1.1 The SD-repeat family of S. aureus
One family of S. aureus cell surface proteins is characterised by the presence of 
serine-aspartate dipeptide repeats (sdr). The family members also contain a signal 
peptide, an ‘A ’ domain, an ‘R ’ domain, composed of SD-repeats, and an ‘M ’ domain, 
containing a proline-rich membrane spanning region, the LPXTG-motif, and the 
membrane anchor (Figure 3). In S. aureus there are 5 members of this family of 
proteins, including the clumping factors, ClfA and ClfB, and SdrC, SdrD, and SdrE 
(Josefsson et al 1998, Foster and Hook 1998, Liu et al 2004).
5.1.1.1.1.1 The serine-aspartate repeat protein SdrE
SdrE, along with SdrC and SdrD, were first characterised by Josefsson et al (1998), 
using Southern blot analysis with a probe against the SD repeat region. All three 
proteins have the typical gene structure described above, with the addition of ‘B ’ 
repeats not found in ClfA and ClfB (see Figure 3). To date, however, no ligand has 
been identified for these proteins, although the role of SdrE in platelet activation has 
been investigated. O ’Brien et al (2002) has shown that, while the absence of the SdrE 
gene alone had no effect on platelet aggregation, in a double mutant with ClfA and a 
triple mutant of ClfA, SpA, and SdrE, increased lag time for aggregation was 
observed, indicating it does have a role in the activation of platelets.
5.1.1.1.1.2 Clumping factors ClfA and ClfB
The observation that S. aureus cells clump together in plasma was first described in 
1908. Later it was found that S. aureus cultures can also induce coagulation of plasma 
(Boden and Flock 1989). The first protein identified to play a role in this process is 
coagulase, an extracellular product of S. aureus that converts fibrinogen into fibrin. 
However, it was determined that other factors also play a role in clumping and 
coagulation; the staphylococcal clumping factors. Recently, S. aureus has been shown 
to be the dominant cause of infective endocarditis (Loughman et al 2005) and a study 
by Moreillon et al (1995) revealed that clumping factor defective mutants of S. aureus 
causes a 50% reduction in cases of endocarditis in a rat model compared to the wild 
type strain.
ClfA and ClfB are both known to bind fibrinogen, which can bind to host platelet 
cells via the GPHb/IQa receptor. Fibrinogen is the precursor of fibrin, which forms
- 1 5 -
blood clots, and it is cleaved by thrombin to form the activated state. The binding of 
S. aureus to fibrinogen on the surface of platelets has been shown to trigger platelet 
activation and leads to platelet aggregation (Siboo et al 2001, O ’Brien et al 2002, 
Loughman et al 2005). This binding is important for S. aureus virulence as was 
shown in a ClfA gene knockout strain, where the absence of the ClfA gene increased 
the lag time for aggregation of platelets (O’Brien et al 2002). However, fibrinogen is 
not the sole ligand for either ClfA or ClfB. In the case of ClfA, Loughman et al 
(2005) showed that fibrinogen alone is insufficient for platelet activation. They found 
that for activation to occur, the serum must also contain anti-ClfA antibodies. These 
bind along with the fibrinogen, thereby attaching the S. aureus bacterium to the 
platelet cells via the fibrinogen receptor and the IgG FcyRIIa receptor (Figure lb). In 
addition, Loughman and co-workers (2005) have shown that activation can also occur 
via the complement pathway. This second mechanism of activation is slower due to 
the time necessary for the assembly of the complement component complexes and it 
also requires IgG. Siboo et al (2001) discovered that ClfA could also bind directly to 
platelets, triggering platelet activation, via a novel cell surface receptor, PI 18.
ClfB was identified via the same method described for SdrC, SdrD, and SdrE. ClfB 
has 26% sequence identity with the A domain of ClfA, and like ClfA it also binds 
fibrinogen (Ni Eidhin et a l, 1998). Unlike ClfA, which binds to the y-chain of 
fibrinogen, ClfB binds to the a -  and p-chains. Walsh et al (2004) showed ClfB has a 
second ligand in the form of cytokeratin 10, an essential component of the cell 
cytoskeleton. Cytokeratin 10 is also found on the surface of squamous cells located in 
the nasal passages, and as such, has been suggested to be a mechanism of attachment 
in nasal colonisation.
5.1.1.1.2 Elastin binding protein EbpS
Elastin is a component of the mammalian ECM, and is found in those tissues that 
require elasticity, such as the lungs, skin and blood vessels (Park et al 1991). Park et 
al (1996) identified and cloned the gene in S. aureus responsible for elastin binding: 
Elastin-binding protein (EbpS), a 23kDa protein that has the ability to inhibit S. 
aureus binding to purified elastin. EbpS, however, lacks the LPXTG cell wall 
anchoring motif characteristic for the MSCRAMM family of proteins.
- 1 6 -
(a) FnBPA 
S Du D1 D2 D3 D4 W M
(b) FnBPB
S A
Figure 4 The arrangement of the domains of the fibronection-binding proteins showing the (S) signal 
domain, the A domain, the B repeats, the D repeats, the (W) cell-wall spanning region, and the (M) 
membrane-spanning region containing the LPXTG motif (Wann, Gurusiddappa and Hook 2000).
5.1.1.1.3 FnBPA and FnBPB
Fibronectin is another component of the ECM, and is also found in blood clots. Two 
S. aureus proteins, fibronectin-binding proteins A and B (FnBPA and FnBPB), were 
shown to bind to coverslips coated with fibronectin (Greene et al 1995). Both are cell 
surface proteins containing the LPXTG-cell wall-anchoring motif. The A regions of
these proteins (shown in Figure 4) share 45% sequence identity while the W and M 
domains (cell-wall spanning, and membrane anchor) show much higher homology 
(Foster and Hook 1998, Greene et al 1995). It is thought that fibronectin binding is 
important in virulence as most invasive strains have the ability to bind fibronectin and 
the binding of S. aureus to fibronectin is required for the internalisation of the 
bacterium by epithelial cells and adhesions to plasma clots (Dziewanowka et al 1999, 
Roche et al 2004). However, Flock et al (1996) showed using a rat model of 
endocarditis, that the elimination of the bacteria’s fibronectin binding properties had 
no effect on virulence.
B1 B2 Du D 1 D 2 D 3 D 4 W M
Like the clumping factors, the fibronectin-binding proteins have multiple ligands. 
FnBPA and FnBPB can also bind fibrinogen, like the clumping factors ClfA and 
ClfB, and supports clumping, although FnBPA has a lower affinity for fibrinogen than 
ClfA (Wann, Gurusiddappa and Hook 2000). FnBPA/B can also bind elastin and this 
activity is present in the N-terminal ‘A’ domain of the two proteins (Roche et al 
2004). In knockout strains, elastin binding is eliminated suggesting that FnBPA/B 
mediates elastin binding and that EbpS is not necessary for this binding.
- 17-
5.1.1.1.4 Collagen-binding protein Cna
S. aureus is the major agent of bacterial arthritis or septic arthritis, causing 80% of 
cases. Strains isolated from such infections are able to bind collagen via the collagen- 
binding protein Cna. Unlike the other adhesion proteins, Cna is not found in most 
strains of S. aureus, however it is found in most strains isolated from patients 
suffering from septic arthritis. The protein has been shown to mediate attachment to 
the cartilage. This attachment via collagen and cartilage is important as was shown in 
a mouse model, where the loss of Cna reduced the rate of arthritis and the degree of 
damage to the joints (Patti et al 1994, Foster and Hook 1998).
- 1 8 -








In mammals the FcyllR
Antigen . /  K receptor plays a central part
binding site <*-Light chain
in the adaptive immune 
response. A number of 
bacterial species also express 
Ig-receptors, examples
include S. aureus, 
Streptococci,
peptrostreptococcus magus 
and haemophilus somnus. 
The S. aureus Ig-receptor 
SpA, for instance, binds IgG 
via both the Fc and Fab
portions of the molecule. It is
thought that these bacterial 
Ig-receptors are involved in 
masking the pathogen from 
the host’s immune system 
(Wilson, McNab and 
Figure 5 (a) showing the arrangement of the domains Henderson 2 0 0 2  Ch 10). The
comprising IgG, also indicating the major IgG fragments, and p re se n c e  0 f  S p A  on the
the composition of peptide chains, (b) showing the crystal
surface of the bacterium,
structure of the intact human IgG b l2  (PDB code 1HZH:
Saphiree,a/2001) c o a tin S th e  cel1 w ith
immunoglobulins, reduces the susceptibility of the bacterial cells to phagocytosis by 
human neutrophils. The absence of IgG in the serum also increases the rate of 
phagocytosis when SpA is expressed by the bacterium. It is thought that this is due to 
activation of the classical complement pathway through the Fab-binding property of 
SpA to IgM (Palmqvist et al 2002).
5.2.1 Immunoglobulins
Most immunoglobulins (Ig) share a characteristic ‘Y’ shaped structure, consisting of 
two heavy chains, and two light chains, as shown in Figure 5. The heavy chain
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consists of 4 globular domains, constant domains 1 to 3 (C h I ,  C h2 , C h 3 ) and a 
variable domain (V h ), while the light chain is comprised of two domains: a constant 
domain ( C l)  and a variable domain (V l) . The combination of the V h  and the V l  
domains form the antigen binding site. This antigen-recognition site is limited to the 
hyper variable region located on the molecule’s loops. Any Ig contains either a kappa 
(k ) or a lambda (X) light chain, and has one of several different types of heavy chain, 
gamma (yl, y2, y3, y4), mu (p), alpha ( a l ,  a2), epsilon (e), or delta (8). The different 
heavy chains give rise to the five main classes of Igs: IgG (y), IgM (p), IgA (a), IgE 
(e), and IgD (8). IgM and IgE have slightly different heavy chains with an additional 
constant domain (C h 4 ). IgM and IgA also contain an extra protein chain, termed the J- 
chain, which links the Igs together to form a pentameric (IgM) or a dimeric (IgA) 
structure. The dimeric form of IgA is only found in mucosal secretions, in serum it 
exists as a monomer. The secreted form contains another protein termed the secretory 
fragment. The different types of Igs are shown in Figure 6.
IgG is the most abundant Ig found in the serum, and exists in 4 subclasses (IgGl, 
IgG2, IgG3, IgG4) all of which have homologous sequences and structure. IgM is the 
first antibody produced in response to a novel antigen. As mentioned before IgA is 
found in the serum, but is also found in secretions such as mucus, saliva, and breast 
milk. The two IgA subclasses (IgAl and IgA2) are thought to have the same function. 
IgE is involved in immunity against parasitic worms and it is important in hyper 
reactive responses to allergens. The function of IgD is unknown (Parham 2000 Ch2, 
Wood 2001 Ch3).
5.2.2 Bacterial immunoglobulin receptors
5.2.2.1 Streptococcal protein G (SpG)
SpG is a cell wall associated protein found on the surface of bacteria from the genus 
Streptococcus, with the ability to bind IgG and serum albumin. The protein contains 
either two or three albumin binding domains at the N-terminus, followed by either 
two or three IgG binding domains; the specific number of both varies between
- 2 0 -







Figure 6 showing the structures of (a) IgA -  secreted form, (b) IgD, (c) IgE, (d) IgG, and (e) IgM. IgE
and IgM have additional C»4 domains, compared to IgG, while IgA and IgM have additional peptide 
chains involved in multimerisation (labelled as J-chain and secretory piece, Wood 2001 Ch3).
different strains. The C-terminal is composed of a cell wall and membrane binding 
domains (Figure 7a, Tashiro and Montelione 1995).
Aybay (2003) investigated the binding of IgG by SpG and compared it to SpA 
binding. While it was known that both SpG, like SpA, could bind both Fab and Fc 
fragments, Aybay (2003) showed that both proteins have unique binding sites on each 
of the fragments.
5.2.2.2 Peptostreptococcal protein L
Protein L is found on the surface of certain strains of Peptostreptococcus magus, and 
binds to the k  chain variable domain of human IgG, IgA and IgM. The protein
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contains 5 Ig-binding domains like SpA (Figure 7b), however the structure of Ig- 
binding domains is the same as SpG: a 4-stranded |3-sheet with a single a-helix 
(Figure 7dii, Tashiro and Montelione 1995).
5.2.2.3 S. aureus Ig-binding protein A (SpA)
SpA is a well-characterised S. aureus cell-surface protein, with a MW of 57kDa, (in S. 
aureus strain 8325-4; Tashiro and Montelione 1995). It contains 4 or 5 highly 
homologous Ig-binding domains in addition to a cell-wall binding region, a cell 
membrane binding region, a transmembrane region in the C-terminal portion of the 
protein, and an LPXTG- cell membrane anchoring motif (see Figure 7c for the 
arrangement of SpA domains, Tashiro and Montelione 1995, Foster and Hook 1998). 
An artificial Z domain has also been generated based on the B domain, differing only 
at a single amino acid position: the B domain to Z domain substitution G22A (Tashiro 
and Montelione 1995, Jansson, Uhlen, and Nygren 1998, the sequences of SpA 
domains are shown in Figure 46).
Early studies found that SpA is specific for mammalian IgGs (Kronvall et a l, 1970). 
No IgGs from fish, amphibians, reptiles or birds (except Rhea americana) serum 
tested positive for IgG binding by SpA. This suggested that the interaction is wide 
spread among mammals and that the ability to immobilise IgG could be important for 
virulence.
Later, Jansson, Uhlen and Nygren (1998) showed that all five SpA Ig-binding 
domains bind to both the IgG Fc fragments and Fab fragments (the engineered Z 
domain binds Fc but lacks the ability to bind Fab). While SpA binds the Fc fragment 
IgG subclasses 1, 2 and 4, no binding has been detected for IgG3; Surolia, Pain and 
Khan 1982. Fab binding is limited to the variable region of heavy chains from gene 
family 3 (V h3, Sasso, Silverman and Mannik 1989). It is interesting to note that it 
only takes a single residue change in SpA to eliminate either Fab or Fc binding. The 
sole difference in domain Z compared to domain B is the substitution of a glycine to 
an alanine (Jansson, Uhlen and Nygren 1998), while inactivation of tyrosine residues 
by iodination eliminates Fc binding in SpA (Romagini et al 1982; Nguyen,
- 2 2 -
Ghebrehiwet and Peerschke 2000). In addition to binding IgG, SpA also binds IgM 
(via Fab Vh3 chains) and IgA (subclass 2) (Surolina, Pain and Khan 1982).
In humans the Vh3 family comprises about half of all inherited Vh genes, and leads to 
about 30% of peripheral B-cells binding SpA via their Fab domains in the surface Igs 
(Palmqvist et al 2005). It has been suggested that SpA, by binding to the Fab









Xr = cell-wall binding; Xc = transmembrane 
Figure 7(a) Crystal structure of SpG Ig-binding domain (PDB code 1IGD: Derrick and Wigley 1994) 
(b) NMR structure of protein L (PDB code: 2PTL: Wikstrom et al 1993) (c) NMR structure of SpA Ig- 
binding domain (PDB code 1BDD: Gouda et al 1992) (d) the arrangement of domains in (i) SpG, (ii) 
protein L and (iii) SpA (Tashiro and Montelione 1995)
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fragment of these B-cell surface Igs can trigger stimulation of B-cells similar to the 
superantigens in T-cells. It has been demonstrated that administration of SpA to mice 
causes the long lasting loss of 80% of splenic B-cells reactive to SpA and reduces the 
levels of circulating SpA-reactive IgM and IgM-secreting cells though supraclonal 
deletion and apoptosis of B-cells (Silvermann and Goodyear 2002, Palmqvist et al 
2005, Silverman and Goodyear 2006). It has also been shown that SpA-specific 
memory B-cells are not formed; however antibodies for conventional antigens form 
normally (Palmqvist et al 2005).
5.2.2.3.1 Other ligands of SpA
SpA has been found to bind a number of other ligands, present both in the serum and 
on the surface of host cells. One of the serum proteins that SpA is now known to bind 
to is von Willebrand factor (vWF; Hartleib et al 2000). vWF is a large multifunctional 
glycoprotein released by activated platelets. It is cleaved after release, and binds to 
various sites to allow platelet adhesion at sites of endothelial damage. As vWF also 
has a platelet bound receptor, it provides a bridging mechanism for attachment of SpA 
to platelet cells and a mechanism to allow the triggering of endovascular disease 
(Hartleib et al 2000, O’Brien et al 2002).
SpA can also bind directly to the surface of platelets via the platelet cell-surface 
receptor gClqR/p33 (Nygren, Grebrehiwet and Peerschke 2000; Peerschke and 
Ghebrehiwet 2001). Its ligand is C lq , which is part of the complement factor C l 
complex, involved in the classical complement pathway (Kishore and Reid 2000). 
The receptor is a multifunctional cellular protein that has a role in modulating platelet 
function at sites of vascular injection and inflammation. Iodination of SpA eliminates 
gC lqR  binding to SpA as well as IgG binding, suggesting that SpA has similar 
structural requirements to bind both ligands (Nygren, Grebrehiwet and Peerschke, 
2000).
A second receptor has also been found to bind SpA, the tumour-necrosis factor-a 
receptor (TNFR1), and this binding was shown by Gomez et al (2004) to induce 
inflammation in the airway epithelium. As TNFR1 is found on the surface of 
epithelial cells, in particularly those of the airways, it gives S. aureus a mechanism to
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attach to these surfaces. It was shown with a spa mutant of S. aureus, that there is 
reduced virulence in a mouse model of pneumonia, suggesting that the TNFRl-SpA 
interaction is important in virulence.
5.2.2.3.2 The role of SpA in virulence
Mastitis is of concern in the dairy industry, due to its impact on milk production. S. 
aureus is known to cause this disease. Jonsson et al (1985) investigated the role of 
three S. aureus proteins, and compared their effects on this disease with alpha- 
haemolysin negative (hla'), coagulase negative (coa~) and SpA negative (spa)  
mutants in a mouse model. The hla' and co d  mutants showed reduced virulence 
compared to the wild type strain, however the level of SpA production did not have 
any observed effect on virulence.
The role of SpA, along with alpha-haemolysin (a-haemolysin, also referred to as a - 
toxin), has also been investigated in subcutaneous lesions in a mouse model. Patel et 
al (1987) injected mice with S. aureus, using a wild type strain, along with mutant 
strains lacking either the a-haemolysin gene or the SpA gene, or both in a double 
mutant. This work found notable physiological differences in the appearance of 
lesions between mice injected strains lacking a -  haemolysin and the wild type strain. 
a-Haemolysin expressing strains were at least 10-fold more virulent: a-haemolysin 
was shown to be a major virulence factor. However comparison of strains lacking 
SpA showed only differences in the size of the lesion, not its appearance. They found 
that SpA negative strains do have slightly reduced virulence, although the difference 
is not as marked as in the case of a-haemolysin.
This pattern, in which loss of SpA causes reduced virulence, but to a much lesser 
degree to the loss of a S. aureus toxin has also been found in models of other bacteria 
diseases. For example Callegan et al (1994) used a rabbit model to compare the 
effects of SpA and a-haemolysin in keratitis. After injection of the rabbit corneas 
with either wild type S. aureus or strains lacking SpA, a-haemolysin or both genes 
showed greater reduced pathology in strains lacking a-haemolysin, however, similar 
to the mouse lesions little difference was observed between spa' or wildtype strains.
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The role of SpA in arthritis and septic death was investigated by Palmqvist et al 
(2002). They showed that the loss of SpA produced a less severe arthritic phenotype, 
and a reduced mortality rate in the mice. However they also showed that injecting the 
SpA protein itself did not trigger arthritis in the animal joints. This suggests other 
components expressed by S. aureus are also involved in causing disease. This is 
supported by the work of O’Brien et al (2002). They looked at the role of SpA in 
platelet aggregation in combination with ClfA. In the presence of a S. aureus mutant- 
lacking SpA, the lag time observed for aggregation was the same as the wild type. 
However in the double knock out of ClfA and SpA, an increased lag time was 
observed when compared to the single ClfA negative mutant.
While the importance of the immunoglobulin binding activity mediated by SpA 
remains unclear the recent identification of a second staphylococcal Ig-binding 
protein may help to clarify the role of Ig-binding in S. aureus virulence.
5.2.3 S. aureus Ig-binding protein Sbi (Sbi)
Zhang et al (1998) used phage display techniques to identify a unique polypeptide 
from S. aureus strain 8325-4 that shared SpA’s ability to bind IgG. They went on to 
clone the gene, and from it expressed the protein, comprised of 436 amino acids. 
Sequence analysis of this gene revealed the gene to contain an Ig-binding domain, a 
predicted Ig-binding domain, a P2GPI-binding domain and a proline rich region 
(Zhang et al 1999). The proline-rich sequence is composed of a proline repeated every 
five residues. Proline rich sequences are commonly found in cell-wall spanning 
regions in bacteria proteins, although Sbi lacks the LPXTG motif also found in these 
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The shotgun phage display method used by Zhang et al (1998) suggested the presence 
of one functional IgG-binding domain, with homology to the Ig-binding domains of 
SpA. The highest homology is in the region of Fc binding determined by Deisenhofer 
(1981). The amino acid sequence suggested the presence of a second Ig-binding 
domain, however Zhang et al (1998) were not able to find any clones that bound IgG 
that mapped to this region of the protein.
When they examined the IgG-binding ability, they used the clone termed IG4, 
comprised of residues 24 to 115. They showed strong binding for human serum IgG, 
pig IgG, guinea pig IgG, and rabbit IgG. The Sbi fragment showed no binding for 
human IgG3, rat IgG, goat IgG and chicken IgG. It did show some binding to human 
IgM and IgA.
Zhang et al (1999) went on to use their phage display against newborn calf serum to 
detect novel interactions. Most clones were IgG-binding or fibrinogen-binding 
domains. However, they also identified overlapping regions of the Sbi gene that does 
not encode for either of the proposed Ig-binding domains, suggesting the ability of Sbi 
to bind a second serum protein. Affinity chromatography was used to isolate this 
protein, and it was identified as (^-glycoprotein I (P2GPI). P2GPI is found in blood 
serum and is a membrane-adhesion glycoprotein. It consists of 5 homologous 
domains, with the fifth domain containing an additional loop that can be inserted into 
membranes. The protein has been implicated in the anti-phospholipid syndrome, 
which is characterised by thrombo-embolic complications and the production of anti­
phospholipid autoantibodies. However, it has been realised that the autoantibodies 
bind, not to the lipids, but to P2GPI (Bouma et al 1999). The minimal P2GPI binding 
sequence in Sbi consists of amino acids 204 to 261 (see Figure 8).
Zhang et al (2000) also examined the effect of the growth conditions on Sbi. Sbi was 
shown to be expressed in all tested S. aureus strains, but its expression level is very 
low. It was found that the level of Sbi expression is up regulated by the presence of 
IgG in the growth media. Zhang et al (2000) suggested that this up regulation 
increases the capacity of Sbi to bind P2GPI and that this could be important in 
virulence. They also suggested that while Sbi contains a characteristic polyproline
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repeat region for cell-wall binding but lacks the LPXTG motif, it is probably not 
proteolytically processed by sortases. And although they note that no membrane- 
spanning region was found, they suggest the C-terminal part of Sbi maybe localised 
intracellularly and could play a role in IgG-mediated cell signalling.
5.2.4 Summary
In this thesis, I will study both structural and functional aspects of Sbi in order to 
understand its role in S. aureus virulence. I start by predicting the structure of Sbi via 
homology modelling, based on its similarity to SpA (Chapter 2). Then I compare the 
binding characteristics of Sbi to those of SpA for a selection of serum IgGs from 
different animal species and for the human IgG subclasses (Chapter 3). In Chapter 4 , 1 
attempt to explain the species and subclass specificity in the IgG-binding between Sbi 
and SpA, observed in Chapter 3, by analysing the sequence variations between the 
IgGs and via the generation of homology models of Sbi-IgG and SpA-IgG complexes. 
In Chapter 5 I further analyse the differences in species specificity in IgG-binding by 
comparing the sequences of the Sbi and SpA genes present in S. aureus strains 
isolated from different animal species, to determine whether these strains have 
evolved specificity for IgGs from their host species. Finally, I use small angle X-ray 
scattering to determine a low-resolution solution structure of the extracellular region 
of Sbi (Chapter 6). In Chapter 7 ,1 will discuss future directions for the continuation of 
this work.
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6 C h a pt e r  2
6.1 3-dimensional structure prediction of the N-terminal domains of 
the Staphylococcus aureus protein Sbi by homology modelling
6.1.1 Introduction
S. aureus contains two Ig-binding 
proteins, SpA and Sbi. Sbi is a 
recent discovery and little is 
known about it other than its 
homology in the N-terminal region 
to the Ig-binding domains of SpA 
(Zhang et al 1998, 1999 and 
2000). Zhang et al (1998) 
characterised its binding with IgG, 
discussed further in Chapters 1 
and 3. SpA on the other hand has 
been well characterised in both in 
terms of its binding characterisitics 
for immunoglobulins (see 
Chapters 1 and 3 for more details) 
and the structure of its Ig-binding 
domains.
The first three-dimensional 
structure determined of SpA was 
of the B domain in complex with a 
human IgG Fc fragment. This 
showed the SpA molecule as two 
Figure 9 (a) Crystal structure of SpA in complex with anti-parallel helices and a C- 
IgG Fc (Deisenhofer 1981). (b) Crystal structure of SpA terminal unstructured region. The
SpA molecule is seen to interact 
with the Fc fragment, via the two 
helices, in a region located
in complex with IgM Fab (Grail le et al 2000)
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between the C h2 and C h3 domains (Figure 9a, Deisenhofer 1981). Later, Gouda et al 
(1992) determined the structure of the uncomplexed B domain, in solution, by NMR. 
This structure is different from Deisenhofer’s in that SpA displays a three-helix 
bundle fold (Figure 9b). At the time it was suggested that the third helix could be 
unwound on binding. However Jendeberg et al (1996) demonstrated that this is not 
the case, and suggested that the difference observed by Deisenhofer (1981) could be 
due to poor structural resolution.
SpA also binds to the Fab fragment of immunoglobulins with a certain type of heavy 
chain (the Vh3 gene family) And in 2000 the crystal structure of the SpA D domain 
was determined in complex with an Fab fragment from a human IgM antibody 
(Graille et al 2000). This structure revealed that SpA has two distinct binding sites for 
Fc and Fab fragments. While SpA binds Fc via helices 1 and 2 (Deisenhofer 1981), it 
binds Fab via helices 2 and 3 (Figure 9b). In the Graille et al (2000) structure SpA 
exists as a dimer, with the dimer interface formed by helices 1 and 2 on each 
monomer. It is unknown whether this dimerisation occurs in vitro or in vivo or 
whether this is an artifact of crystallisation. Today several additional structures of the 
SpA domains exist that were determined by NMR. So far, there are no structures for 
SpA with multiple Ig-binding domains.
6.1.1.1.1 Aim of this study
Phage display and sequencing analysis by Zhang et al (1998) revealed the presence of 
one Ig-binding domain in the Sbi sequence, and predicted the presence of another. In 
this chapter, I attempt to predict the structure of the Ig-binding protein Sbi based on 
its sequence and the differences therein when compared to SpA. I will use the above- 
mentioned structures of SpA and its complexes to envisage the role of Sbi in S. aureus 
immunoglobulin binding. Furthermore, I will use sequence alignment and homology 
modelling to assign structure and function to those Sbi regions with unknown 
structure and functions.
6.1.1.1.2 Homology modelling
Homology modelling is used to predict a protein’s 3D structure based on its amino 
acid sequence and the 3D structure of proteins with a similar sequence (Kirton, Baxter 
and Sutcliffe 2002). The first stage in this process is the identification of the structure
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with similar sequence to the unknown target. If multiple structures can be identified, it 
can aid in the additional modelling of loop regions, which tend to be more flexible 
and less conserved in structure and sequence. The generation of a homology model of 
a protein involves a systematic replacement of residues in the template structure with 
those of the target sequence. Insertions and deletions should preferably occur in loop 
regions rather than in regions with a conserved secondary structure. There are 
programs that can be used for manual model building such as O (Jones et al 1991) 
while there are others that will build models automatically based on the structural 
templates, such as the Molecular Operating Environment (MOE; Chemical 
Computing Group Inc.: http://www.chemcomp.com/). In the final stages of modelling 
the structural model is validated in order to determine whether it meets the allowed 
rules of protein folding by checking whether its backbone angles are within the 
allowed regions of the Ramachandran plot and that it is does not have residues 
exposed to unfavourable environments, i.e. large numbers of exposed hydrophobic 
side chains (Kirton, Baxter, and Sutcliffe 2002).
The first step is to identify homologous sequences through a BLAST search (Basic 
Local Alignment Search Tool; Altschul et al 1997), which is a “statistically driven 
search method.” It is possible to restrict such a search to entries in the Protein 
Database (PDB; Bernstein et al 1977; http://www.rcsb.org/pdb/), and avoiding those 
matches that do not have known structures. However there are many cases where it is 
not possible to identify a suitable structure though this method. For such proteins 
there may be other suitable templates available, because certain sequences that are 
only distantly related can also have conserved structure (Kirton, Baxter, and Sutcliffe
2002). These sequences can be identified via a number of structure prediction servers 
on the web that are designed to detect homologous structures that are more remotely 
related than the ones detected by BLAST (see Methods for examples). This method 
can in some cases provide suitable templates for model building.
6.1.2 Methods
6.1.2.1 Calculation of protein hydrophobicity
Pepplot+ (Wisconsin Package Version 10.2) was used determine hydrophobic regions 
in the Sbi protein sequence (PubMed accession number: BAB96206). To do this two 
methods were used. Kyte and Doolittle (1982) calculates an average of a residue-
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specific hydrophobicity index over a window of nine residues, while the Goldman, 
Engelman and Steitz curve is an average of a residue-specific hydrophobicity scale 
over a window of 20 residues. For both methods, a curve in the upper half of the plot 
indicates hydrophobicity, while the curves in the lower half indicates a hydrophilic 
region (see Figure 10).
6.1.2.2 Prediction of protein secondary structure
PEPTIDESTRUCTURE (Wisconsin Package Version 10.2) was used to calculate 
secondary structure of Sbi with two different methods; the Chou-Fasman method (CF- 
pred, Chou and Fasman 1978), and the Robson Gamier (GORpred, Gamier et al 
1978) method. These prediction methods generate their prediction through statistical 
methods (Lin et al 1989). In addition the protein prediction server 3D-PSSM was used 
(see below) which also predicts the protein’s secondary structure.
6.1.2.3 Identification of sequences homologous to Sbi
BLAST (Basic Local Alignment Search Tool) matches a query sequence to those in a 
database though a “statistically driven search method” (Altschul et al 1997). The 
complete Sbi protein sequence was input against the non-redundant GenBank 
database and against the database of sequences from the RCSB protein data bank 
(http://www.rcsb.org/pdb/ Bernstein et al 1977). In addition, shorter fragments of Sbi 
were also input against the same databases for the fragments consisting of residues 
145 to 270 (incorporating the fcGPl binding domain), 260 to 315 (the polyproline 
region) and 305 to 436 (the C-terminal region of Sbi).
Hits produces in BLAST all have an Expect (E) value. This described the number of 
hits occurring by chance. The closer the value is to “0”, the more significant the 
match is (http://O-www.ncbi.nlm.nih.gov.milH .sjlibrary.org/blast/blast_FAQs.shtml)
Protein prediction servers can also be used to determine structures that are 
homologous to a protein sequence with an unknown structure. Three different servers 
were used on the complete Sbi protein. One of these (3D-PSSM) was also used on the 
three shorter fragments described above.
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6.1.2.3.1 3D-PSSM
Three-dimensional position-specific scoring matrix (3D-PSSM) is a method that 
detects remote protein sequence homology though structural alignments (Kelley et al 
2000) available at http://www.sbg.bio.ic.ac.uk/~3dpssm/. The database used for this 
server is SCOP version 1.53 (Murzin et al 1995).
6.1.2.3.2 GenTHREADER
GenTHREADER is a fast and reliable method of fold recognition though sequence 
alignment, calculation of threading potentials, and completed by evaluation by a 
neural network (Jones 1999, McGuffm, Bryson, Jones, 2000) at 
http://bioinf.cs.ucl.ac.uk/psipred/psiform.html. The method uses the PDB (updated 
Thu May 26 01:07:51 2005).
6.1.2.3.3 SAM-T99
SAM-T99 predicts protein structure though an “iterative hidden Markov model-based 
method for constructing protein family profiles,” available at 
http://www.cse.ucsc.edu/research/compbio/HMM-apps/T99-model-library- 
search.html (Karplus et al 1998). This server searches the PDB and SCOP databases 
(SCOP available at http://scop.mrc-lmb.cam.ac.uk/scop/index.html, Murzin et al
1995).
Multiple methods were used in the identification of protein hydrophobicity, secondary 
structure and tertiary structure, so results could be compared and allow the 
determination of similarities between results for the different methods. For example 
the identification of the same fold in different proteins by the various prediction 
servers for a query protein sequence would suggest the identification of the correct 
fold opposed to the identification of different folds by each of the prediction servers.
6.1.2.4 Generation of protein models
Sequences were aligned with the alignment program ClustalX (Thompson et al 1997) 
in the multiple alignment mode.
Protein structures used for building models on were obtained from the Protein Data 
Bank (PDB). Structural alignments were carried out with the program LSQMAN, and
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pdb files modified with MOLEMAN, both programs were supplied by the Uppsala 
Software Factory (http://xray.bmc.uu.se/usf/, Kleywegt 1996).
Protein modelling was carried out in O (Jones et al 1991), a software program initially 
designed to allow manipulation of electron density maps produced by 
macromolecules. For homology modelling, a known protein structure is taken and 
manipulated using the @ mutator function to replace the residues in the template 
structure (obtained from the PDB database) to the corresponding residue in target 
sequence. Residues can also be added or removed in loop regions (or at the end of 
secondary structure elements, to maintain the secondary structure backbone of the 
template structure), and the loops redrawn with the Lego-loop function. Lego can also 
be used to change the orientation of residue side-chains to avoid side chain clashes 
and optimise interactions.
6.1.2.4.1 Determination of interactions in complexes
The amino acid residues in the SpA complexes with IgG Fc (1FC2, Deisenhofer 
1981) and with IgM Fab (IDEE Graille et al 2000) involved in interactions between 
the SpA molecule and its ligand were determined by analysing all atoms in the SpA 
molecule at a distance between 1.8A and 5.2A from residues in the IgG Fc fragm ent, 
using the CCP4 program CONTACT (Collaborative Computational Program 1994). 
The Sbi homology models were superimposed onto the structures of the SpA-Fc and 
Fab complexes to generate models of Sbi in complex with IgG.
6.1.2.4.2 Validation of structures
Two methods were used to check models generated. Ramachandran plots were 
calculated in O (Jones et al 1991) and using PROCHECK (Laskowski et al 1993, 
Morris e ta l  1992), and any unfavourable backbone angles were adjusted.
Verify_3D was used to analyse the environment of amino acids, and to determine 
those “sequences that are most compatible with the environment of the residues in the 
3D structure” (Bowie et al 1991). Verify_3D uses a 21-residue sliding window to 
calculate the average 3D-ID score, the centre of which is indicated on the x-axis. The
- 3 4 -






Figure 10 Hydrophobicity plot of the Sbi protein determined by Pepplot+.
sliding window is renders the scores for the first nine and last nine residues in the plot 
meaningless. The output is produced in a graph format (see Figure 13c for an 
example). A line above the axis indicates correctly modelled segments, while lines 
under the axis indicate a segment that is incorrectly modelled. This is a web-based 
program at http://www.doe-mbi.ucla.edu/Services/Verify_3D/ (Luthy et al 1992, 
Bowie et al 1991).
6.1.2.4.3 Generation of protein structure images
All images of molecular models were generated using Molscript (Kraulis 1991) and 
subsequently rendered using Povray™.
6.1.3 Results
6.1.3.1 Calculation of protein hydrophobicity of Sbi
Zhang et al (2000) suggested that Sbi contains a transmembrane region and 
cytoplasmic domain based on the fact that its expression is upregulated when S. 
aureus is grown in the presence of IgG. It was suggested that the C-terminal region of 
Sbi could be located in the cytoplasm and may be involved in protein signalling. The 
hydrophobicity plots shown in Figure 10, generated with both Goldman et al and 
Kyte-Doolittle techniques, show that the protein is very hydrophilic. The only region 
of the protein where both plots agree on the hydrophobic nature of the protein is a 
stretch of 20 residues at the N-terminus of the protein, which comprise the signal 
peptide. Only the Goldman method identified short hydrophobic regions at the C- 
terminal of Sbi. These regions may be involved in membrane crossing, but could also 
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Figure 11 Secondary structure prediction of Sbi, indicating the regions with predicted functionality 
marked. Predicted helices (H) are shown in red and beta sheets (E) are shown in blue. Coils are 
depicted with ‘C’ and turns are highlighted in green. The 3D-PSSM prediction identified coils while 
the other methods identified turns.
6.1.3.2 Prediction of Sbi’s secondary structure
Three different secondary structure predictions were obtained for Sbi (Figure 11) and 
the results aligned. The alignments show notable differences, but at least two plots 
were in agreement for each region of Sbi. Both Ig-binding domains were predicted as 
helical by 3D-PSSM, and a mixture beta-strand and alpha-helices by the other
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programs. The P2GPI -binding region is predicted to be a-helical by all methods, 
while all predictions produced different results for the poly-proline region. The C- 
terminal region is predicted to consist of a a-(3-structure by two methods, although the 
GORpred method expects it to adopt an all beta structure.
6.1.3.3 Identification of sequences homologous to the full length Sbi protein 
sequence
Sbi was identified by Zhang et al (1998) through its IgG-binding ability. Sequencing 
of the gene revealed the presence of sequence homology in the N-terminal region of 
Sbi with the Ig-binding domains of SpA. By searching the BLAST database with the 
full length Sbi sequence we looked to identify other proteins with similarity to all or 
part of the Sbi protein sequence.
Searches against the non-redundant database in BLAST identified hits against Sbi 
sequences present in the database and also SpA sequences, all with E values of less 
than l.OOE"10. Other sequences identified to have homology to Sbi all had E values of 
5.00E'06 or more. These hits with high E values include a Drosophila protein 
CG32793-PA, a neurofilament protein from Canis familiarlis, Xenopus protein 
Flj25286-prov, and a tail protein from Methanobacterium phage psiM2. The top ten 
hits after removal of all Sbi and SpA sequences are shown in Table 1, along with the 
region of Sbi for which the sequence shows homology.
As a method to identify functional homology of Sbi other than the Ig-binding function 
already identified in SpA, the BLAST search does not appear to be successful as there 
is no clear pattern of conserved structure or function in the homologous proteins 
identified.
Subsequently, the Sbi sequence was used to search structure prediction servers for 
possible conserved structures. However these were not able to provide better 
templates for model building. All results (except for those matches with SpA) had E 
values of more than 6.00 E'09, and all contained a large number of gaps. While most 
of the structures found were a-helical, their tertiary structures did not show any
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Table 1 Top 10 matches for the sequence of the Sbi protein in the BLAST search after removal of Sbi 
matches and of multiple matches for the same sequence (mainly SpA).
Sequences producing significant alignments: i r
s  y  oS' I Sbi regions which the BLAST hit has homology to
AAW38738
immunoglobulin G binding 
protein A precursor ^  
[Staphylococcus aureus 
subsp. aureus COL]_________
2 7 % 4 9 % 1 0% 
3.00E-14 24% 42% 15% 
3 1 % 5 1 % 9 %
NP 726835 CG32793-PA [Drosophila 55
melanogaster] 5.00E-06
2 9 % 5 2 %
NP 001003352 heavy neurofflament protein J3 
[Cams famuians]
1.00E-05
2 9 % 5 1 % 0 %
AAH55988
Flj25286-prov protein 
[Xenopus laevis] 52 3.00E-05
2 9 % 5 1 % 0 %
tail protein - 
T12737 Methanobacterium phage 
psiM2
19% 4 4 % 6 % 
52 3.00E-05 2 0 % 4 3 % 14%
2 2 % 4 4 % 4 %
3 2 % 5 9 % 1%
54% 7 8 %
5 2 % 7 2 %
4 5 % 7 0 %
AAC52610 osmotic stress protein 94 51 6.00E-05
Mature parasite-infected 
erythrocyte surface antigen 
NPJ703354 (MESA) or PfEMP2 51 7.00E-05
[Plasmodium falciparum 
3D7]
2 3 % 4 2 % 1 7 % 
1 9% 4 4 % 1 0 %
19% 4 2 % 1 2%
2 4 % 4 3 % 1 5 %
17% 3 8 % 9 %
mature parasite-infected 
AAC13303 erythrocyte surface antigen 50 
_______________ [Plasmodium falciparum]______
1.00E-04 2 3 % 4 3 % 17%
NP 035150 osmotic stress protein [Mus ^  
musculus]
2.00E-04
19% 4 4 % 8 % 
2 1 % 3 9 % 1 5 % 
2 0 % 3 9 % 1 0 % 
18% 3 9 % 3 %
BAA08446 APG-1 [Mus musculus] 50 2.00E-04
19% 3 9 % 6 % 
2 2 % 4 0 % 1 6 %
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Table 2 Results of structure prediction server 3D-PSSM for Sbi sequence fragments encoding the (a)
P2GP1 binding domains, (b) the polyproline repeat and the (c) C-terminal region.
Table 2 
(a)











1LRZ Chain A, X-Ray Crystal Structure O f Staphylococcus 
Aureus Fema
32 0.034 27% 54%
1LT8
Chain B, Reduced Homo Sapiens Betaine-Homocysteine 
S-Methyltransferase In Complex With S-(Delta- 
Carboxybutyl)-L- Homocysteine
27 1.1 35% 60% 15%
1SMQ
Chain D, Structure O f The Ribonucleotide Reductase
26 1.4 39% 52% 8%)Rnr2 Homodimer From Saccharomyces Cerevisiae
1JK0 Chain A, Ribonucleotide Reductase Y 2y4 Heterodimer 26 1.4 39% 52% 8%)
1U5P Chain A, Crystal Structure Of Repeats 15 And 16 Of 
Chicken Brain Alpha Spectrin 26 1.9 22%
42%
1U4Q Chain B, Crystal Structure O f Repeats 15, 16 And 17 O f Chicken Brain Alpha Spectrin 26 1.9 22% 42%
1UMY Chain D, Bhmt From Rat Liver 25 3.2 32% 60% 15%
1E24 Chain A, Lysyl-Trna Synthetase (Lysu) Hexagonal Form Complexed With Lysine And Atp And Mn2+ 24 5.5 23% 48%
1BBW Chain A, Lysyl-Trna Synthetase (Lyss) 24 7.1 22% 48%
1KRT
Mol_id: 1; Molecule: Lysyl-Trna Synthetase (Product O f 
Lyss Gene); Chain: Null; Domain: Anticodon-Binding 
Domain (Residues 40 - 149); Ec: 6.1.1.6; Engineered: 
Yes
24 7.1 22% 48%
1J7G Chain A, Structure O f Yihz From Haemophilus Influenzae (Hi0670), A D- Tyr-Tma(Tyr) Deacylase 23 9.3 34% 48%
1US8 Chain B, The Rad50 Signature Motif: Essential To Atp Binding And Biological Function 23 9.3 27% 69% 3%)
1118 Chain B, Crystal Structure Of The P. Furiosus Rad50 
Atpase Domain 23 9.3 27% 69% 3%)
1F2T
Chain B, Crystal Structure Of Atp-Free Rad50 Abc- 
















Chain B, Crystal Structure O f The 2'-Specific And Double- 
Stranded Rna-Activated Interferon-Induced Antiviral 
Protein 2'-5'- Oligoadenylate Synthetase
24 7.2 43% 69%
10E6
Chain B, Xenopus Sm ugl, An Anti-Mutator Uracil-Dna 
Glycosylase 24 7.2 37% 58% 3%
1T11 Chain B, Trigger Factor 23 9.4 32% 61%
Table 2 continued overleaf
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Table 2 
(c)
















Chain C, Osmoporin (Ompk36) From Klebsiella
27 0.85 44% 55%Pneumoniae
10PF The Structure Of Ompf Porin In A Tetragonal Crystal Form 27 1.5 43% 59% 6%
1HXX Chain A, Ompf Porin Mutant Y106f 27 1.5 43% 59% 6%
1HXU Chain A, Ompf Porin Mutant Kk 27 1.5 43% 59% 6%
1HXT Chain A, Ompf Porin Mutant Nqaaa 27 1.5 43% 59% 6%
1BT9 Chain A, Ompf Porin Mutant D74a 27 1.5 43% 59% 6%
1GFQ Ompf Porin (Mutant R82c) 27 1.5 43% 59% 6%
1GFP Ompf Porin (Mutant R42c) 27 1.5 43% 59% 6%
1GFO Ompf Porin (Mutant R132p) 27 1.5 43% 59% 6%
1GFN Ompf Porin Deletion (Mutant Delta 109-114) 27 1.5 43% 59% 6%
1GFM Ompf Porin (Mutant D113g) 27 1.5 43% 59% 6%
1MPF Matrix Porin (Ompf) Mutant With Gly 119 Replaced By 27 1.5 43% 59% 6%Asp (G119d)
1H6V Chain F, Mammalian Thioredoxin Reductase 25 3.2 68% 78% 5%
1MIQ
Chain B, Crystal Structure O f Proplasmepsin From The
25 4.2 26% 50%Human Malarial Pathogen Plasmodium Vivax
1W0P
Chain A, Vibrio Cholerae Sialidase With Alpha-2,6- 24 7.2 36% 63%Sialyllactose
1EW9 Chain B, Alkaline Phosphatase (E.C. 3.1.3.1) Complex 24 7.2 26% 45% 3%With Mercaptomethyl Phosphonate
117 A Chain D, Evhl Domain From Murine Homer 2bVESL 2 24 7.2 37% 49% 5%
1B8J Chain B, Alkaline Phosphatase Complexed With Vanadate 24 7.2 26% 45% 3%
2ANH Chain B, Alkaline Phosphatase (D153h) 24 7.2 26% 45% 3%
1URB Chain B, Alkaline Phosphatase (N51mg) 24 7.2 26% 45% 3%
1KIT Vibrio Cholerae Neuraminidase 24 7.2 36% 63%
1HQA Chain B, Alkaline Phosphatase (H412q) 24 7.2 26% 45% 3%
1HJK Chain B, Alkaline Phosphatase Mutant H331q 24 7.2 26% 45% 3%
1ELZ Chain B, E. Coli Alkaline Phosphatase Mutant (S102g) 24 7.2 26% 45% 3%
1ELY Chain B, E. Coli Alkaline Phosphatase Mutant (S 102c) 24 7.2 26% 45% 3%
1ELX Chain B, E. Coli Alkaline Phosphatase Mutant (S102a) 24 7.2 26% 45% 3%
1ANJ Chain B, Alkaline Phosphatase (K328h) 24 7.2 26% 45% 3%
1ANI Chain B, Alkaline Phosphatase (D153h, K328h) 24 7.2 26% 45% 3%
1A U Chain B, Alkaline Phosphatase Mutant (H412n) 24 7.2 26% 45% 3%
1EHI Chain B, D-Alanine:d-Lactate Ligase (Lmddl2) Of 24 9.4 50% 66%Vancomycin-Resistant Leuconostoc Mesenteroides
1MCW
Chain W, Immunoglobulin Heterologous Light Chain
24 9.4 26% 43% 1%Dimer (MCG-WEIR Hybrid)
similarity. From these results we can conclude that it is not possible to predict the 
structures for any portion other than the Ig-binding region of Sbi. The level of 
sequence similarity of the domains with the Ig-binding domains of SpA is very high, 
with E-values of less than 5.00 E '11 (E-values obtained from the BLAST search).
In order to identify proteins homologous to regions other than the Ig-binding domains 
we searched the databases using several truncated Sbi sequences.
6.1.3.3.1 Identification of sequences homologous to the p2GPI-binding domain, 
the polyproline region and the C-terminal region of Sbi.
In order to identify sequences homologous to the p2GPl-binding domain, the 
polyproline region and the C-terminal region of Sbi, truncated Sbi sequences of each 
of these domains were used to search the structure prediction server 3D-PSSM for 
homologous structures. However, all the structures identified with homology to these 
regions of Sbi had E values of less than l.OOE02 (see Table 2). In addition, although 
many of the structures homologous to these regions of Sbi had structures composed of 
a-helices, none of the structures identified by the searches showed a conserved fold. It 
is therefore impossible to use these results alone to predict a fold motif for the 
(52GP1 -binding domain, the polyproline region or the C-terminal region of Sbi. Other 
information would be required to make a prediction of the structure of these regions 
of the Sbi protein.
CLUSTAL X (1.81) MULTIPLE SEQUENCE ALIGNMENT 
File: /u/hsl/p/b.spkla/h/Protein_sequences/SpA_Sbi.ps Date: Fri Nov 5 09:40:04 2004
Page 1 of 1
LiLfcuh-N »d -
Figure 12 Sequence alignment of Sbi and SpA generated by ClustalX.
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6.1.3.4 Homology modelling of Sbi’s immunoglobulin binding domains
In Figure 12 the full-length protein sequences of both Sbi and SpA are aligned. SpA 
consists of five Ig-binding domains (known as E, D, A, B, and C) in addition to two 
domains involved in cell wall anchoring. Sbi consists of two Ig-binding domains, a 
P2-glycoprotein binding domain, a proline-rich region, and a proposed intracellular C- 
terminal domain. The sequence alignment most notably aligns the first Ig-binding 
domain of Sbi to the second Ig-binding domain of SpA (D). This alignment shows 
conservation in the first four domains of Sbi, but at a much higher level in the Ig- 
binding domains. On this basis, the Sbi Ig-binding domains are expected to adopt the 
three-helix bundle fold typical for the SpA domains. The regions C-terminally from 
the Ig-binding domains (including the p2-glycoprotein binding domain) show a 
certain level of homology with SpA, suggesting that they may have some structural 
similarity with SpA’s Ig-binding domains.
As the Sbi Ig-binding domains share high sequence similarity to those of SpA, the 
structure of SpA in complex with the Fab fragment of IgM (IDEE) (Graille et al 
2000) was selected as a structural template for homology modelling. This structure 
was chosen rather than the structure of SpA in complex with Fc (1FC2) determined by 
Deisenhofer (1981), in which the C-terminal third of the molecule is unstructured. In 
IDEE (and other the SpA structures solved by NMR) all 3 helices are well defined. 
Both Sbi Ig-binding domains were modelled using IDEE as a template and 
subsequently linked together, using an extended spacer peptide (Figure 13). Analysis 
of the model with both a Ramachandran plot and Verify 3D showed that all backbone 
angles were in allowed conformations and that all side chains are in favourable 
environments (Figure 13).
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Figure 13(a) Predicted structure of Sbi’s two Ig-binding domains (b) Ramachandran plot of the two Ig- 
domain model, produced by Procheck (Laskowski et al 1993), showing the majority of residues (black 
squares) fall within core and allowed regions. Residues falling in generous and disallowed regions are 
labelled in red. (c) Verify 3D analysis of the two-domain structure. The result for the Sbi model is 
entirely in the upper portion (above the x-axis) of the plot, suggesting it has been correctly modelled.
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R R V A Q Q N A F  Y ;N VflL K N D N L T  e B H n  N Y l  A q R k I E N  P D R  S Q o k / W
k [ f jn  k e Iq q n Ia If y M H l I h l  p n l  I e e Iq Ir In Ig m  1q s I l  k R d Ip  s |q J s  a [n ] l  l
l~~l= Fc binding residues 0 =  Fab binding residues
Figure 14 (a) Alignment of the Sbi Ig-binding domains to the B domain of SpA, with the residues 
implicated in binding indicated, (b) Surface structure of the first Sbi Ig-binding domain with conserved 
residues highlighted in green, forming a stripe on the surface of the molecule; the structure is shown in 
120° rotations. The structure of the first Sbi Ig-binding domain superimposed on the (c) SpA-Fc 
complex (Deisenhofer 1981) and the (d) SpA-Fab complex (Graille et al 2000), with those residues 
that are identical between the two sequences represented by ball-and-stick side chains, (e) shows the 
location on intact IgG of the complexes shown in (c) and (d).
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6.1.3.4.1 Prediction of Fc/Fab binding characteristics of Sbi
Superimposing the Sbi structures onto the SpA part of the SpA/IgG Fc complex and 
the SpA/IgG Fab complex allows comparison of the residues of SpA involved in the 
interaction with IgG to those of in the corresponding location in the Sbi structure (see 
Figure 14c&d).
In the X-ray structure of SpA bound to the Fc fragment of IgG, the Fc fragment only 
interacts with two of these three helices. The SpA residues involved in binding Fc 
show high conservation in Sbi, as is indicated in Figure 14b. This suggests that Sbi 
very likely binds to the Fc region of the IgG molecule.
The structure of the SpA/IgG Fab complex and Sbi were superimposed in a similar 
fashion. This revealed that of the large number of residues in SpA involved in Fab 
binding only three were conserved in Sbi (Figure 14a, c & d). On this basis, we 
suggest that is unlikely that Sbi interacts with Fab in a fashion similar to SpA.
6.1.3.4.2 Predicted structure for the P2GPI-binding region.
While the structure prediction servers did not detect any good matches for the Sbi 
fragments containing the |32GP1 -binding domain, the sequence alignments show that 
it does have some similarities to the SpA Ig-binding domains. We therefore attempted 
to model the sequence of this region of Sbi onto the SpA structure IDEE. However, 
the region of Sbi between the second Ig-binding domain and the poly-proline region is 
twice as long as the SpA Ig-binding domains, so the sequence was modelled onto two 
of these domains (Figure 15a) linked together. While the backbone angles all fall 
within allowed regions of the Ramachandran plot (Figure 15b), Verify 3D identifies 
several areas of the model with residues in unfavourable environments suggesting that 
this model may be incorrect (Figure 15c).
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Figure 15 (a) Predicted structure of the p2GPl -binding domain, including the region between this 
domain and the second Ig-binding domain, (b) The Ramachandran plot of the structure produced by 
Procheck (Laskowski et al 1993) showing the majority of residues (black squares) fall within core and 
allowed regions. Residues falling in generous and disallowed regions are labelled in red (c) Results 
produced by Verify_3D,. The result for this portion of the Sbi protein is almost entirely in the lower 
portion (below the x-axis) of the plot, indicating the poor quality of the model.
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Figure 16 (a) Ribbon diagram of proline pipe-helix structure Tus (Butcher et al 1996, PDB accession 
code: 1SUT) (b) Backbone structure of the polyproline repeat region model from Sbi (proline side 
chains are shown in ball-and-stick representation), (c) Molecular surface representation of Sbi’s 
polyproline repeat region homology model, coloured to indicate (i) surface charge (+ in blue and -  in 
red) and (ii) hydrophobicity. All surfaces are generated with GRASP (Nicholls, Sharp and Honig 
1991).
6.1.3.4.3 Predicted structure for the polyproline region.
A suitable template structure for the poly-proline domain was not apparent in the 
BLAST searches or structure prediction server results. However we were able to 
identify a poly-proline pipe-helix in the literature (1SUT, Figure 16a, Butcher et al
1996) that displays the same proline repeat unit length (a proline residue every fifth 
amino acid). This proline pipe-helix sequence is shorter than the region in Sbi. On this 
basis, we decided to use 1SUT as a template, and extend it to account for the longer 
Sbi sequence (Figure 16b). Most of the backbone angles do not fall within the allowed
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regions of the Ramachandran plot, but neither do the angles for the template structure, 
because of the rare structural arrangement of the amino acids in this helix. It is not 
possible to analyse the structure with Verify 3D as the peptide is not long enough for 
such an analysis. Interestingly, the analysis of the surface hydrophobicity and surface 
charge distribution reveals a band of hydrophobic residues on either side of the 
molecule, along the longest axis of the molecule (Figure 16c), and also a band of 
positively changed and a band of negatively changed amino acids.
6.1.4 Discussion
6.1.4.1 Homology analysis as a basis for predicting the structure of Sbi
We used BLAST searches and structure prediction servers to identify any structures 
with homology to the Sbi protein sequence in order to be able to predict folds for the 
various Sbi regions (Table 1). We found high homology in the N-terminal region of 
Sbi (the Ig-binding domains) to the Ig-binding domains of SpA suggesting that these 
domains in Sbi form the same three-helix bundle fold that they do in SpA. However 
for the remainder of the Sbi protein, we were unable to determine any probable fold. 
None of the prediction servers predicted a common fold for the |32GP1 -binding 
domain, the polyproline region or the C-terminal region. Therefore either Sbi contains 
unique folds in these regions, or is composed of an already identified fold, but that is 
not identifiable by the prediction servers. However, hits generated by the prediction 
servers did tend to favour a-helical structures, and this is in general agreement with 
the secondary structure predictions, suggesting that most of the Sbi protein has a 
mainly a-helical secondary structure.
6.1.4.2 Homology analysis as a basis for predicting the function of Sbi
BLAST database and structure prediction searches generated a large number of hits 
with homology to the Ig-binding domains of SpA. These hits include the region in Sbi 
that was shown to be a functional Ig-binding domain by Zhang et al (1998) and the 
second, putative Ig-binding domain for which the Ig-binding properties have yet to be 
confirmed (see Chapter 3 for studies into the binding properties of the second Ig- 
binding domain of Sbi).
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The other regions of Sbi, the |32GP1 -binding domain, the polyproline region and the 
C-terminal region also produce a number of hits in the database searches. However,
-07all these hits had high E values (higher than 100.E ). The database searches using 
truncated Sbi sequences also failed to produce any matches with patterns of common 
structure or function for either the (32GP1-binding domain, the polyproline region or 
the C-terminal region. These regions of Sbi may therefore display novel structural and 
functional features.
6.1.4.3 Predictions for the function of Sbi’s Ig-binding domains
Based on the high sequence identity and functional similarity of the Ig-binding 
domains of SpA and Sbi we predict that both the Sbi Ig-binding domains adopt a 
similar structure to those of SpA. This is also important in predicting the functionality 
of Sbi. The early work on Sbi by Zhang et al (1998) showed IgG binding ability in the 
first Sbi Ig-binding domain but the method of phage display that they used did not 
provide a fragment of the second putative Ig-binding domain.
Comparison of the models of both the Sbi Ig-binding domains with the structures of 
SpA’s Ig-binding domains (Deisenhofer 1981, Graille et al 2000) reveals that there 
are regions of sequence conservation in the 3D structure (Figure 14). The residues that 
are conserved between the two proteins, Sbi and SpA, are conserved in a patch on one 
face of the molecule, shown in Figure 14b. This conservation corresponds to the face 
of the SpA molecule identified to bind the Fc fragment of IgG (Figure 14c, 
Deisenhofer 1980), while the face on the SpA molecule that binds the Fab fragment in 
IgM (Figure 14d, Graille et al 2000) is not conserved. This suggests the Fc binding 
characteristics of the SpA domains is conserved in both of the Ig-binding domains of 
Sbi. We also predict that Sbi lacks the Fab binding characteristics observed in SpA as 
this region is not conserved in the corresponding Sbi domains (Graille et al 2000). It 
is possible that Sbi does not bind Fab at all or that it displays a Vh chain specificity 
for Fabs that is different from SpA.
6.1.4.4 Predicted structure of f^GPl-binding region
The sequence alignment of Sbi showed homology between the f^GPI-binding region 
of Sbi and the corresponding domains of SpA suggesting that there was some
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conservation between Sbi and SpA in this region. Therefore we modelled this region 
of Sbi onto two three-helix bundle domains of SpA, linking them together. Analysis 
of the side-chain environment of this model suggested that this is not a favourable 
conformation for Sbi. Circular dichroism (CD) experiments carried out on a protein 
fragment containing this region of Sbi (data not shown) confirm our prediction that 
this region is a-helical.
6.1.4.5 The structure of the polyproline repeat region and its role in anchoring 
Sbi to the bacterial cell wall
SpA and Sbi share a sequence feature other than the conserved Ig-binding domains, 
the presence of a proline rich region. Little is known about these elements as studies 
on SpA have concentrated on the role of the Ig-binding domains, but it has been 
implicated in cell-wall binding (Tashiro and Montelione 1995). However, there are 
also differences in the sequence of this region between SpA and Sbi. In both proteins 
the proline residues form part of a proline repeat element. The main differences are 
that in SpA it is an octapeptide repeat and there is a large variation in the number of 
repeats between SpA sequences (see also chapter 5). In Sbi a proline occurs every 5th 
position and there is no variation in the number of repeats. There are eight of these 
repeats in the Sbi sequences found in the database so far (see also chapter 5).
The homology model of the polyproline region of Sbi was generated based on the 
structure of a polyproline pipe helix from the replication arrest protein Tus (Butcher et 
al 1996). Of interest to note, is that when the hydrophobicity of the model was 
examined, two hydrophobic bands were found on either side of the protein as well as 
two bands composed of charged residues. Could this be of any functional importance? 
In other S. aureus cell surface adhesion proteins, the proline-rich regions are known to 
be a feature of the cell-wall binding regions (Zhang et al 2000). MSCRAMM proteins 
such as the Sdr proteins, ClfA and ClfB, FnBPB, Cna, and of course SpA, all contain 
proline rich regions associated with cell wall binding. However in these proteins the 
proline-rich region is followed by the LPXTG motif, which is proteolytically cleaved 
for anchoring to the cell-wall. Sbi lacks this motif, and is probably not proteolytically 
cleaved. The question if and how Sbi is covalently attached to the cell-wall and cell 
membrane therefore remains although it seems likely that it is attached to the cell wall
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via the proline rich region. Is it perhaps linked to another membrane protein; or is it 
directly linked to the membrane though a novel mechanism?
The C-terminal region of Sbi is also very different from other S. aureus cell-surface 
adhesion proteins and our database searches did not identify any matches with 
proteins of known function in this region of Sbi. It is therefore difficult to identify the 
role of the C-terminal domain or its structure. Interestingly, this region of Sbi contains 
a large number of tyrosine and threonine residues, which can perhaps function as a 
target for phosphorylation (Zhang et al 2000).
The only way forward to find and answer these questions is to clone, express and 
characterise the Sbi domains both structurally and functionally. In the next chapter I 
will describe the cloning, expression, and purification of the N-terminal domains of 
Sbi and compare their immunoglobulin binding characteristics with SpA.
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7 Chapter 3
7.1 A comparison of the immunoglobulin binding properties of Staphylococcus 
aureus adhesion proteins SpA and Sbi
7.1.1 Introduction
Ig-binding proteins expressed by bacteria on their surface are thought to be important 
in masking the bacterium from the host’s immune system. S. aureus is known to 
express two Ig-binding proteins on its surface. These are the proteins SpA and Sbi. 
SpA has been shown to have a role in infectious diseases including mastitis, 
subcutaneous lesions and arthritis (Jonsson et al 1985, Patel et al 1987, Palmqvist et 
al 2002). In addition SpA has been shown to be important, through its role in binding 
IgGs in phagocytosis, as the absence of IgG in the serum increases the rate of 
phagocytosis. The Ig-binding characteristics of SpA have previously been 
characterised by Kronvall et al (1970), Jansson, Uhlen, and Nygren (1998), and Oda 
et al (2003) and its interactions with serum IgGs and the IgG fragments described in 
detail. Little is known about the IgG-binding properties of Sbi. Zhang et al (1998) 
have described the binding of the first Ig-binding domain of Sbi with serum IgG. Here 
we will further investigate and compare the interactions of the Sbi Ig-binding domains 
with both serum IgGs, IgG fragments and subclasses to those observed with SpA. 
This comparison is of particular interest as SpA and Sbi have a different number of 
Ig-binding domains (4 or 5 for SpA against 2 for Sbi) as described in Chapter 1, and 
we will investigate if this results in a difference in avidity for IgG molecules in the 
binding characteristics of the two proteins.
7.1.1.1.1 Immunoglobulin binding characteristics of SpA
Early studies characterising the binding of SpA to Ig, present in the blood sera, used 
Ouchterlony assays (Kronvall et al 1970). This method was used to study both 
precipitation of IgG by SpA and inhibition of the human IgG-SpA reaction. This 
showed that SpA binds to most mammalian IgGs, although not all mammalian IgGs 
are precipitated by SpA. Analysis of non-mammalian serum Igs showed no reaction 
with SpA.
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Later the enzyme-linked immunosorbant assay (ELISA) method became the most 
popular technique to study binding of SpA with Igs. The information supplied with 
the commercially sold SpA from Pierce
(http://www.piercenet.com/products/browse.cfm?fldID=01021504) lists the binding 
of SpA for the serum IgG of several species, and includes binding results with some 
of the IgG subclasses, and the other types of Ig.
More recent binding studies with SpA concentrate on measuring the affinity of SpA 
for human or mouse immunoglobulins (Jansson, Uhlen, and Nygren 1998, Oda et al
2003). Jansson Uhlen and Nygren (1998) used surface plasmon resonance (SPR) to 
determine the relative binding of SpA to human IgG fragments, showing that all SpA 
Ig-binding domains display near equal relative binding with the Fc fragment, while 
the SpA domains A, B, and C bind the Fab fragment better compared to the SpA E 
and D domains (Jansson, Uhlen, and Nygren 1998, Oda et al 2003). The artificial Z 
domain, based on the B domain, differing only by a single amino acid substitution 
G29A (Tashiro and Montelione 1995, Jansson, Uhlen, and Nygren 1998), binds only 
Fc fragments. Oda et al (2003) used SPR to measure the affinity of SpA for mouse 
monoclonal antibodies, of two IgG subclasses, IgGl and IgG2. Using full-length 
recombinant SpA and a construct containing only the SpA B domain, they found 
similar affinities for both forms of SpA for each monoclonal IgG, although full-length 
SpA had a greater affinity for mouse IgG2 than for IgG l.
7.1.1.1.2 Immunoglobulin binding characteristics of Sbi
Zhang et al (1998, 1999) characterised the structure of the Sbi gene with a phage 
display shotgun approach. This method identified functional domains of IgG binding 
and (32GP1 binding. Analysis of the gene sequence identified a second possible IgG 
binding domain, although the phage display method only detected the first one. The 
data available on the binding of the N-terminal Ig-binding domain of Sbi with Igs was 
obtained using an ELISA-based method. Sbi displayed the highest relative binding for 
human, pig, guinea pig and rabbit serum IgGs. Sbi does not bind the human subclass 
IgG3, rat, goat or chicken IgG. Sbi does show some binding for IgA and IgM (see 
Figure 17).
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2500
Figure 17 ELISA results of Sbi with IgG, taken from Zhang et al 1998.
7.1.1.1.3 Aim of this study
Here we analyse the interactions between Sbi and immunoglobulins from mammalian 
and avian sources, species that are like humans affected by S. aureus infections. In 
addition, the interactions between Sbi and human IgG are studied in more detail by 
analysing IgG subclass specificity and the interaction with Fc and Fab fragments. 
These results are than compared to our results from the interaction between IgG and 
SpA. In order to study the types of complexes formed between Sbi and 
immunoglobulins, the stoichiometry of the interaction, the role of multiple Ig-binding 
domains (avidity) and individual Ig-binding domains (affinity) in the formation of 
these complexes we generated four Sbi protein constructs. These constructs are 
comprised of an N-terminal construct (referred to as Sbi-e) containing the Sbi region 
adjacent to the poly-proline repeat region, a construct containing the two proposed Ig- 
binding domains (Sbi-S) and two constructs containing each of the Ig-binding 
domains (Sbi-1 and Sbi-2). The organisation of these constructs is shown in Figure 
18. To analyse all these different aspects of complex formation we used size exclusion 
(SE) chromatography in addition to agar diffusion studies and surface plasmon 
resonance (SPR).
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Figure 18 The structure of the Sbi gene, and the 4 constructs cloned from it.
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While the ELISA method gives us the relative affinity of the two proteins for Igs, it 
does not produce a complete picture of the complex formation as can be gained 
though use of several different methods. In the original results from Kronvall et al 
(1970), the inhibition method gives only qualitative results. Agar diffusion (or 
Ouchterlony assay) methods can only gives qualitative results by indicating whether 
or not a complex forms an insoluble precipitate and whether this complex formation 
can be inhibited. It cannot be used to quantify the binding relationships, or infer 
complex sizes and therefore does not give any information about complex 
composition. And where quantitative methods such as ELISA or SPR have been used, 
it still tells us very little about what kind of complexes are formed, and in the case of 
the ELISA results it tells us only that binding occurs, it can not be determined whether 
there are differences in the formation of complexes in the serum IgGs of different 
species. There are also other limitations with the use of ELISA, particularly when 
polyclonal Ig is used, as was done by Zhang et al (1998). Friguet et al (1995) 
described how there is no simple correlation between absorbance measured by 
ELISA, the amount of each species of bound molecule, and the concentration of free
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molecules. This means that with a mixture of IgG molecules, such as those found in 
serum, the different IgG subclasses will bind the ligand (for example Sbi) with 
different affinities. Therefore those IgG subclasses with highest affinity for the ligand 
will bind when there is a low concentration of ligand present, while with high 
concentrations of ligand, a disproportionally high fraction of IgG molecules with high 
affinity will bind to the ligand.
7.1.1.1.4 Size Exclusion Chromatography
The principle of SE chromatography is the separation of particles based on their size. 
For our experiments, it allowed us to measure the sizes of complexes composed of 
components of known size. Once insoluble components of the mixture have been 
removed, it is possible to estimate the size of the peaks eluted from the column, using 
the elution times of proteins of known molecular weight (MW) and predict their 
composition. A limitation of this quantitative method is that it does not give any 
kinetic information for the eluted complexes, and it also has limitations in the 
separation resolution of the sepharose column, meaning, it is difficult to estimate the 
size of peaks outside the calibration range of the column, and overlapping peaks can 
cause difficulties in obtaining an exact elution volume (Goetz et al 2004, Stulik, 
Pacakova, Ticha 2003).
7.1.1.1.5 Surface Plasmon Resonance
In order to study binding kinetics of the complexes between IgGs and Ig-binding 
proteins, SPR was employed. This is an optical technique that uses the evanescent 
wave phenomenon to measure changes in the refractive index very close to a sensor 
surface (McDonnell 2001). SPR measures the reflected light intensity as a function of 
incident light angle (see Figure 19).
A polarised light beam is reflected though a prism, onto a gold covered surface. Only 
at a certain incident light angle is the light refleated back into the prism (see Figure 
19); this is known as total internal reflection and is the SPR angle. Some energy in the 
light beam is lost as an energy wave (surface plasmon) upon interaction with the gold 
surface, resulting in a reduction of intensity of the reflective light. If the surface of the 
gold changes, i.e. a protein layer is absorbed, changes in the refractive index occur on 
the surface and results in a change of the SPR angle. There is a linear relationship
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I
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Figure 19 Polarised light is introduced into a gold film  (00, at an angle for total intemel reflection to 
occur. Changes in the refractive index on the gold surface due to binding of protein m olecule to the 
surface result in a change in 0j needed for this to occur.
between the amount of bound protein and the shift of the SPR angle 
(http://www.xantec.com/html/spr.html). This shift allows the measurement of real 
time changes in the gold surface as protein molecules are bound to the surface (Green 
et al 2000). Measurement of the real time response (Rt) allows the rate of ks (or ko„) to 
be determined. ks is the pseudo 1st order rate constant. The relationship between Rt 
and ks is:
R, = Req ( 1 - exp -(kass [P] + kdis) t) (1)
Rt = Req (1 -  exp (-ks t)) (2)
ks = kass [P] + kdis (3)
Therefore with at least Rt vs. time curves for three different analyte concentrations, 
the real time response curves can be fitted to the above equation (2) to produce a 
value for ks (see Figure 22a). Chi square (%2) indicates the quality of the fit of the data 
to the equation. A plot of ks vs. analyte concentration [P] gives the association and
dissociation rate constants from the gradient -  kass and the y-axis intercept - kdis (see
Equation (3) above and Figure 22b). The KA and Kd equilibration constants are 
determined from kass and kdis (see Figure 22c).
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Table 3 Concentration o f IgG stock solutions determined by BIORAD assay and sizes o f serum IgGs 
as determined by size exclusion chromatography. The human IgG subclasses* concentrations for SE 
experiments were taken as given by Sigma (lm g/m l). *The SE profile of Human IgG l appear 
abnormal, indicated partly by the lower than expected molecular weight, however the protein sample 
appeared normal on an SDS-PAGE.
Species o f IgG 
Origin
IgG peak sizes as 
determined by SE 
(kDa)
Concentration for 















169 5.86 18.87 1.26E-04
Goat serum IgG 379
169
6.52 7.99 5.33E-05





Horse serum IgG 430178 6.68 7.38 4.92E-05
Human serum IgG 285155 6.26 6.69 4.46E-05
Mouse serum IgG 212 7.90 7.90 5.27E-05





Sheep serum IgG 474193 9.61 6.51 4.34E-05
Human IgGl 42* 1.0* 0.12 8.00E-07
Human IgG2 187 1.0* 0.29 1.93E-06
Human IgG4 479214 1.0* 0.54 3.60E-06




determined 13.34 N/A N/A
By combining these three methods we aim to get a much clearer understanding of the 
interactions of Sbi with IgG, and also how these differ in the complexes formed with 
SpA.
7.1.2 Materials and methods
Serum IgGs were supplied as lyophilized powder by Sigma for several mammalian 
species and for chicken as a representative of a non-mammalian species. Those IgGs 
used were dissolved in PBS buffer, and the species used are listed in Table 3, along 
with their concentrations as determined by the Bio-Rad Protein Assay method (with
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BSA as the standard). 25pl of the stock solutions of the serum IgG (50pl for chicken 
IgG) were supplemented with equilibration buffer (20mM Tris-HCl, 200mM NaCl 
pH7) to a volume of 100 pi and spun at maximum speed in the micro-centrifuge for 
10 minutes to remove precipitated protein. The sample was then injected into the size 
exclusion column to determine the IgG size in kDa (see below for size exclusion 
method, determined sizes and concentrations of serum IgGs are shown in Table 3).
The four human k  IgG subclasses were also obtained from Sigma, provided at a 
concentration of 1 mg/ml in Tris buffered saline pH8. lOOpl of this was added to 
lOOpl of 2x PBS and injected into the size exclusion column to obtain an elution 
profile. IgG I k  produced an atypical profile for an IgG (as shown in Figure 31a, IgGl 
is eluted much later than the other IgGs in Figure 28 and Figure 31), but as it appeared 
normal on a SDS-PAGE, this was taken as standard for this IgG. The concentrations 
were determined for SPR experiments using BIO-RAD assay to allow the 
determination of molar concentration of the protein, shown in Table 3 along with size 
exclusion sizes. A calibration curve for the BIORAD assay is shown in Figure 20
1.00
y = 0 .4758X  + 0 .2 5 0 2
0.90 R =0.9915
£  0 .8 0  
CD






0.00 0 .5 0
Protein concentration (mg/ml)
1.00 1.50
Figure 20 Calibration curve for the BIORAD assay, using a BSA standard. The spectrophometer was 
zero-ed against water.
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The molar concentrations for all IgGs were calculated based on their expected 
molecular weights of 150kDa.
P2GPI was supplied in PBS at a concentration of 7.5mg/ml.
Human serum albumin (HSA) was obtained from Sigma, and was diluted in PBS. 
25pi was supplemented with equilibration buffer to a volume of lOOpl and injected 
into the size exclusion column to determine its elution profile (see Table 3 for 
concentration).
BSA was obtained from BIORAD protein assay kit. This was stored in 1ml aliquots at 
1.42mg/ml. This was diluted 1:10 with running buffer for SPR experiments.
Recombinant SpA was obtained from Pierce and dissolved in lx  PBS to give a 
concentration of lOmg/ml.
7.1.2.1 Cloning of Sbi fragm ents
7.1.2.1.1 P C R  am plification of the Sbi gene, nucleotides 86 to 799 (Sbi-e)
The Sbi gene was cloned from nucleotide 86 to 799; to be referred to as Sbi-e. The 
primers used were 5’ -  CAT GCC ATG GCG AGT GAA AAC ACG CAA CAA -  3’ 
(forward primer A) and 5’ -  CCG CTC GAG TCA TTA CGC CAC TTT CTT TTC 
A G C - 3’ (reverse primer B) incorporating Ncol (forward primer) and Xhol (reverse 
primer) restriction sites. All primers were obtained from MWG biotech AG. Template 
DNA was from Staphylococcus aureus strain Mu50. The PCR reaction mixture was 
composed of 0.5nmol of each of the primers, lOnmol of each dNTP (Roche), Pwo 
polymerase buffer, 4u of Pwo polymerase (both from Roche), and lul of template 
DNA per lOOpl (made up to volume with sterile water). Reactions were heated at 
95°C for 7 minutes and than subjected to 35 cycles of 45 seconds at 95°C; 1 minute at 
63.4°C; and 2 minutes 72°C. The reactions were held at 72°C for a further 10 minutes 
and than stored at 4°C.
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7.1.2.1.2 PCR amplification of the Sbi gene, nucleotides 86 to 469, 127 to 283 
and 278 TO 469 (Sbi-S, Sbi-1 and Sbi-2)
N-terminal regions of the Sbi gene were cloned, Sbi-S (nucleotides 86 to 469) 
containing both the proposed Ig-binding domains; Sbi-1 (127 to 283) the first 
proposed Ig-binding domain; and Sbi-2 (nucleotides 278 to 469) the second proposed 
Ig-binding domain. Sbi-S was cloned with forward primer A and reverse primer C (5’ 
-  CCG CTC GAG GAG TCA TTA ATT TTC AAT ATT TTG ACG -  3’). Sbi-1 was 
cloned with forward primer D (5’ -  CAT GCC ATG GGA ACT CAA AAC AAC 
TAC GTA ACA -  3’) and reverse primer E (5’ -  CCG CTC GAG TCA CTA GCT 
GTC T IT  AAG TGA TTC AGA -  3’). Sbi-2 was cloned with forward primer F (5’ -  
CAT GCC ATG GAC AGC AAG ACC CCA GAC CGA -  3’) and reverse primer C. 
all forward primers contained an Ncol site, and the reverse primers an Xhol site. PCR 
reactions were set-up up as described above, and heated at 95°C for 7 minutes, then 
subjected to 35 cycles of 45s at 95°C, 1 minute at 47°C (for Sbi-S and Sbi-1) or 60°C 
(for Sbi-2), and 45s at 72°C. Reactions were held at 72°C for a further 10 minutes and 
than held a 4°C. A schematic representation of the constructs is shown in Figure 18.
7.1.2.1.3 Insertion into the His-tagged parallel vector
PCR fragments were purified with the QIAquick purification kit (QIAGEN) using the 
micro-centrifuge method and eluted into 30|ll of buffer EB. Purified fragments were 
digested in a volume of 50pl containing 30|il of PCR fragments, Nebuffer 2, BSA 
(5jig), Ncol (40u), Xhol (15u) (all from New England Biolabs) and sterile water, and 
incubated overnight at 37°C.
pHIS parallel vector 1 was obtained from Peter Sheffield (described by Sheffield et al 
1999). The vectors were grown in E. coli strain XLl-Blue™  (Stratagene) and purified 
from the cells with the QIAprep Spin Miniprep kit (QIAGEN) using the micro­
centrifuge method. The vectors were digested in a volume of 20(il containing 5jil of 
purified vector, Nebuffer 2, BSA (2|ig), Ncol (16u), Xhol (8u) and sterile water and 
digested overnight at 37°C.
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2pl of digested vector and 6.5|il of digested PCR fragment were added to 200u T4 
ligase and T4 ligase buffer (both New England Biolabs) (final volume 10|xl) and 
incubated at 16°C overnight.
2|Hl of the ligation mixture was added to 100|il of component cells (E. coli XL1- 
blue™). After Vi hour on ice, the cells were heat shocked at 42°C for 30 seconds. 
After incubation for 1 hour at 37°C in Luria-Bertani (LB) media (lOg Tryptone 
(Fischer Biotech), 5g yeast extract (Merck) and lOg sodium chloride per litre), the 
cells were spread on LB agar plates (15g agar per litre of LB media) containing 
ampicillin (lm g per litre of LB media). The plates were incubated overnight at 37°C. 
Colonies were used to inoculate 10ml LB media containing ampicillin (100 mg/1) and 
cultured overnight at 37°C.
The vectors were purified, and those containing the correct inserts identified with 
PCR, restriction digests, and sequencing. The Sbi-e and Sbi-S vectors were then 
transformed into BL21 star™ cells (Invitogen), and the Sbi-1 and Sbi-2 vectors were 
transformed into Rossetta™ cells (Novagene). These clones were used to generate 
glycerol stocks (1ml overnight culture plus 0.5ml 50% sterile glycerol)
7.1.2.1.4 Expression in E. coli
1 litre E. coli cultures were grown in LB media with ampicillin at 100 mg per litre, 
inoculated with 10ml of starter culture (10ml LB media plus lOp.1 ampicillin grown at 
37°C overnight, inoculated from either transformations on a LB ampicillin plate or 
glycerol stocks) at 37°C. Upon reaching an optical density (OD) of 0.6 at 600nm, the 
Sbi-e and Sbi-S cultures were induced with 1ml IPTG (0.5M). Sbi-e was grown for 3 
hour at 28°C, while Sbi-S was grown at 25°C. Sbi-1 and Sbi-2 cultures were grown at 
37°C for 4 to 6 hours, and induced with IPTG overnight at 25°C for agar diffusion 
experiments, and at 20°C to improve expression and solubility for the SPR 
experiments. Cells were collected by centrifugation (7,000rpm for 20 minutes) and 
subjected to a freeze-thaw cycle at -20°C.
The pelleted cells were resuspensed in lysis buffer (20mM Tris-HCl, 500mM NaCl, 
10% glycerol, ImM  PMSF, lOmM P-mercaptoethanol), pH 7 for Sbi-e and pH8 for
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all other clones and sonicated according to the following protocol: a cycle of 0.3 
second pulse followed by 1.0 second cooling, for one minute; this is repeated 5 times 
with one minute of cooling between each cycle. This was carried out on ice. Soluble 
and insoluble fractions were separated by centrifugation.
All samples taken from cultures were analysed by SDS-PAGE on 15% glycine gels 
using Novex gel system (run at 180 volts until the dye front reach the base of the gel).
7.1.2.2 Purification of Sbi-e by ion exchange chromatography
Sbi-e was purified via ion-exchange chromatography as this gave purer protein than 
affinity chromatography on a nickel column did. However all the other constructs 
produced purer protein by affinity chromatography (described below). The soluble 
fraction of the Sbi-e cell lysate was loaded onto a Resource S column (Amersham 
Biosciences) connected to an AKTA purifier machine (Amersham Biosciences). The 
soluble fraction was passed though the column and the column washed with 2ml 
lOmM Tris-HCl pH7, collected in a single fraction. Bound protein was eluted with a 
gradient of lOmM Tris-HCl pH7 1M NaCl in two steps; a target of 40% over 5ml and 
100% over a further 5ml. The eluate was collected in 1ml fractions and the Sbi-e 
containing fractions were determined by SDS-PAGE. Protein fractions were 
concentrated with Centricon-10 concentrators (Amicon)
Ion exchange chromatography gave pure protein (>95%), eluted at approximately 
40% salt concentration. Sbi-e is highly soluble and could be concentrated up to 
30mg/ml. However the protein was not stable and prone to degradation. Aliquots were 
kept at -80°C for long-term storage, and at -20°C for short-term storage. Purity and 
stability of the protein were determined by SDS-PAGE.
A stock solution of Sbi-e was concentrated as described above to a concentration of 
23.7mg/ml, measured by UV absorption at 280nm (extinction co-efficient for Sbi-e at 
280nm = 20400 M '1 cm '1; Abs 0.1% (=1 g/1) 0.6; calculated by ProtParam: 
http://us.expasy.org/tools/protparam.html Gasteiger et al 2005). This was aliquoted 
into tubes containing 42pl, each containing lm g of protein.
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7.1.2.3 Affinity purification of Sbi-1 and Sbi-2
Sbi-1 and Sbi-2 were both purified by affinity chromatography with a chelating 
HiTrap column (Amersham Biosciences) connected to the AKTA purification system. 
The column was loaded according to the manufacturer’s instructions with nickel 
sulphate and equilibrated in binding buffer (lOmM Tris-HCl pH8, 300mM NaCl). The 
column was loaded with the soluble protein fraction and washed with binding buffer. 
The protein was eluted with elution buffer (lOmM Tris-HCl pH8, 300mM NaCl, 1M 
Imidazole) on a 0% to 25% gradient over 60min at a flow rate of 0.5ml/min. This 
yielded pure protein for both constructs (>90%), both eluted at about 15% imidazole. 
The imidazole was removed with a PD-10 column (Amersham Biosciences) to leave 
the proteins in binding buffer.
Both Sbi Ig-binding domains were used for SPR; Sbi-1 at a concentration of 4.45e"5M 
(0.43mg/ml); Sbi-2 = 3.50e'5 M (0.35mg/ml). The concentrations of the Sbi domains 
were determined by BIORAD assay, for which a calibration curve is shown in Figure 
20.
See Chapter 6 for purification of Sbi-S.
7.1.2.4 Binding studies
7.1.2.4.1 Double diffusion assay
Double immunodiffusion experiments were performed on Petri dishes containing a 
1% agarose gel. Wells were punched in the agar and individual wells filled with 100 
(il of Sbi-E lmg/ml in PBS; Human serum IgG (Sigma) or IgG Fc (Bethyl 
Laboratories) lmg/ml in PBS; or recombinant SpA (Pierce) lmg/ml in PBS and left to 
incubate for 48 hours at room temperature. Insoluble ‘immune complexes’ formed at 
the zone of equivalence were visualised by Coomassie staining.
7.1.2.4.2 Size exclusion chromatography
IgG and HSA samples were prepared as described before for obtaining an elution 
profile with either lp l of the Sbi-e stock (7.41e"4M) or 2(il of the SpA stock solutions 
(2.38e‘4 M) added. This was incubated on ice for 10 minutes and then spun at 
maximum speed for 10 minutes in the microcentrifuge. Samples were injected into the
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Figure 21 Calibration curve for the Superdex HR 200 10/30 column, using the protein standards 
aprotinin, cytochrome C, carbonic anhydrase, albumin, alcohol dehydragenase, P-amylase, and urease 
proteins (all from Sigma).
Superdex HR 200 10/30 column (Amersham Biosciences) connected to the AKTA 
purifier, equilibrated in 20mM Tris-HCl pH7, 200mM NaCl. The column was washed 
with 1.5 column volumes (approximately 37ml) of equilibration buffer, and the peak 
size(s) measured from the standard curve calculated using the standard proteins: 
aprotinin, cytochrome C, carbonic anhydrase, albumin, alcohol dehydragenase, 13- 
amylase, and urease proteins (all from Sigma). The void volume of the column was 
determined with blue dextran (Sigma). The calibration curve is shown in Figure 21.
A sample of Sbi-1 was collected from the protein purification. To test this product for 
binding ability, SE experiments were carried out. The concentration of the eluted 
protein was not determined. It was added to human or goat IgG to determine the effect 
on the IgG elution profile. A  set amount of eluate was added to the serum IgG prior to 
loading the sample on the SE column. A fixed volume Sbi-1 was used in the 
experiments, or a multiple thereof.
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7.1.2.4.3 Surface plasmon resonance (SPR)
All previously listed IgGs were used (Table 3). The IgG was dissolved in lx PBS and 
further dilutions for experiments were in running buffer.
SPR experiments were carried out using a two-channel Autolab ESPRIT machine and 
SPR sensor discs coated with Ni2+ ions complexed on a 2D chelating surface 
(Winsdor Ltd/Xantec). Measurements were carried out with the Electrochemical
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Figure 22. Soluble serum IgG is added to Sbi-1 bound to a gold sensor disc at different concentrations. 
The relative refractive angle o f the laser beam was then measured. This gives a set of binding curves, 
one for each concentration of IgG used, (a) shows a typical set of SPR sensograms for the binding of 
human serum IgG to Sbi-1. (b) Typical example o f a plot of ks vs protein concentration, where kass is 
the gradient and k ^  is the intercept with the y-axis. In experimental data, the ks valves are determined 
from the curves in (a) by the fitting the data, using the kinetic evaluation program ESPRIT, (c) Kinetic 
equations used in the determination of the kinetic constants KA and KD.
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Figure 23 SDS-PAGE analysis of the expression of recombinant Sbi constructs, with the pre-induction 
sample (P), post-induction sample (I), soluble fraction (S) and insoluble fraction (In) for (a) Sbi-S and 
(b) Sbi-e and (c) Sbi-1.
Surface Plasmon Resonance Interaction Technology Data Acquisition program (Eco 
Chemie B.V. The Netherlands, version 4.1.0 (2004)). Experimental design was based 
on the work by Nieba et al (1997). Running buffer was lOmM Tris-HCl pH8.0, 
300mM NaCl, 0.005% v/v Tween 20. The surface was activated with 300|iM NiSCTt, 
lOmM Tris-HCl pH8, 300mM NaCl, 0.005% v/v Tween 20. Regeneration buffer was 
0.35M EDTA pH8.5.
A baseline was run for 60s, the Sbi construct was then added, and association 
monitored for 400s, and dissociation measured for 20s. A further baseline was run for 
another 60s, and than the IgG sample was added in one channel, the control BSA was 
added to the other channel. Association was measured for 400s and dissociation for 
20s. EDTA was than added to regenerate the surface.
Kinetics were determined with the ESPRIT Kinetic Evaluation program (Eco Chemie 
B.V. The Netherlands), version 4.1.0 2004). The differential data (the IgG channel 
minus the BSA channel) was analysed using a monophasic-fitting model. The fitting 
program was used to determine a value of ks for all concentrations. The ks value was 
then plotted against IgG concentrations in Microsoft Excel, and a trendline calculated. 
The kass value was taken from the gradient of this line, and the k<jiS value from the 
intercept with the y-axis. KA is kass divided by kdis (Figure 22). x2 values give an
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Figure 24 SDS-PAGE analysis of protein purification of (a) Sbi-S by affinity chromatography, (b) Sbi- 
e by ion exchange chromatography and (c) Sbi-1 by affinity chromatography.
indication of the quality of the fitting of the response data to the the real time response 
equation, calculated by the ESPRIT Kinetic Evaluation program, while R2 is an 
indication of the fitting of the trendline to the data by Microsoft Excel, and of the 
reliability of and kdis-
Sbi-1 and Sbi-2 under went some dissociation from the nickel surface in the absence 
of EDTA after long periods of time on the surface. Therefore the association phase 
measurements were limited to 400s to minimise the loss of Sbi-1 and Sbi-2. The 
dissociation phase was not used to determine a value of kdiss as after 400s Sbi-1 and 
Sbi-2 appeared dissociate from the nickel disc as evidence in association phase 
readings were the amount of protein on the surface started to decrease from its peak 
level, suggesting the dissociation of Sbi in addition to its IgG ligand.
7.1.3 Results
7.1.3.1 Cloning and expression of Sbi constructs
PCR amplification of the fragments of sbi gave single bands for the constructs Sbi-e, 
Sbi-S, Sbi-1 and Sbi-2 (data not shown). These fragments were inserted into the pHIS 
parallel vector (Sheffield et al 1999), and transformed into XLl-Blue E. coli cells. 
The presence of the correct insert was confirmed by sequencing of the plasmid. The 
plasmid containing the Sbi-e and Sbi-S inserts were then transformed into BL21 
star™ E. coli cells, while the ones containing the Sbi-1 and Sbi-2 inserts were
transformed into Rossetta™ E. coli cells. All clones showed good expression at 
optimum temperatures of 28°C (Sbi-e) and 25°C (other clones). Reducing the 
induction temperature of Sbi-1 and Sbi-2 to 20°C further improved the amount and 
solubility of the purified protein. There was no evidence of leaky expression in pre­
induction samples; induction with IPTG gave good levels of expression (Figure 23) at 
the expected protein sizes. Affinity (for the Sbi-1 and Sbi-2 constructs) or ion 
exchange chromatography (for sbi-e only) with all proteins gave pure protein (Figure 
24).
The purified Sbi-e fragment could be concentrated up to 30mg/ml. Initial binding 
studies were carried out to both check functionality and to optimise the method for 
size exclusion chromatography with a mouse monoclonal antibody, and a sample of 
P2GPI (a kind gift from Ph. de Groot). This showed Sbi-e binds both proteins (Figure 
25a&b, the calibration curve is shown in Figure 21) with a shift of 30kDa when Sbi-e 
is in the presence of the mouse IgG, and a shift o f 60kDa when Sbi-e is added to 
P2GPI. The profile of Sbi-e in the absence of either ligand is shown in Figure 26. 
ELISA-based binding studies with an Sbi construct and truncated fJ2GPl constructs 
carried out in the de Groot lab, showed that Sbi only binds |32GP1 constructs 
composed of domains I-H-III and domains I-H-III-IV as well as the full-length (32GP1 
(Figure 25c). Size exclusion chromatography with IgG in the presence of Sbi-e 
showed a shift in the peak size of IgG corresponding to 30kDa in the presence of Sbi- 
e, while the p2GPl peak shifted by 60kDa. These results indicate that the 
recombinant Sbi-e construct produces a functional protein product with both IgG- 
binding and (32GP1 -binding characteristics.
7.1.3.2 Binding studies
7.1.3.2.1 Analysis of insoluble SpA-IgG and Sbi-IgG complexes
It is know that in the presence of certain species of IgGs, SpA precipitates the IgG. 
This can be tested by placing a sample of SpA in one well of an agar plate, IgG in 
another, and allowing diffusion to occur. Precipitation can then occurs between the 
two wells, as shown in Figure 27. To determine whether Sbi shows the same patterns 
of precipitation as SpA, both Sbi and SpA where placed in wells in an agar plate 
along with samples of human serum IgG and the human IgG Fc fragment in a double
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OD of ELISA sam ples consisting of Sbi B2GPI- 
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Figure 25 Size exclusion chromatography elution profiles of 
(ai) mouse monoclonal IgG and (aii) p2GPl in the presence 
and absence of sbi-e. (b) ELISA results (carried out by de 
Groot; Utrecht) with |32GP1 and the P2GP1-binding domain of 
Sbi.
diffusion assay, shown in 
Figure 27. The arch-shaped 
pattern of precipitation in the 
diffusion equivalence zone 
between SpA, Sbi, and 
human serum IgG indicates 
that the two Ig-binding 
proteins share the same 
epitope on human IgG 
presumably the Fc fraction. 
The line of precipitation 
produced by the SpA-IgG 
complex is broader 
compared to the line of 
precipitation of the Sbi-IgG 
reaction and a spur formation 
of precipitate towards the Sbi 
well (highlighted by an arrow 
in Figure 27) indicates that 
SpA possesses a binding 
specificity for a human IgG 
epitope that is not shared by 
Sbi (presumably the Fab 
binding ability of SpA). In 
the absence of the Fab 
fragment SpA’s capacity to 
precipitate human IgG Fc 
was completely eliminated, 
while precipitation with Sbi 
remains unchanged (see 
Figure 27).








Figure 26 Size exclusion elution profile of Sbi-e in the absence of IgG or p2GPl
Figure 27 Double immunodiffusion assay with recombinant SpA and Sbi against human serum IgG 
and IgG Fc fragment. The spur of precipitation, indicating partial identity between the IgG binding 
epitopes of SpA and Sbi, is indicated by an arrow.
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When tested against both the animal serum IgGs and the human subclasses, Sbi-e 
formed insoluble complexes with mouse, rabbit, Guinea pig, and human serum IgGs 
in addition to the human subclasses IgG l and IgG2. SpA differs from Sbi in that, in 
addition to human and Guinea pig serum IgG, it also precipitates very strongly with 
pig serum. The results with Sbi-S show the same precipitation patterns as found with 
Sbi-e, indicating that the insoluble complexes formed by Sbi are caused solely by 
presence of Sbi’s two immunoglobulin binding domains. Although the formation of 
insoluble complexes was expected to require the presence of multiple binding 
domains, the single Ig-binding constructs Sbi-1 and Sbi-2, also produce insoluble 
complexes but only with Guinea pig serum IgG (see Table 4 for precipitation results).
7.1.3.2.1.1 Analysis of soluble SpA-IgG an d  Sbi-IgG complexes
Before analysing the binding characteristics of Sbi and SpA with size exclusion 
chromatography, elution profiles for each of the IgG samples were
obtained first. Subsequently a fixed concentration of either Sbi or SpA was added to 
the same amount of IgG used to generate the IgG profile. From the difference 
between the two elution profiles we analysed the size (molecular weight) of the 
complexes formed. The elution profile of the purified Sbi-e at the concentration used 
in the size exclusion experiments is shown in Figure 25 a. Precipitation of the serum 
IgGs in the size exclusion chromatography experiments was deteated by the addition 
of SDS buffer to the microcentrifuge tube and heated to dissolve any precipitated or 
pelleted protein. This mixture was than loaded an SDS-PAGE gel for separation and 
detection of protein bands.
We found that both Sbi and SpA bind human serum IgG, with most protein 
precipitating before injection (Figure 28a). In addition, a small amount of residual 
soluble protein was observed, as both unbound IgG and large complexes eluted at the 
void volume. Sbi and SpA also bound most of the tested mammalian serum IgGs, 
with different binding characteristics (Figure 28b to Figure 28g). With rabbit IgG, 
most of the IgG in complex with SpA was eluted as a large soluble complex at the 
void volume; no insoluble complexes were detected by SDS-PAGE analysis on the 
residual protein complexes that precipitated in the centrifugation step preceding the 
protein injection. In contrast, all rabbit IgG in complex with Sbi-e was lost as
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Figure 28 Size exclusion chromatography elution profiles for the serum IgGs from (a) human, (b) 
rabbit, (c) Guinea pig, (d) pig, (e) mouse, (f) cow, (g) goat, (h) horse and (i) sheep in the presence and 
absence of Sbi-e and SpA.
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Table 4 Insoluble complexes form by serum IgGs in the presence o f the Ig-binding proteins SpA and 
Sbi. + indicates the formation o f white precipitation on the agar gel, while ++ and +++ indicate 
increasing amounts o f precipitation.
Ig-binding protein or domain
Serum IgG
SpA Sbi-e Sbi-S Sbi-1 Sbi-1
Mouse + + + +




Guinea Pig + + + + + + +
Sheep
Horse
Human + + + + + +
Pig + + +
precipitate. However when with SpA in complex with Guinea pig serum IgGs, all 
protein is lost as precipitate, while in complex with Sbi-e, only about half the IgG is 
lost as insoluble precipitate, the remainder was present as a soluble complex, with 
anapproximate size of 201 kDa (see Table 5), a size very close to the size of Guinea 
pig IgG (192kDa). While complexes of pig IgG and Sbi show no formation of 
insoluble precipitate, it does form a number of different soluble complexes (with an 
approximate size of 181kDa for the major complex peak), which are eluted between 
unbound pig IgG and the void volume. This peak indicates that in the presence of Sbi- 
e, most of the pig serum IgG is forming a 1:1 complex with Sbi-e. In the presence of 
SpA, virtually all the pig serum IgG is lost as insoluble complexes. In the presence of 
mouse serum IgG, Sbi-e causes precipitation. A soluble peak is also detected, 
however, of a similar size as the mouse serum IgG peak detected in the absence of an 
Ig-binding protein, suggesting some components in the mouse serum IgG fraction 
does not bind to Sbi-e. Mouse serum IgG, in the presence of SpA, is eluted in a 
complex of about 400kDa, approximately twice the size of the mouse serum IgG, 
suggesting that SpA causes mouse IgG dimerisation. In the case of both cow and goat 
serum IgGs, the complex formed with Sbi-e resulted in a shift of the IgG peak by
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about 30kDa, suggesting a 1:1 complex formation. However, in the presence of SpA, 
larger complexes were also observed (Table 5). Complexes of SpA with cow IgG 
were much larger than the complexes with goat IgG, with the largest eluted at the void 
volume. The size exclusion chromatography profile of Sbi-e-goat IgG complexes 
contained one major peak, with an approximate size of 197kDa. Only for the 
complexes with the serum IgGs from pig, cow and goat it is possible to estimate the 
complex composition; for these species in the presence of Sbi a 1:1 complex is 
formed.
Two other mammalian IgGs were also examined with different results. Horse IgG in 
complex with both Sbi-e and SpA initially did not appear to cause the elution peaks to 
shift, but resulted in the broadening of the peaks (Figure 28h). Addition of ten times 
the original amount of Ig-binding protein resulted in a shift of the peaks eluted, with 
an SpA-IgG complex of about 320kDa and a larger Sbi-e peak complex of about 
335kDa. Sbi-e in complex with horse IgG produces a broad peak suggesting the 
presence of more than one type of complex (Table 5).
Sheep IgG produced peaks of identical size both in the presence and absence of the 
Ig-binding proteins, and thereby suggesting that there is no binding of sheep protein 
by Sbi-e and SpA (Figure 28i).
The only non-mammalian serum IgG tested, that of chicken, differences shown in the 
elution profiles when the Ig-binding proteins were added were not larger enough to 
correspond to Sbi or SpA binding (Figure 29). Human serum albumin (HSA) was 
used as a control. This again showed no shift in the elution profile in the presence of 
either Ig-binding protein (data not shown).
Elution profiles of human and goat serum IgGs were also determined in the presence 
of Sbi-1. Human and goat serum IgGs were use to compare the complex formation of 
Sbi-1 with serum IgGs predicted to form complexes of high and low molecular weight 
complexes in its presence, respectively. In the case of goat serum IgG, the major peak 
shifted about 18kDa. This suggests that there are two molecules of Sbi-1 bound to a 
single IgG molecule. In the elution profile of human serum IgG with the same amount
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Table 5 The peak sizes determined by size exclusion chromatography for IgG molecules and the Sbi 
and SpA IgG complexes, calculated from elution volumes (a) serum IgGs and (b) human IgG 
subclasses. The presence o f precipitated protein was confirmed through the addition o f SDS-PAGE  
buffer to the microcentrifuge tube, and heating it to dissolve any precipitated protein present. This 
mixture was then loaded onto an SDS-PAGE gel for separation and straining of protein bands. Refer to 
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M easurem ent of the shift of the ch icken  IgG p e ak s  in the  
p re sen c e  of Sbi-e
-20
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Figure 29 Size exclusion chromatography elution profiles for chicken serum IgG in the presence and 
absence of Sbi-e and SpA.
Table 6 Peak sizes for the complexes formed by Human and Goat serum IgGs in the presence of Sbi-1
IgG
species
IgG peak sizes as 
determined by 
SE (kDa)














of Sbi-1, the major peak showed a similar shift in size (23kDa), again suggesting the 
possibility of two Sbi-1 molecules being bound to the IgG molecule. However some 
protein was eluted at an earlier time, with a calculated size of 726kDa, suggesting the 
formation of a large soluble complex. An additional elution profile of human IgG with 
five times the amount of Sbi-1 showed an increase in the amount of protein in the 
larger complex, with an additional increase in the size of this complex, (see Table 6 
for peak sizes, and Figure 30 for elution profiles).
















Goat Serum Ig G  plus Sbi-1
Figure 30 Elution profiles for human serum IgG and goat serum IgG in the presence and absence of 
Sbi-1
7.1.3.2.1.2 Analysis of soluble complexes of SpA and Sbi with Hum an IgG 
subclasses
Sbi-e interactions with the four human IgG subclasses were compared to those of 
SpA. With IgGlK, both Ig-binding proteins formed complexes that precipitated; SpA 
also formed some soluble complexes (Figure 31a). Sbi-e in complex with IgG2K and 
IgG4K formed large soluble complexes, eluted at the void volume (Figure 31b and 
Figure 3 Id). SpA also formed soluble complexes in the presence of IgG2K and 
IgG4K, but after the void volume (see Table 5 for peak sizes and Figure 31b & d for 
elution profiles). There was no precipitate with SpA in complex with IgG4ic, but a
- 7 8 -
(a) M easurem ent of the Shift in the  lgG1 k peak in the  
presence of Sbi-e and SpA
11 13 15
B utton volum e (ml)
- IgG! k  plus Sbi-e plus SpA
7 9 11 13 15 17
B utton volum e (ml)
 lgG2 plus HisB plus SpA
( C )  Measurement of the shift in the lgG3 k peaks in the 
presence of Sbi-e and SpA
10.5 11
Button volume (ml)
—  lg G 3k  pus S b -e  pus SpA
(b) M easurem ent of the shift in the lgG2 k peaks in the 
presence of Sbi-e and SpA
 lg G 4  p u s  S b i - e  plus SpA
( d )  Measurement of the shift in the lgG4 k peaks in the presence 
of Sbi-e and SpA
10 12 14
B ution volum e (ml)
Figure 31 Size exclusion chromatography elution profiles for the human IgG subclasses (a) IgGl, (b) 
lgG2, (c) IgG3, and (d) IgG4 in the presence and absence of Sbi-e and SpA.
large amount with IgG2ic (data not shown). Both Sbi-e and SpA failed to show any 
binding for IgG3K, indicated by the absence of a shift in the IgG peak, (Figure 31c).
7.1.3.2.2 Surface plasmon resonance studies
7.1.3.2.2.1 Immunoglobulin-binding characteristics of Sbi’s individual Ig- 
binding domains
Rate constants (kass and kdiS) and equilibration constants (K a  and K d) were determined 
for all antibodies, and compared. These binding results are shown in Figure 32 and 
Table 7a.
The quality of data fitting varies between species, as is indicated by the chi square (x2) 
values. We believe this discrepancy is due to using serum IgGs in our experiments, 
rather than monoclonal antibodies, as the different IgG subclasses present in the 
serum are expected to give different kass and kdiS rate constants, and therefore affect 
the determination of equilibrium constants. ^  are given in Appendix 2. The







S erum  IgG
Figure 32 Association constants for the Sbi Ig-binding domain Sbi-1 in the presence of the serum 
IgGs.
heterogeneity of the IgG means that the binding curve produced and the resulting 
value of ks (or kon) is an average for the binding and dissociation of the different IgG 
subclasses on the surface. Therefore the values produces for k^s, kdiS, Ka, and Kd give 
the affinity for a defined collection of IgG subclasses (i.e. the serum IgG) for the Sbi- 
1 ligand.
The values for the association rate constant (kass: the rate at which the components in 
the reaction combine to form the product) indicate binding occurs with all antibodies, 
(see Figure 22 for the theoretical reaction equation and the calculation of rate and 
equilibration constants). Chicken IgG has the lowest association rate (kass = 3.54e' s '1 
M '1) and mouse serum IgG has the highest (kass = 7.81e4s '1 M’1). The IgGs of species 
that show poor binding with Sbi-e (goat, horse, sheep, and chicken) all have a k^s 
value of less than l.Oe'3 s"1. Guinea pig IgG has the highest dissociation rate of 7.3e’3 
s’1. The values of equilibrium constant Ka are the lowest for chicken, cow, horse, pig, 
and sheep serum antibodies (K a  less than 2 .16e6 M’1; K d greater than 4.64e’7 M). 
Goat serum IgG occurs at the other end of the spectrum, with very high affinity (KA = 
4.07e7), but it shows virtually no dissociation (kdis = 1 .OOe’05).
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Table 7 Affinity values for the complexes o f (a) Sbi-1 with the serum IgGs (all R2 values were 
calculated from three data points on a k^kajJPJ+kdis line, except for human serum IgG which used 
five) and (b) Sbi-1 and Sbi-2 with the Human IgG subclasses, calculated from SPR measurements (the 
number o f data points for R2 values are in brackets). R2 is the value produced by Microsoft Excel© to 
show the quality o f fitting a set o f data points to a line.
(a) kassCM'V1) kdis (s ) Ka (M '1) Kd (M) R z
Chicken serum IgG 3.53E+01 9.00E-04 3.93E+04 2.55E-05 1.0000
Cow serum IgG 3.98E+03 2.30E-03 1.73E+06 5.78E-07 0.9561
Goat serum IgG 4.07E+02 1.00E-05 4.07E+07 2.46E-08 0.8868
Guinea Pig serum IgG 3.13E+04 7.30E-03 4.28E+06 2.34E-07 0.9601
Horse serum IgG 2.16E+02 1.00E-04 2.16E+06 4.64E-07 0.9371
Human serum IgG 1.88E+04 2.70E-03 6.95E+06 1.44E-07 0.8717
Mouse serum IgG 9.88E+04 3.70E-03 2.67E+07 3.74E-08 0.9549
Pig serum IgG 3.11E+03 5.80E-03 5.36E+05 1.87E-06 1.0000
Rabbit serum IgG 1.09E+04 3.80E-03 2.86E+06 3.49E-07 0.9854
Sheep serum IgG 8.39E+01 9.00E-05 9.32E+05 1.07E-06 0.9966
(b) k ass kdiss Ka
Sbil Sbi2 Sbil Sbi2 Sbil Sbi 2
IgGl 2.03E+05 2.07E+05 5.80E-03 4.80E-03 3.51E+07 4.30E+07
IgG2 7.18E+04 1.42E+04 1.80E-03 4.50E-03 3.99E+07 3.15E+06
IgG4 3.94E+04 2.51E+04 5.20E-03 4.00E-03 7.59E+06 6.27E+06
(b) Kd Rz
cont. Sbil Sbi2 Sbil Sbi2
IgGl 2.85E-08 2.32E-08 0.8853 (5) 0.9422 (3)
IgG2 2.51E-08 3.17E-07 0.8825 (6) 0.9351 (6)
IgG4 1.32E-07 1.59E-07 0.9504 (7) 0.999 (4)
7.1.3.2.2.2 Affinity of Sbi-1 and Sbi-2 for human IgG subclasses
Rate and equilibration constants were also determined for the human IgG subclasses 
against both Sbi Ig-binding domains. As expected, the fitting of the data for the 
human IgG subclasses is generally better than for the serum IgGs, with %2 values for 
all three measured IgG subclasses and two Sbi Ig-binding proteins of less than 12000 
(A limit of 12000 for % was used as all values for ks with a % below this could be 
fitted onto a straight line. ks values with a x2 above this tend to be outliers). Results 
for the human subclasses are shown in Figure 33 and Table 7b. The kaSS values for 
IgG l are similar for both Sbi-1 and Sbi-2, while the k ^  values for IgG2 and IgG4 are 
similar to each other in complex with both Sbi-1 and Sbi-2. All three IgG subclasses 











O Sbil o S b i2
Figure 33 Affinity constant for the Sbi Ig-binding domains Sbi-1 and Sbi-2 with the human IgG
subclasses.
IgG2 that have a lower kdis). When the affinity of Sbi-1 and Sbi-2 is compared for 
each of the IgGs, it was found that both Sbi domains bind IgGl with similar affinity, 
as do they with IgG4. Sbi-1 binds both IgGl and IgG2 with similar affinity, however 
the Sbi-2 plus IgG2 has affinity, which is significantly lower.
7.1.4 Discussion
SpA was the first of the S. aureus Ig-binding proteins to be discovered. The early 
binding studies with SpA and IgGs from different species were performed with 
diffusion assays. Kronvall et al (1970) tested a wide range of mammalian sera and we 
have obtained serum IgG samples for a number of these. Kronvall et al (1970) 
showed that Guinea pig, rabbit and pig serum IgGs precipitated in the presence of 
SpA (human myeloma precipitated as the control in all reactions), while mouse, 
horse, goat and sheep serum IgGs all showed inhibition of the myeloma protein 
reaction.
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The first work on the characterisation of Sbi binding to Ig was carried out by Zhang et 
al (1998). They used ELISA to examine the binding between Sbi and mammalian 
serum IgGs and also the different classes of human IgGs. The highest binding was 
observed with human, Guinea pig, rabbit and pig IgGs. Goat, sheep and chicken did 
not appear to bind Sbi, while cow and horse IgGs gave an intermediate reaction.
How though can the results of SpA obtained via diffusion assay and Sbi obtained by 
ELISA be compared? It would appear to be necessary to compare the reactions of 
IgGs with either SpA or Sbi under the same conditions. To understand this we 
analysed the binding patterns of both SpA and Sbi under the same conditions, both 
proteins were subjected to diffusion assays and size exclusion (SE) chromatography 
to determine the size and stochiometry of the complexes formed, and SPR to study the 
binding kinetics.
The Sbi protein was cloned into 4 different constructs, one containing the N-terminal 
region domains (Sbi-e), one containing both the proposed Ig-binding domains (Sbi-S), 
and two containing the individual Ig-binding domains (Sbi-1 and Sbi-2). All four 
constructs showed binding to IgG. In the agar diffusion assays, Sbi-e and Sbi-S 
showed the same pattern of precipitation, while in the SPR experiments Sbi-1 showed 
the highest affinity for those IgGs that were precipitated in the agar diffusion assays. 
This suggests that, although we did not confirm the Sbi domains in the different 
constructs maintained the same structure through structural methods, as the binding 
ability is conserved, either the correct structure is maintained in the Ig-binding 
domains in the different constructs, or the Ig-binding domains fold correctly on 
binding to the IgG molecules. Evidence to support the hypothesis of the Ig-binding 
domains of Sbi binding corrently folded when in a construct as a single domain is 
available in the structure of the SpA Ig-binding domain structure solved by Gouda et 
al (1992). In this structure, solved by NMR, a single SpA Ig-binding domain is folded 
into the typical three-helix bundle expected for Ig-binding domain in the absence of 
either its ligand or the other SpA Ig-binding domains in the protein.
The sizes of the IgG molecules used in the binding studies were measured by size 
exclusion chromatography. This revealed variation from the expected size of an IgG 
molecule of 150kDa. The size of different IgG molecules are difficult to calculate as
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the complete sequences of all the polypeptide chains are required, and many of the 
IgG sequences available are not complete. It was possible to use the sequences for the 
human IgG structure solved by Saphire et al (2001) to calculate a size for the protein 
of 148kDa. However this did not include the size of the carbohydrate attached to the 
IgG molecule. This is the only example where we were able to use sequences for a 
complete IgG molecule. It is reasonable to assume that IgGs from different species 
have different carbohydrates attached to them, and therefore affecting the IgG 
molecule size in addition to any variations in the lengths of the protein chain 
sequences themselves. In addition the differences in the protein chains between the 
species of IgGs would affect the extinction co-efficents and absorbance of the proteins 
at 280nm, meaning that this in addition to the varations in the concentrations of the 
protein stock solutions (discussed below) result in variation of the height of the IgG 
peaks formed in the elution profiles in Figure 28.
One of the factors influencing the height of the IgG peaks in Figure 28 is the protein 
concentration. The stock solutions of IgG were prepared in a fixed volume of buffer, 
however concentration measurements revealed variation in the concentration of the 
different stock solutions produced. This gives rise to the variation in the height of the 
IgG peaks in Figure 28. However this does not affect the parameter measured in the 
size exclusion results, where the change in the IgG profile after the addition of Sbi or 
SpA was determined. Molar concentrations of the IgG stock solutions were 
determined for use in the SPR experiments for determination of the affinity constants 
from protein concentrations determined by the BIORAD assay .
Different buffer conditions were used for the SPR experiments compared to the size 
exclusion experiments (a change of pH7 to pH8 in the lOmM Tris-HCl 300mM NaCl 
buffer plus the addition of 0.005% v/v Tween 20). This was due previously work had 
optimised the SPR conditions with this buffer (Nieba et al 1997) and the Sbi-1 and 
Sbi-2 constructs proved to be more stable under these conditions than the conditions 
used in the size exclusion experiments where Sbi-e was used.
Three different binding studies methods were used, the agar diffusion assay identified 
which combinations of IgG, Sbi and SpA formed insoluble complexes, size exclusion 
chromatography allowed measurement of the sizes of any soluble complexes present,
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and SPR gave data on the affinity of Sbi for IgG. Insoluble complexes were also 
detected through size exclusion chromatography as the insoluble protein was collected 
in microcentrifuge tubes prior to the injection of the soluble complexes into the 
column. Such protein was run on SDS-PAGE gels, however the results (other than the 
presence or absence of precipitated protein) where unclear due to the large amounts of 
protein present. In addition analysis of soluble complexes eluted from the column 
showed on SDS-PAGE that not all the protein bands expected for IgG and Sbi or SpA 
could be detected due to low amounts of protein present and the dilute nature of the 
eluted fractions collected.
7.1.4.1 Implications of the differences observed in the binding of Sbi and SpA to 
IgG
The double diffusion assay with SpA and Sbi against human serum IgG showed the 
formation of an arch around the IgG well (Figure 27), indicating identity in the 
binding site on the IgG molecule for both proteins. This supports our previous 
prediction that both SpA and Sbi bind to the same site on the Fc fragment (see 
Chapter 2). The formation of a spur in the reaction in the direction of the Sbi well, 
however, indicates that there is an additional binding component in SpA. Our agarose 
diffusion experiments using human IgG Fc fragments indicate that Fab-binding by 
SpA plays a major role in the formation of insoluble complexes with human IgG. The 
absence of Fab, as predicted in Chapter 2, does not affect the formation of insoluble 
Sbi-IgG complexes. From these results we conclude that it is therefore unlikely that 
Sbi has a Vr family Fab specificity different from SpA, ruling out its possible role as 
a B cell super antigen. It may well be that the helix 2-helix 3 face of Sbi binds to other 
yet to be identified ligands.
As precipitation of IgG by SpA requires the intact IgG (Kronvall and Frommel 1970, 
Figure 27), it can aid in explaining the formation of the very large soluble complexes 
formed by some serum IgG such as rabbit serum IgG (Figure 28 and Table 5). The 
formation of these large soluble complexes suggests that, in the case of rabbit IgG, 
SpA cannot bind to the Fab regions of the IgG, thereby reducing its ability to 
crosslink between IgG molecules and subsequent precipitation. In the examples where 
SpA does form precipitation, as is the case with human serum IgG, SpA is known to 
bind certain subclasses of V r  chains ( V h I I I ,  Roben, Salem, Silverman 1995). This
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indicates that Fab-induced crosslinking may also play a role in other serum IgGs that 
also precipitate in the presence of SpA (pig and Guinea pig serum IgG).
Comparison of the SpA and Sbi binding reactions by both the diffusion assay and SE 
chromatography revealed significant differences between the two proteins. SpA 
appears to react most strongly with pig IgG while Sbi reacts strongly with the human 
and rodent IgGs. Both precipitate human IgG. Interestingly, while no precipitation is 
observed for the rabbit IgG in the presence of SpA, it is entirely eluted at the void 
volume as very large soluble complexes in the SE chromatography experiments. Also 
of interest is that of those serums IgGs tested, all those that have strong affinity for 
Sbi in the SPR experiments are precipitated by at least one of the Ig-binding proteins.
We also showed that the individual Sbi Ig-binding domains, Sbi-1 and Sbi-2, both 
bind to IgGs. Sbi-1 formed large soluble complexes in the presence of human IgG, 
and both domains are capable of precipitating Guinea pig IgG. As SpA required the 
presence of Fab binding for precipitation to occur, it is not clear how Sbi is triggering 
precipitation. This phenomenon is discussed further in Chapters 4 and 6.
7.1.4.2 Heterogeneity in immunoglobulin binding
The elution profiles of the tested IgGs indicate that many of the IgG complexes 
consist of components with a variety of molecular weights, including, in some cases 
insoluble complexes that accumulated in the microcentrifuge vial before injection. 
What is the origin of this variation in the SE results? One likely explanation is that the 
serum IgGs tested, and the different IgG subclasses therein, have different individual 
affinities for the two Ig-binding proteins. For example, for both Sbi and SpA in the 
presence of human IgG, most protein is precipitated, however a small amount remains 
unbound in solution. This is in agreement with the SPR results with the human IgG 
subclasses, where IgG 1, 2 and 4 all bind strongly (Figure 31), while no binding was 
detected for IgG3. Apart from the difference in valency between SpA (four Ig-binding 
domains in the construct used in the experiments described here) and Sbi (two Ig- 
binding domains), there are also differences between the Ig-binding domains 
themselves. In the case of SpA, where the domains are very highly conserved, this 
results in small differences in the binding of the Fc fragments (Jansson, Uhlen, 
Nygren 1998). Similarly, the individual Ig-binding domains of Sbi in our SPR
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experiments showed that the two domains do not have equal affinity for all the human 
IgG subclasses (Figure 33).
The Guinea pig elution profile in the presence of Sbi-e shows that, in addition to a 
large amount of precipitation, there is unbound IgG present. Guinea pig serum IgGs 
are known to exist in two subclasses (1 and 2) and it is possible that only one of these 
can bind Sbi-e. In the case of SpA they both appear to be able to bind, as we see no 
unbound IgG in the presence of SpA. This variation in affinity between the different 
IgGs in the serum is supported to a degree by the difficulty to fit the SPR data 
acquired for some serum IgGs. However when the human IgG subclasses were used, a 
consistently better fit was obtained. It was noted by Friguet et al (1995) in ELISA 
experiments where serum IgGs were used opposed to monoclonal antibodies that 
measured binding is an average of the different IgGs. Of the serum IgGs with higher 
affinity, the results of the fitting data for rabbit serum IgG is better than most of the 
other serum results. We were only able to find references to a single rabbit IgG class 
in the databases, appearing to support the view that the more consistent results are 
obtained in the absence of multiple IgG subclasses.
7.1.4.3 Affinity versus avidity
SpA contains 4 Ig-binding domains while there are only two domains present in Sbi-e. 
Does SpA therefore form larger complexes than Sbi? With pig and cow serum IgGs, 
Sbi forms a 1:1 complex (discussed below), but with SpA, large insoluble (pig) or 
soluble (cow) complexes are formed. Although it was impossible to determine the 
complex size for either species (the size of the soluble complexes of cow IgG-SpA 
complex are outside the calibration range of the column), these results suggest that the 
complexes formed in the presence of SpA are larger than the complexes with Sbi. The 
size of such complexes could be determined by analytical ultracentifugation. In the 
case of human, rabbit, mouse and Guinea pig IgGs all complexes formed in the 
presence of Sbi or SpA are insoluble (the rabbit IgG-SpA complex is soluble, but its 
size could not be resolved by the SE column) and it is not possible to determine which 
Ig-binding protein forms the larger complex. The formation of these large complexes 
with Sbi and SpA are discussed further in Chapter 4.
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The size exclusion profiles showed that in addition to large complexes there are also 
complexes that indicate the formation of 1:1 complexes with the serum IgGs from pig 
and cow in the presence of Sbi, and also with sheep, horse and goat IgGs with both 
Sbi and SpA. Possible explanations for the formation of these 1:1 complexes rather 
than larger complexes are: steric hindrance, interfering with the binding of more than 
one IgG for these serum IgG, or that only one of the Ig-binding domains is specific 
for a particular serum IgG present. The 1:1 complexes formed appear to be stable due 
to the narrow peaks produced in the elution profile (if dissociation and re-binding 
were occurring throughout the the elution from the column, broading of the eluted 
peak would be expected to occur due to acceleration and deceleration of the 
complexes as the size of the complexes increases and decreases).
All the other serum IgGs tested other than Chicken IgG produce complexes that are 
either not soluble or are above the resolution limit of the column. In order to 
determine the sizes of the different types of complexes formed in the presence of 
human, rabbit, Guinea pig (in the presence of both SpA and Sbi), cow and pig (in the 
presence of SpA only) requires a method such as analytical ultracentrifugation, which 
has a higher resolution for complex sizes.
The serum IgGs, for which we analysed the interaction with the Ig-binding proteins 
SpA and Sbi, are from animals that are known to acquire serious infections with S. 
aureus. Compared to the binding of human IgG, most of these IgGs (with the 
exception of pig IgG) bind both Ig-binding proteins to a lesser extent. What is 
responsible for this variability in binding and the ability to form insoluble complexes?
Are the differences observed in the binding due to changes in the amino acid 
sequence/structure of the IgGs from the different animal species, and if so what are 
these changes? The Sbi constructs, and SpA used in our experiments are both derived 
from S. aureus strains isolated from human hosts. Is it possible that the Ig-binding 
proteins from strains of S. aureus specific for these animals have acquired a high 
specificity for immunoglobulins from these animals? These questions will be 
addressed in the next two chapters of this thesis.
8 Chapter 4
8.1 Analysis of the interactions between Sbi and its ligands through 
homology models of the Sbi-IgG and SpA-IgG complexes
8.1.1 Introduction
8.1.1.1 SpA Ig-binding domain structures
Figure 34 NMR structure of SpA with the residues identified SpA binds to the Fc portion
of the IgG molecule 
(Deisenhofer 1981, Kronvall 
et al 1970, Jansson, Uhlen, 
Nygren 1998) via interactions 
with the Ch2 and Ch3 
domains of IgG. These
interactions were first
described by Deisenhofer 
(1981) from crystallographic 
data of SpA domain B in 
complex with the Fc fragment 
of human IgG. Two other 
studies helped to shed light on 
the importance of the 
interacting residues in the 
formation of this complex. Romangnani et al (1982) used iodination of SpA, a
technique that specifically inactivates tyrosine residues in the protein of interest.
Iodination of the single tyrosine present in every SpA Ig-binding domain eliminates 
Fc binding, although the Fab binding is unaffected. This tyrosine residue (Y48, Y109, 
Y167, Y225, Y283 in domains E, D, A, B and C, respectively) is not only conserved 
in all SpA Ig-binding domains but also in both of the Sbi Ig-binding domains. Other 
work by Gouda et al (1998) studied the interaction between SpA and Fc using NMR. 
The NMR structure of SpA is shown in Figure 34, with the residues determined by 
NMR to be involved in Fc binding shown. Table 8 lists the residues identified by
*
Deisenhofer (1981) and Gouda et al (1998) to be involved in Fc binding.
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to be involved in binding IgG shown as ball-and-stick 
representations.
Table 8 Residues identified by Deisenhofer (1981) and Gouda et al (1998) to be involved in Fc binding 
by X-ray and NMR studies respectively
NMR study (Gouda et al 




























While there is structural data available for the SpA Ig-binding domain and its 
interaction with IgG, there is no structural information about the formation of the 
large SpA-IgG complexes. W e have confirmed earlier work by Kronvall et al (1970) 
that certain species of serum IgG form insoluble complexes with SpA, such as human 
and pig serum IgGs, while others such as cow and goat serum IgGs bind SpA but do 
not precipitate in its presence. The structure of an Fc fragment in complex with the Z 
domain (the artificial SpA Ig-binding domain) shows a Z domain molecule in
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SpA  m olecu le  IgG  Fc frag m en t 
(end-on)
Figure 35 (a) cartoon of SpA/IgG multimer as predicted by Hanson and Schumaker (1984). (b) Crystal 
structure of an Fc fragment in complex with 2 SpA domains (Raju et al 2003, PDB accession code: 
10Q 0).
complex with each of the two Fc polypeptide chains (Figure 35a), suggesting that an 
IgG Fc molecule has two functional SpA binding sites (Raju et al (2003; PDB 
accession code lOQO). This observation supports earlier work from Hanson, Phillips,
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and Schumaker (1984), and Hanson and Schumaker (1984). Hanson, Phillips and 
Schumaker (1984) used analytical ultracentrifugation to measure the size of the 
complexes formed between SpA and rabbit serum IgG. They identified several 
different complexes with sizes: 7S, 10S, 13S, and 15S. They also showed that the 
formation of these complexes and their distribution was sensitive to the ratio between 
SpA and rabbit serum IgG. Indeed when the ratio of IgG to SpA was >2, the 
complexes formed were a unique 17S complex. Electron microscope analysis of this 
complex, suggested it is composed of four molecules of IgG and 2 of SpA. In a later 
study by Hanson and Schumaker (1984) they tried to explain the complexes observed 
in the analytical ultracentifugation. For the larger 17S complex, they predicted that the 
four IgG molecules are stacked on top of each other, with an SpA molecule running 
down each side (Figure 35a). This model by Hanson and Schumaker (see Figure 35 a) 
is supported by the SpA structure determined by Raju et al (2003) which shows a 
single IgG Fc fragment with a SpA Z domain molecule bound to each IgG peptide 
(see Figure 35b).
Aim of this study
In Chapter 3 ,1 showed that Sbi and SpA have different binding properties for a set of 
serum IgGs. But what causes these differences? As discussed in Chapter 2, there are 
differences in the sequences of Sbi and SpA, but the Fc binding face is largely 
conserved. There are also differences between the sequences of the IgGs used in 
Chapter 3. How, though, are these sequence variations arranged on the three- 
dimensional IgG structure, and is the binding site for SpA (and Sbi) affected. To 
investigate this, I will use the structure of the complex of SpA with a human IgG Fc 
fragment to analyse the interactions between SpA, Sbi and the set of serum IgGs used 
in Chapter 3 in homology models. In addition, I will present a model, based on the 
work by Hanson and Schumaker (1984) and Raju et al (2003), to explain the 
differences in immune-complex formation between SpA and Sbi.
8.1.2 Methods
8.1.2.1 Sequence alignment
Protein sequences for Sbi, SpA and the IgGs were obtained from the PubMed 
database (http://www.ncbi.nih.gov/entrez/query.fcgi) in fasta format, and aligned with 
the alignment program ClustalX (Thompson et al 1999) in the multiple alignment
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mode. Accession numbers for the human, horse, cow, sheep, pig, Guinea pig, rabbit 
and chicken IgGs used in this modelling study are listed in Table 9a and the accession 
numbers for Ig-binding protein sequences are listed in Table 9b. Sequences for the 
structure used as templates for modelling IgG and Sbi were obtained from the RCSB 
Protein Database (PDB) (http://www.rcsb.org/pdb/), again in fasta format; PDB code 
1FC2 (Deisenhofer 1981).
Table 9(a) Accession numbers for the IgG protein sequences, (b) Accession numbers for Sbi and SpA  
protein sequences.
(a) Species and IgG 
Subclass
PUBMED Accession
number for protein 
sequence




















Chicken IgG (clone 
36)* S00390





- 9 3 -
8.1.2.2 Homology modelling
Protein structure coordinates were obtained from the PDB. The X-ray crystal structure 
of the SpA domain B in complex with an IgG Fc fragment (PDB accession code 
1FC2) was used as a template for the models of the complexes between the Sbi Ig- 
binding domains and the IgG Fc fragments from seven different animal sera listed in 
Table 9. The models were generated by systemically replacing the residues of the 
template with those of the sequence being modelled in the program ‘O’ (see Chapter 2 
for more details).
All IgG sequences except those for rabbit and chicken contained a two-residue 
insertion between amino acids E388 and N389 (according to the numbering of the 
human IgG Fc structure) in the sequence. This insertion is located in a loop region, 
and the lego function in ‘O’ was used to convert the extended loop into a single turn 
helix. Chicken IgG contains two insertions, 2 residues between amino acids G385 and 
Q386, and 9 residues between D399 and S400, according to the amino acid 
numbering of the human IgG Fc structure, and a single residue deletion that is not
PSVFLFPPKPKDTLM  I SRTPHVTCVVVDVSp[eJ)PQVKFNWYVDCVQVHNAKTKPRF.QQYN 
238 2^5 25) 2?5 25) 265 25i 2?5 25) 285 290 2§5
A B . r r B  C H3
STYRVV SVLTVLHQNWLDGKEYKCKVSNKAL P A P I E K T I SXAKGQPREPQVYTLPP S REE 
~305 3?0 3?5 320 325 1)30 335 35) M5 35) 3$5
,C o v D o o O C  C n C H4
MTKNQVS LTCl. VKGFYPSDIAVEWESNGQP HNNYKTT P PVLDKDGS F FLYSKLTVDKS RW
358 365 370 375 380 385 > 390 395 400 405 410 415
" b C
q q g n v f s c s  v m h e a l h n h y t q k s l s  lsnfnmmngmn  D Deletions in modelled structures
Insertions in modelled structures418 425 430 435 440
a u a a a a a a a
g c g n n g l n g
Figure 36 Sequence and secondary structure of human IgG Fc fragment for 1FC2. Marked are the 
locations where the insertions and deletions occur in the Fc models. The sequence for the CH2 domain 
is in red while the sequence for the CH3 domain is in blue
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present in any of the other sequences (E269 in the human sequence). Figure 36 shows 
the human IgG Fc amino acid sequence for the structure that is used as a template for 
modelling, with the sites of insertions and deletions highlighted (the amino acid 
numbering used follows the 1FC2 sequence). The insertion and deletion sites in the 
homology models were refined using the lego-loop function. In cases of long 
insertions in loop regions, the expected level of confidence for the particular loop in 
the resulting model is low. With the exception of these regions in the IgG Fc 
homology models, there were no significant alterations to the backbone structure of 
the remainder of the IgG Fc structures or the Sbi models. Side-chains replacements in 
the Sbi Ig-binding domain models, were adjusted to a position that resembles the 
corresponding SpA residue side-chain as closely as possible, using the rotamers that 
were available in the lego loop function. In the case of the Fc molecules, alterations to 
the side-chain conformations were only performed in the regions of loop modelling 
due to insertions or deletions, unless a clash was identified by visual examination of 
the molecule.
8.1.2.3 Determination of potential interactions between Sbi/ SpA and the IgG 
Fc models
For the homology models of the complexes of IgG Fc and each of the Sbi Ig-binding 
domains or SpA Ig-binding domain B, the 1FC2 structure was used as a template. The 
resulting complexes were energy minimised using the M oleculer Operating 
Environment (MOE; Chemical Computing Group Inc.: http://www.chemcomp.com/) 
software, and all atoms of the binding partners within 1.8A and 5.2A were analysed 
using the CCP4 program CONTACT (Collaborative Computational Program 1994). 
The residues that comprised the interface between the IgG Fc and the Ig-binding 
protein were compared for all the combinations of IgG species used with the three Ig- 
binding protein models (SpA-B, Sbi-1 and Sbi-2).
The interacting residues at the interface of the two constant (C h ) domains of the Fc 
molecule were also taken into account. This was done by separating constant domains 
(at residues 338 and 339 according to the PDB file 1FC2). Subsequently, CONTACT 
was used to determine all atoms within OA to 5.2A distance of an atom in the other 
half of the molecule. All residues that were detected in this region on both halves of 
the molecule were than compared to those of the other species examined.
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Figure 37 Sequence alignment of the SpA domain B to both the Ig-binding domains of Sbi. This 
alignment was used in the generation of models of the Sbi domains.
8.1.2.4 Analysis of the side-chain environment with VERITY 3D
The environments of the residue side-chains of the IgG Fc models were analysed to 
determine if any residues were exposed to unfavourable environments. This was done 
with the web-based program VERIFY_3D (http://doe-mbi.ucla.edu/Services/ 
Verify_3D/) (Luthy et al 1992).
8.1.3 Results
8.1.3.1 Homology modelling of Sbi’s Ig-binding domains
The two Sbi Ig-binding domains were aligned to the B domain of SpA in the 1FC2 
structure (Figure 37). The Sbi domains were modelled onto this structure rather than 
using the previous models generated in Chapter 2 to conserve any changes in the 
structure that are the result of binding SpA to IgG Fc and that are present in the SpA- 
Fc complex, but are absent in the SpA-Fab complex.
8.1.3.2 Homology modelling of IgG Fc fragments
We used IgG sequences from eight mammalian, and a single avian species that were 
available in the sequence databases (corresponding to the IgGs tested in binding 
studies with Sbi in Chapter 2 (a sequence for goat IgG could not be found in the 
Pubmed database)). These sequences were aligned with the sequence of the IgG in the 
structure of the human IgG Fc -  SpA complex (Deisenhofer 1981). The sequence 
identity and similarity of these IgGs with the sequence of the human Fc template 
(1FC2) are indicated in Table 10. The sequences for the human and chicken IgGs 
shared only 35.4% identity. Of the mammalian sequences analysed, cow IgG was the 
least similar to human IgG (with 63.9% identity and 74.0% similarity), while rabbit 
was the most similar (with 73.1% identity and 80.3% similarity). These data are also
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Figure 38 Alignment of IgG sequences. The sequences indicated with * were used in the generation of 
IgG models.
shown in Table 10. The alignment of the mammalian IgGs (Figure 38) contained a 
two-residue insertion in most of the sequences between residues E388 and N389 of 
the human sequence (rabbit IgG was the only exception). This loop, however, is 
located at a position in the structure that is not likely to interfere with SpA and Sbi 
binding.
lLpmxTJ
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The chicken IgG model contains a short insertion in the same loop as the mammalian 
insertion, and a single residue deletion in another loop (residue E269, following to the 
human sequence) that is also unlikely to interfere with the binding to SpA and Sbi 
(Figure 38). Chicken IgG also contains a longer insertion, in a loop region located 
near the hinge region of the two Fc domains (between residues D399 and S400 in the 
human sequence; Figure 38). While in human IgG Fc this loop appears not to be 
involved in SpA binding, the resulting loop in the chicken IgG model is lengthened, 
and could interfere with the angle between the two constant domains and also affect 
the SpA binding site.
All modelled IgG structures were analysed with VERIFY 3D. This analysis revealed 
that, while most structures are very similar, certain IgGs have regions that differ from 
the template structure (human IgG Fc: 1FC2). These differences could be related to 
the differences in binding, as most of these areas involve regions on the protein 
backbone that compose the link between the C h 2 -C h 3  domains (residues S337 to 
R344 in the human sequence) (Figure 39).














clone36 100 36 35 37 33 38 37 34
Cow IgG2 36 100 64 63 61 74 64 80
1FC2 35 64 100 71 69 72 73 68
Guinea Pig 
IgG2
37 63 71 100 62 67 69 68
Horse IgG6 33 61 69 62 100 68 63 64
Pig IgG4 38 74 72 67 68 100 70 73
Rabbit IgG 37 64 73 69 63 70 100 69
Sheep IgG l 34 80 68 68 64 73 69 100
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Figure 39 Verify 3D results for the IgG models. The result for all the IgG models are entirely in the 
upper portion of the plot, suggesting it has been correctly modelled (except for the first nine residues of 
the Chicken IgG sequence, however the first and last nine residues of all protein analysed by this 
method are meanless, see 6.1.1.1.2).
8.1.3.3 Analysis of the SpA and Sbi residues involved in the interaction with 
human IgG Fc
The program CONTACT was used to determine which pairs of residues interact 
between the Ig-binding protein and its IgG Fc ligand. The interactions detected in the 
SpA-Fc complex were compared to the interactions seen in the models of the Sbi-1 Fc 
and Sbi-2 Fc complexes, to determine whether the changes in the sequence of the 
three Ig-binding domains could affect the interaction between the two components of 
the complex. The interaction pairs are shown in Figure 40a for all three Ig-binding 
domain models (SpAB, Sbi-1, and Sbi-2) in complex with a human IgG Fc. The plots 
in Figure 40a show the interactions between the human IgG molecule and an Ig- 
binding domain. Residues 250 to 438 are the human IgG residues whilst residues 1 to 
31 are those of the Ig-binding protein. CONTACT (see methods and Chapter 2) was 
used to calculate those residues in the IgG molecule that are within a fixed distance 
(1.8 to 5.2A) of one in the Ig-binding domain. Residues within this distance are 
assumed to be interacting. The present of a green square in the horizontal row 
indicates that residue is interacting with the residue labelled at the top of that column.
Changes in the interaction patterns do not necessarily correspond to changes in the 
sequence of the Ig-binding protein; such changes could also be the result of changes
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Figure 40 (a) Interaction patterns for (i) SpA, (ii) Sbi-1 and (iii) Sbi-2 with human IgG Fc fragment, 
(b) 1FC2 showing the N terminal region wrapped around the IgG. Residues 250 to 438 are the human 
IgG residues while residues 1 to 31 are those of the Ig-binding protein. A green square indicates an 
interaction between the IgG residue and the residue in the Ig-binding domain.
elsewhere in the Ig-binding domain, resulting in the adjustment of the backbone of 
both components of the complex in the MOE energy minimisation program. The 
substitutions that appear to influence the interaction pattern are Q28K and K31R in 
Sbi-1 and FIR and Q28A in Sbi-2. Of these, the FIR substitution of Sbi-2 is probably 
of least interest as (1) this residue was not identified to interact with IgG in the NMR 
study of Gouda et al (1998) and (2) we believe that in the full length SpA molecule, 
the N-terminal of the B domain will not interfere with the binding of the Fc molecule 
as it does in the 1FC2 structure with the N-terminal part of the SpA molecule wrapped 
around the Fc molecule (Figure 40b). Of the remaining residues mentioned here, all
- 1 0 0 -
were identified to be involved in binding Fc by Gouda et al (1998), however we are 
unsure as to how these affect the binding of Sbi to IgG in comparison to SpA.
8.1.3.4 Analysis of the IgG Fc residues involved in the interaction with the Ig- 
binding proteins
The same methods as described in 8.1.3.3, were used to determine where substitutions 
in the IgG sequence between the different IgG species resulted in changes in the 
contacts between the IgG molecule and the Ig-binding domain. Examination of the 
interaction patterns between the Ig-binding proteins and the models of the different 
species’ IgGs reveals numerous differences (the interaction data are shown in 
Appendix 4to Appendix 6). Comparison of the interactions between pairs of residues 
reveals that, while some interactions occur in all models, there are other interactions 
that only occur in a few models (which I termed ‘gain’ of interactions), or interactions 
that occur in most of the models, but not all (where an interaction occurs in 7 or more 
cases, any model lacking this interaction is termed as having ‘lost’ the interaction).
When the sequences are examined for differences, not all changes in the interactions 
between residues can be accounted for by differences in sequence. This suggests that 
differences in other regions of the Fc molecule may cause small changes in 
conformation at the Ch2 and Ch3 domain interface that perhaps affect the interaction 
with Ig-binding proteins without the sequence in the binding region itself being 
altered. It was however possible to identify several Fc residue substitutions affecting 
the interactions with the Ig-binding proteins. The interactions between the Fc models 
and the Ig-binding proteins of interest are listed in Table 11, Table 12, and Table 13.
Changes in the contacts between the IgG Fc molecule and the Ig-binding domain 
include the gain of an interaction Q6-F436 in the chicken IgG model complex, 
compared to the human Fc sequence: Y436, and lost another N24-S309 (Q309 in 
human Fc sequence). In the case of the F436Y substitution, it is not clear how the 
substitution changes the interaction. It could be due, not to the substitution, but re­
arrangement of the backbone due to the larger number of substitutions present in the 
chicken IgG sequence. However the same substitution (F436Y) is found in the human 
IgG3 sequence in addition to a H435R substitution (from the sequence of Human 
IgG l), which also occurs in both chicken and human IgG3. Human IgG3 is unique
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among the naturally occurring human IgG subclasses in that it does not bind either 
SpA or Sbi (see chapter 3). The H435R substitution in the Chicken IgG model is not 
observed in any of the complexes with Ig-binding proteins, however it is observed in 
the interactions between the C h 2 -C h 3  domains. Therefore, while F436Y alone 
probably does not prevent binding, in combination with II435R, its effect could 
knockout SpA and Sbi binding. Indeed, Jendeburg et al (1997) showed the 
introduction of the H435R F436Y mutations into human IgGl eliminated its ability to 
bind SpA. The Q309S substitution probably causes the loss of the interaction with 
N24 in the Ig-binding domain due to the reduced size and length of the serine side 
chain in comparison to the glutamine side chain.
Table 11 Changes in interactions between the Fc homology models and SpA. Superscript numbers 
refer to interactions marked in Appendix 4.
Species Gained mutations Lost Mutations

































Table 12 Changes in interactions between the Fc homology models and Sbi-1. Superscript numbers
refer to interactions marked in Appendix 5.
Species Gained mutations Lost Mutations












































Of all the interactions lost or gained in the Fc models, the only amino acids for which 
a pattern can be found between the side chains present and the level of binding 
observed in Chapter 3 is residue 315 (see Table 14 for the identity of this residue in 
all models). The role of side chain of residue 315 appears to be the strongest in 
determining the pattern of binding. Several of the Fc models have gained an 
interaction for residue 315 with at least one of the Ig-binding domains, however 
interactions involving residue 315 are absent in the Fc models for human (1FC2), 
chicken, cow, horse IgG4 and sheep. This amino acid is the most variable residue 
detected in the Fc-Ig-binding protein interface. We find that there is a strong
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T a b le  13 C hanges in  interactions betw een the Fc hom ology m odels and Sbi-2. Superscript numbers
refer to interactions marked in Appendix 6.
Species Gained mutations Lost Mutations





































correlation between the residue type at position 315 and the binding characteristic 
described in chapter 3, across all ten species. We propose that large charged residues 
such as arginine and asparagine are required for the high binding levels while the 
small side chains such as glycine and serine are linked with low binding species.
In ten Fc models, residue 315 exists as five different residues. The species for which 
an interaction was observed in our homology models of the Ig-binding domain -  Fc 
complexes are Guinea pig IgG2 (R315), horse IgG6 (R315), mouse IgGl (N315), pig 
IgG4 (N315), and rabbit IgG (R315). For all these species high levels of binding was 
observed, except for horse IgG6. The only species to show high levels of binding 
(Chapter 3) not in this list is the human Fc model determined by Deisenhofer (1981).
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Table 14 Summary of residues present at position 315 in the IgG models. The affinity of Sbi and SpA 
for the different serum IgGs was determined in Chapter 3. * marks the IgG sequences used in the 
generation of the models. & Human IgG3 shares the high binding residue at position 315 found in the
other human IgG sequences, however it lacks SpA or Sbi binding due to the present of the substitutions 
H435R and F436Y.







Sheep IgGl G Low binding
Cow IgGl G




High bindingPig IgG2b N
Pig IgG4* N






Rabbit IgG* R High binding
Mouse IgG2a S
High bindingMouse IgG2b SMouse IgG3 R
Mouse IgG 1 * N
Guinea Pig IgG2* R High binding
Chicken clone 36* S Low binding
Here, the residue 315 is an aspartate, while in the other human Fc sequences listed in 
Table 14, this residue is an asparagine. As N315 is also found in other IgG species, 
this supports Human IgG being a high binding species based on sequence alone, as 
shown in the binding studies (Chapter 3). It is assumed that the low binding for horse 
serum IgG, in the case of the IgG6 subclass, despite the presence of R 315 is due to the 
presence of a substitution at position 314 (L314R), with the larger arginine side chain 
disrupting the interacting between the IgG and the Ig-binding domain.
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Table 15 Differences in interactions between the CH2 and CH3 domains between the IgG models.
Numbers in superscript refer to squares in Appendix 3.
Species Gained interactions? Lost interactions?
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Figure 41 (a) Summary of interactions observed in Appendix 1 between the IgG CH2 and CH3
domains. The numbered squares refer to the interactions listed in Table 15. Interactions detected in all 
models are marked in black. Changed interaction pattern: marked in red do not correspond to changes 
in sequence; blue corresponds to changes in the CH2 domain; green to changes in the CH3 domain; 
yellow to changes in both domains, (b) Sequence of the IgG models in the regions identified to be 
involved in interacting with the other domain. Conserved residues are highlighted in yellow. Residues 
conserved in all sequences have a black mark under them.
8.1.3.5 Analysis of the interactions at the CH2 and CH3 interface of the IgG Fc 
models
The interactions between the Ch2 and Ch3 domains and information on the loss or 
gain of interactions is shown in Appendix 2.
Analysis o f  the interaction data showed numerous changes in the pattern of 
interactions between the two C h domains in all m odels (listed in Table 15). However
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not all variations in the interactions between the C h 2  and C h3  domains are due to 
changes in side chains. This can occur if a substitution in the sequence causes a change 
in the conformation of the backbone at a different point in the sequence. Table 15a shows all 
interactions between the Ch2 and Ch3 domains, and indicates which interactions are 
the result of residue substitution, and those interactions which are not.
There are unique sequence changes that could be affecting the interactions between 
the two domains. These substitutions observed in the Fc models are shown in Table 
15. The Chicken Fc model contains several interactions that appear to be affected by 
sequence substitutions. These include the gain of interactions at E250-D476; T340- 
P374; E250-R435; and T310-R435, and loss of interactions at T340-R373 and Y252- 
V428. Interaction changes in the other models include residues T339 (Guinea pig 
IgG2 and Mouse IgG l), T340 (Horse IgG4), H436 (Mouse IgG l), and Y376 (Sheep 
IgGl).
8.1.3.6 Homology model of SpAED in complex with multiple IgG molecules
No structure of SpA determined by a structural method exists with more than one Ig- 
binding domain in a single polypeptide chain. We therefore generated our own using 
the SpA structure of the D domain in IDEE, and linking the two identical molecules 
together in O. The sequence of second Ig-binding domain was altered to match that of 
the SpA A domain (the sequence of the model is shown in Figure 42a). The PDB 
structure lOQO (Raju et al 2003) contains the Fc fragment of an IgG in complex with 
a Z domain bound to each polypeptide chain (Figure 35b: the Z domain is the 
artificial SpA Ig-binding domain). The two-domain SpA model was rotated onto each 
of the Z domains and a second copy of lOQO moved onto the other Ig-binding 
domain. The finished structure is shown in Figure 42b. This structure clearly shows 
that it is possible to fit two Fc molecules sandwiched between two SpA molecules in a 
fashion that corresponds to the Hanson and Schumaker model (Figure 35).
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Figure 42(a) Sequence alignment o f the SpA and Sbi tw o domain structures used in the generation o f  
the large IgG com plexes, (b) Predicted structure o f  SpA in com plex with 2 IgG m olecules, (c) 
Predicted structure o f  Sbi in com plex with two IgG m olecules.
al
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8.1.3.7 Homology model of Sbil-2 in complex with multiple IgG molecules
A similar model of Sbi in complex with IgG was also generated. The above complex 
of SpA and IgG was used as a template. Sbi was built onto each of the two SpA 
molecules in the complex. However the region of peptide chain linking the Sbi Ig- 
binding domains together is shorter by four residues than the linker in SpA. Therefore 
the extra residues were removed, and as a consequence the two-bound Fc molecules 
are positioned closer together. The resulting structure (Figure 42c) shows that such a 
complex cannot exist without significant steric clashes between the bound Fc 
molecules.
8.1.4 Discussion
In this chapter we used molecular modelling to examine and predict the amino acids 
and their interactions at the binding interface in complexes between IgG Fc fragments
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and Ig-binding proteins Sbi and SpA. Since this interaction is located near the 
junction between the C h 2  and C h 3  domains, we also included the residues at this 
domain interface and the interactions that may affect binding.
8.1.4.1 Prediction of the IgG Fc residues that are important in the complexes 
with SpA and Sbi
The examination of the interface of the C h 2  and C h3  domains revealed a number of 
interactions that differ between the various IgG Fc models. For example the sheep 
IgGl model is the only one to contain a tyrosine at position 376, all other models have 
an aspartate at this position. The tyrosine side chain is larger and bulkier than the 
aspartate side chain, and probably affects the tilt angle between the Ch domains, 
thereby affecting the distance between the two halves of the SpA binding site.
Two substitutions in the IgG Fc protein correspond to observed binding levels to the 
Ig-binding protein.
The interaction pattern analysis identified residue 315 to be important in the binding 
of IgG to Sbi and SpA. At position 315, an arginine was found in three models 
(Guinea pig, horse IgG6, and rabbit IgG) while an asparagine (pig, mouse and human) 
was found in three others. Serum IgGs from all these animal species were all shown to 
bind strongly to both Sbi and SpA. The serum IgGs that show low binding affinity for 
SpA and Sbi in Chapter 3 (horse, sheep, cow and chicken) have either a glycine or a 
serine at position 315.
Positions 435 and 436 also affect binding to Sbi and SpA. Almost all sequences have 
the residues tyrosine (435) histidine (436). Guinea pig IgG2 has the substitution 
Y435V, however it is not possible to determine from the binding studies on the serum 
IgG whether this substitution affects binding. A clear relationship however could be 
determined for both human IgG3 and chicken IgG. While a model for human IgG3 
was not generated, we showed that this subclass did not bind to either Sbi or SpA. 
Chicken IgG also failed to show any binding to Sbi and SpA. And in its model, the 
substitutions Y435F H436R were shown to affect the interaction pattern. It therefore 
appears that these substitutions can completely eliminate all binding of an IgG to Sbi 
and SpA. This is supported by the work of Jendeberg et al (1997), who showed that
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the introduction of the Y435F H436R substitution into IgG l eliminates its ability to 
bind SpA. It is therefore possible that other IgGs, both mammalian and non­
mammalian, that do not bind SpA (or Sbi) could share this substitution.
The type of residue present at positions 315, 435 and 436 give the only patterns that 
we detected that could be clearly correlated to the binding results already obtained in 
Chapter 3. Other substitutions could also affect binding, but to determine whether any 
of the identified substitutions do in themselves affect binding to Ig-binding proteins, it 
would be necessary to carry out site directed mutagenesis on an IgG molecule.
8.1.4.2 Predictions on the formation of insoluble complexes of Sbi and IgG
Comparisons of the SpA complexes with Fc and Fab fragments (Chapter 2) to the 
sequence of the Sbi Ig-binding domains strongly suggested that Sbi can only bind to 
the Fc portion of an immunoglobulin. This is confirmed by the binding studies 
described in Chapter 3 where the results of the SE experiments showed that Sbi only 
binds to the Fc fragments of digested IgGs. It therefore appears that Fab binding is not 
an important factor in the formation of large complexes as Sbi can form large 
insoluble complexes with only the Fc region of IgGs. SpA however required the Fab 
region to be present for the precipitation of IgG to occur (see Figure 27).
Hanson and Schumaker (1984) proposed a model for the formation of the large 
soluble complexes seen with rabbit serum IgG in the presence of SpA composed of 2 
SpA molecules and 4 IgG molecules. The most likely model for such a binding ratio 
is a complex of four IgG molecules stacked in the same orientation, with SpA 
molecules running up and down each side of the Fc molecules (Figure 35).
We generated a 2-domain model of SpA, by linking adjacent SpA domains together 
based on the crystal structure of IgG with 2 Z-domains bound (Z-domains are the 
artificial protein A domains, Raju et al 2003). This model shows that it is possible to 
fit IgG molecules between the Ig-binding domains of two SpA molecules (Figure 
42b).
We replaced the SpA molecules with Sbi on the 2-domain model we had generated. 
However, unlike SpA, it was not possible to get the Sbi domains far enough apart to
- I l l  -
Figure 43(a) The SpA/IgG complex from Figure 35a with additional Fab regions present (green) on 
IgG Fc molecules, (b) Crosslinking of the SpA/IgG complexes via Fab. (c) Representation of the 
Sbi/IgG complex from Figure 42, showing the clash of the IgG Fc molecules, (d) Possible mechanism 
of cross-linking IgG Fc (yellow, Fab regions removed) with Sbi molecules (blue).
(b)
(c)
prevent overlapping of the IgG side chains on the adjacent IgG faces (Figure 42c and 
Figure 43c) strongly suggesting that Sbi cannot form such complexes, but it could 
form complexes with other arrangements of the subunits.
The only question remaining regarding the SpA-IgG complex is whether this is 
important in the formation of precipitation. This question is important as Hanson, 
Philips, and Schumaker (1984) carried out their experiments with rabbit IgG. Our 
experiments with rabbit serum IgG and SpA showed that this species is unique as it 
was the only example where high molecular weight complexes were formed, but 
remained completely soluble. In addition SpA requires the presence of the Fab region 
of the IgG molecule for precipitation to occur with human IgG, suggesting the SpA 
does not bind rabbit IgG via its Fab regions. (The previous work of Kronvall et al 
(1970) did show precipitation of rabbit sera by SpA, but as their SpA was purified 
from S. aureus cultures, it could have been contaminated with Sbi (both molecules are
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of similar size, and both would bind to an affinity column based on SpA’s affinity for 
IgG). Our SpA and Sbi are both recombinant proteins and should not contain any 
other S. aureus proteins.
Our immunodiffusion results (Chapter 2) suggest that SpA:Fc complexes indeed form 
the structure predicted by Hanson and Schumaker (1984, Figure 35a). This is 
supported by the modelling studies presented here. We predict though that the 
formation of this complex is not sufficient for precipitation to occur. We suggest that 
this complex forms with SpA in the presence of rabbit IgGs, assuming that SpA does 
not bind to the Fab regions of rabbit IgGs. In species such as human or pig, we think 
precipitation is triggered because, although the complex structure predicted here is 
formed between the Fc and SpA, binding also occurs between SpA and the Fab 
regions, cross-linking the stacked complexes, and causing precipitation (see Figure 
43b).
The precipitation of IgG by Sbi could also be the result of crosslinking by IgG 
molecules. Rather than stacking of IgGs, and crosslinking via the Fab region, as we 
predicted to occur for the SpA Fc complexes, we envisage that Sbi can crosslink IgG 
molecules via the Fc region, as shown in Figure 43c&d.
However the individual Sbi Ig-binding domains, Sbi-1 and Sbi-2, can also precipitate 
IgG (see Chapter 3). Analysis of Sbi-1 by size exclusion chromatography and SAXS 
(Chapter 6) shows that this construct has a tendency to oligomerise. Could this have a 
role in the ability of the Sbi-1 and Sbi-2 to precipitate IgG?
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9 Chapter 5
9.1 Sequence comparison of Immunoglobulin binding proteins SpA 
and Sbi isolated from different animal species
9.1.1 Introduction
As we have described in Chapter 3, Sbi and SpA show different binding 
characteristics to the IgGs isolated from serum of different animal species. Sbi for 
instance binds particularly well to human and rodent (rabbit, Guinea pig and mouse) 
serum IgGs, while SpA favours human, pig and Guinea pig serum IgGs and forms 
large soluble complexes with rabbit serum IgG. W e have also found that both SpA 
and Sbi display poor affinity for serum IgGs from species such as goat, horse and 
cow. S. aureus, however , is known to cause infections and disease in these domestic 
animals. A well-known example is mastitis in dairy cattle. This raises questions about 
the role of Ig-binding proteins in infection of these animal species. In the previous 
chapter (Chapter 4), we have examined the molecular origin of the observed 
differences in IgG binding, but in our studies to this point, all binding experiments 
have been carried out with Ig-binding proteins cloned from a strain of S. aureus 
isolated from humans. In addition, the available SpA and Sbi sequences used in the 
analysis in Chapter 4 are obtained from S. aureus strains isolated from human hosts. 
Are the SpA and Sbi genes from strains infecting animal hosts different from the 
strains infecting humans? Could it perhaps be that Sbi and SpA from S. aureus strains 
specifically infecting domestic animal species have acquired specific affinity for IgGs 
from these animals?
In order to address these questions we have sequenced the Sbi and SpA genes from S. 
aureus strains isolated from a number of different species and analysed them for 
sequence changes and the functional implications of these changes. The sequence data 
are also used to assess the evolution of SpA and Sbi genes relative to their sequence 
type and host, and to investigate selective pressures that may act on these genes.
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Primer sequence (5’ - 3’)
1 F o r w a r d  - CGC TTT TTT ACA TAG TTA ACA CTA
R e v e r s e  - GGC TTC TAT CAG GGT TTT CTT TAA
2
Sbi
F o r w a r d  -  















3 F o r w a r d  - GAT GCT GAA AAG AAA GTG GCG
R e v e r s e  - CGA TGT AAG GAT TAT TTA ACA AG
4 F o r w a r d  - TTT TAG TAT TGC AAT ACA TAA TTC G
R e v e r s e  - CTT TGG ATG AAA CCA TTG CG
5
SpA
F o r w a r d  - GGT GAA GCT AAA AAA TAA AAC G
R e v e r s e  - GCT CAC TGA AGG ATC GTC
6 F o r w a r d  - GAA GAA CAA CGT AAC GGC
R e v e r s e  - TGA TAA GAA TCA TCA AAA TGC
9.1.2 Methods
9.1.2.1 PCR amplification of the Sbi and SpA genes
The S. aureus strain collection used for sequencing was provided by Bernard Poutrel, 
INRA, Pathologie Infectieuse et Immunologie.
The PCR mix consisted of 5jll lOx Mg2+ free buffer, 5|il MgCl2 , l |l l  lOmM dNTPs, 
0.2|il Taq polymerase, lji.1 of each of the two primers at lOOpmol, 0.5|il of DNA 
template, and made up to a reaction volume of 50(1.1 with SDW. A heating protocol of 
5 minutes at 95°C followed by 34 cycles of 95°C for 30 seconds, 50°C for 30seconds 
(55°C for primer set 1 and 2), 72°C for 60 seconds, and finished with 10 minutes at 
72°C.
Primers are shown in Table 16. Forward primer 4 and reverse primer 6 were used to 
amplify SpA, while all six SpA primers were used for sequencing it due to the 
repetitive nature of the gene. Sbi was amplified in three fragments with the 6 different 
primers. The presence of the correct fragments from the amplification reaction was 
checked with a 0.8% agarose-ethidium bromide gel, run for 15 to 20 minutes at 200 to
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250 volts. Sbi reactions produce three fragments while the SpA reactions produced a 
single fragment.
The PCR products were purified by adding 50(il of 95% ethanol and 2 |il sodium 
acetate to each sample, and frozen for one hour. The samples were centrifuged at 
3500rpm for one hour to pellet the PCR products. The supernatant was removed by 
inverting the plates onto paper towel and centrifuged at 500rpm for one minute. The 
pellets were washed in 150jxl of 70% ethanol and centrifuged at 3500rpm for 30 
minutes. The supernatant was removed by inverting the plates onto paper towel and 
centrifuged at 750rpm for 1 minute. The samples were left to air dry for 10 minutes. 
The pellets were resuspended in 15pl of distilled water, vortexed for 2 to 3 minutes 
and these samples were spun at lOOOrpm.
9.1.2.2 Sequencing reaction
l |i l  of primer (either forward or reverse) was added to 2(il of the purified PCR 
product and 2pl of Big dye (Version 2.0, Applied Biosystems). Each Sbi PCR product 
reaction required two reaction mixtures (one forward primer, and one reverse primer), 
while the SpA PCR products required six reaction mixtures (three forward primers, 
and three reverse primers). The resulting products were purified as described above, 
except they were not resuspended in water, but were sealed and stored at -20°C until 
they were loaded onto the ABI Prism 377 DNA sequencer.
9.1.2.3 Databases and programs
Seqmen program (DNASTAR, http://www.dnastar.com/web/rl3.php) was used to 
trim and aligne the obtained sequences. Sequences were aligned using the ClustalX 
programme followed by manual inspection of variable sites.
MEGA (Molecular Evolutionary Genetic Analysis) version 2.1 software (Kumar S., 
Tamura K., Jakobsen IB., Nei M., Arizona State University, Tempe, 2001) was used 
to identify variable sites and calculate ds/dn ratios by the modified Nei and Gojobori 
method (Nei and Gojobori 1986) with Jukes Cantor correction. This program was also 
used to translate the sequences for use in protein modelling.
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PAUP program (Phylogenetic Analysis Using Parismony) version 4.0b 10 was used to 
construct Neighbour Joining Trees and maximum likehood trees (Swofford 2000).
Table 17 S. aureus strains from which the Sbi and SpA genes were sequenced. Those strains for which 
a gene was successfully sequenced are indicated (X).
Sbi SpA
8325 human X X
C101 human X X
D2-95.40 Cow X X
D4-121.24 Goat X X
D4-135.45 Cow X X
D 8-452.ll Rabbit X X
D8-496.17 Rabbit X
D8-520.25 Pig X
D8-520.26 Pig X X
D8-522.05 Pig X X
D8-522.13 Poultry X X
D8-522.16 Poultry X
D8-522.18 Poultry X X




D8-610.13 Ewe X X
D8-660.22 Goat X
D9-786.04 Goat X X
D9-786.05 Ewe X X
D 9-786.ll Ewe X
H783 human X X
MRSA252 human X X
MSSA476 human X X
MW 2 human X X
N315 human X X







The Bellerophon server (http://foo.maths.uq.edu.au/~huber/bellerophon.pl) was used 
to identify chimeric sequences (Huber et al 2004).
Datamonkey (www.datamonkey.org) was used to detect any areas of gene sequence 
that are subjected to positive or negative selection (Kosakovsky, Pond and Frost 
2005).
9.1.3 Results
9.1.3.1 Analysis of gene sequences of Sbi and SpA from S. aureus strains 
isolated from goat, cow, horse, rabbit, sheep, human and poultry
Sequences of Sbi were obtained from a collection of 23 strains, while 21 strains gave 
sequences for SpA. 5 additional sequences, available in sequence databases, were 
obtained from human S. aureus strains 8325, MW2, N315, MRSA252, and 
MSSA476. The strains used and the organisms from which they were isolated are 
listed in Table 17. All Sbi nucleotide sequences display conserved gene lengths of 
1311 or 1314 nucleotides, while the SpA sequences showed much greater variability, 
with sequences between 1293 and 1624 nucleotides long.
9.1.3.1.1 Sbi
Sbi sequences show high levels of conservation in both nucleotide and protein 
sequence. A total number of 140 nucleotide changes were observed, giving rise to 60 
amino acid changes and some synonymous (silent) substitutions. Interestingly, most 
of these changes are restricted to Sbi’s C-terminal region. 111 nucleotide changes (47 
amino acid changes) out of 140 in total (60 amino acid changes) were observed in this 
region. The number of substitutions in each region of Sbi are shown in Table 18. For 
the N-terminal part of the protein, the signal sequence of Sbi has a single residue 
change occurring in only one strain (S7X). The first Sbi Ig-binding domain has two 
residue changes, one occurring in a single strain (V48I), and the other (N96K) 
occurring in four of the analysed strains. For the second Sbi Ig-binding domain no 
substitutions were found, while the region 151 to 203 (to be referred to as domain 3) 
contains one substitution in a single strain (D163G). The (32GPI binding region has a 
number of substitutions, most of which occur only once (S218T, N222Q, E223K,
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Table 18 The number of mutations at protein level in each o f the Sbi domains, the length o f each 
domain, and the number o f mutations as a percentage of the domain residues.
Sbi domains No. o f mutations
No. o f residues in
Number of 
mutations as a
domain percentage of the 
domain residues















Proline rich region 2 41 5%
C-terminal 45 132 34%
K224S and Q249H), while others occur in four different strains (V244I, K245Q, and 
E246K). One substitution (E223V) occurs in eleven strains. The polyproline repeat 
has two substitutions: A284V occurs in three strains, while K288Q occurs only once. 
None of the analysed substitutions shown any pattern related to a specific host from 
which the strain was isolated.
9.1.3.1.2 SpA
As with Sbi, the most variable region of the SpA gene is located in the C-terminal 
part, but this variability is restricted to the first portion of the C-terminal region, 
comprised of the proline octa-repeat region. This region is characterised by the 
octapeptide repeat motif XKPGKEDZ (where X is G or N, while Z can be K or N). 
The number of repeats is highly variable, ranging from 4 to 16 in the strains 
sequenced. Other than the octapeptide repeat region, the C-terminal of SpA in the 
strains sequences is completely conserved (see Table 19 for the number of changes in 
each domain). There appears to be no relationship between the number of proline 
repeats and the species from which the S. aureus strain was isolated (Table 21). The 
SpA gene is well conserved in the Ig-binding domains, with between 9 and 23 
nucleotide changes and 2 to 6  amino acid changes in any one domain. However, while 
the sequences of these domains are conserved, not all sequences contain all 5 Ig- 
binding domains. In several SpA sequences one domain was missing; Table 21 shows 
the Ig-binding domains found in each strain as well as the number of octapeptide
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Table 19 The number of mutations at the protein level found in each o f the SpA Ig-binding domains, 
the length of each domain, and the number o f mutations are shown as a percentage o f the domain 
residues.
Sbi domains No. of mutations
No. of residues in 
domain
Number of 
mutations as a 
percentage of the 
domain residues
E 2 57 4%
D 5 61 8%
A 4 58 7%
B 5 58 9%
C 4 58 7%
repeats. Domain D is absent in strains D 8-452.ll, D8-526.03, and D8-610, while 
strains D2-95.40, D8-526.03 and H560 are missing domain B. Strain HI 16 is missing 
part of domain C.
Two strains (HI 16 and D8-610.13) contain a single nucleotide insertion 3’ after the 
Ig-binding domains, resulting in a frameshift and subsequent mis-translation. Whether 
this is a genuine frameshift or a sequencing error needs to be clarified.
9.1.3.2 Synonymous and non-synonmous substitutions
Ds/dn ratios for the sequences were obtained. This is ratio between of the number of 
synonymous (silent) mutations and the number of nonsynonyous (changes in the 
DNA sequence that result changes in the amino acid sequence) mutations. This 
suggested that there is no selection pressure on either the whole genes of Sbi or SpA, 
or any of the domains contained within the genes (except for the P2GPI binding 
domain of Sbi for which a ds/dn ratio of 0.786 was found, as shown in Table 20).
Table 20 Ratio o f synonymous and non-synonymous changes in each gene or domain. A ratio o f less 
than one indicates positive selection, a value if  1 means there is no selection pressure.
Gene o r Domain ds/dn
Sbi
•  B2GPI binding domain
• C-terminal 
SpA







Table 21 The Ig-binding domains of SpA that are present in each strain (indicated with x), and the 
number o f proline octapeptide repeats for each strain. HI 16 (&) contains part o f domain C.
SpA Ig-binding domains present 




C101 Human X X X X X 11
D2-95.40 Cow X X X X 12
D4-121.24 Goat X X X X X 4
D4-135.45 Cow X X X X X 12
D 8 -4 5 2 .ll Rabbit X X X X 10
D8-520.26 Pig X X X X X 10
D8-522.05 Pig X X X X X 12
D8-522.13 Poultry X X X X X 12
D8-522.18 Poultry X X X X 10
D8-526.03 Rabbit X X X X 8
D8-660.22 Goat X X X X X 4
D9-786.04 Goat X X X X X 10
D9-786.05 Ewe X X X X X 10
Etoile cow X X X X X 4
H116 Human X X X X & 7
H783 human X X X X X 13
D8-524.04 Poultry X X X X X 13
D8-526.12 Rabbit X X X X X 12
D8-610.13 Ewe X X X X 16
H560 Human X X X X 12
N315 Human X X X X X 12
MW2 Human X X X X X 10
M SSA476 Human X X X X X 10
MRSA252 Human X X X X X 13
8325 Human X X X X X 13
9.1.3.3 Phylogenetic trees
Phylogenetic trees were generated to show the evolutionary relationship between the 
SpA and Sbi genes in the different strains sequenced. Two types of tree were 
generated, a maximum likehood tree and a neighbour joining tree. Trees generated for 
both the Sbi and SpA genes show that the sequences group to sequence type of the S. 
aureus strain; there is no apparent pattern relationship with the host from which the 
bacterium was isolated. The maximum likehood tree of Sbi is shown in Figure 44 and 
the neighbour joining tree of SpA is shown in , and the sequence types are also 
indicated.
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Figure 44 Maximum likehood tree of Sbi, generated by PAUP program (Swofford 2000).
C101 - human (ST30)
D2-95.40 - cow (ST97) 
D4-121.24 - goat (ST97) 
D4-135.45- cow (ST97) 
Etoile -  cow (ST71) 
D8-520.25 - pig (ST9) 
D8-520.26 - pig (ST9) 
D8-660.22 - goat 
H 783-hum an (ST15)
| -  D8-452.11 - rabbit (ST121)
D8-542.04 - ewe (SLV133)
D8-610.13 - ewe (SLV133)
D9-786.11 - ewe (ST 121)
D9-786.04 - goat (SLV133)
D8-496.17 -rabbit (ST407) 
D8-522.18 - poultry (ST407)
D8-526.12-rabbit (ST121)
83?S - human tSTftt
D8-522.13 - poultry
D8-522.16 - poultry (ST221/SLV5) 
  D9-786.05 - ewe
N315 - human (ST5)
D8-534.30 -  cow (ST573) 
MW2- human (ST1) 
MSSA476 - human (ST1)
D8-660.22 - goat
D8-526.16 - pig (ST30)
MRSA252 -  human (ST36) 
—  0.005 substitutions/site
9.1.3.4 Functional implications of the amino acid substitutions in the Ig-binding 
regions of the SpA and Sbi genes
Consensus sequences were generated for each of the SpA Ig-binding domains, and 
used to generate an alignment of the domains. This shows that there are amino acid 
substitutions at 15 positions in these domains out of 58 residues. The alignments are 
shown in Figure 46. Also marked are the positions of the three helices as they occur in 
the NMR structure of SpA domain B (PDB code: 1BDD). This alignment indicates 
that few of the changes found occur in the first two helices in the domain.
- 1 2 2 -
Figure 45 Neighbour joining tree of SpA, generated by PAUP program (Swofford 2000).
0 9 - 7 8 6 . 0 5  e w e
8 3 2 5  • h u m a n  ( S T 8 )
0 8 - 5 2 6  12 - rabb it  ( S T  1 2 1 )  
  N 3 1 5  - h u m a n  ( S T 5 )
0 8 - 5 2 2  .13 - p o u lt ry
---------------------------  H 7 8 3  - h u m a n  ( S T 1 5 )
.  M S S A 4 7 6  - h u m a n  ( S T 1 )
L  M W 2  - h u m a n  ( S T 1 )
D 4 -1 3 5  45 - cow ( S T 9 7 )
D2 -9  5.40 - cow ( S T 9 7 )
D 8 - 5 2 2 . 0 5  - pig ( S T 9 7 )
0 8 - 6 6 0 . 2 2  - g oa t
0 8 - 5 2 0  .26 pig ( S T 9 )
H 116 - h u m a n  ( S T 9 )
H 5 6 0  - h u m a n  ( S T 1 2 1 )
|------- 0 8 - 4 5 2  .11 - rabbit  ( S T  1 2 1 )
Id 8 - 5 2 6 . 0 3  - ra b b it  ( S T  1 2 1 )
D 8 - 5 2 2  18 - poul try ( S T 4 0 7 )
D 8 - 5 2 4 . 0 4  - po u ltr y
 D 8 - 6 1 0  .13 - e w e  ( S L V 1 3 3 )
D 9 - 7 8 6  05 - e w e  
.  M R S A 2 5 2  - h u m a n  ( S T 3 6 )
C 1 0 1  - h u m a n  ( S T 3 0 )
D 4 -1 2  1 . 2 4  - g o a t  ( S T 7 1 )
Etoi le - cow ( S T 7 1 )
Those that do lie in this region, occur either in the loop regions or at the ends of the a- 
helices, substitutions N11H, M12L (both domain A) and T16N (domain C) are both 
predicted to be part of the loop region between helices 1 and 2 (see Figure 46) while 
E17D (domain C) and E18A (domain D) occur at the N-terminus of helix 2. More 
importantly, only one change occurs in the residues identified to be involved in
a l  a2 a3
E A A . . . . O H D E A Q G N A F V E  l
3  2 S S S 3 3
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D P  5 0 s  a  H l  L A E B J  K l  H J  8  O
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Figure 46 Alignment of SpA Ig-binding domains with the substitutions that occur in the different 
strains highlighted. The positions of the helices are marked.
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Figure 47 The sequence of Sbi with the substitutions at each position shown with the number of strains 
in which that that substitution occurs.
Fc-binding (as identified by Gouda et al 1998); this is in the A domain at residue 
N 11H, and this substitution results in the presence of an histidine which occurs in 
domains B and C at this position. The alignment shows that the third helix is much 
more variable in its sequence. As a number of these changes occur in the residues 
involved in the binding of Fab (Meininger et al 2000), this could imply that they are
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perhaps important in determining the Fab Vh chain specificity in different host 
species.
Compared to SpA, the N-terminal region of the Sbi sequences is much more 
conserved at the protein level. There are only 14 changes in the first 304 residues 
(including the signal peptide), none of these changes occur in more than 4 strains 
(except at residue 223). The C-terminal region, in contrast, is much more variable. In 
the region from residues 305 to 437, there are 45 changes, some of which are 
observed in over 10 different strains. A portion of these changes are clustered (see 
Figure 47), perhaps indicating the presence of loop regions in the protein’s structure?
9.1.4 Discussion
Analysis has shown differences in the binding of Sbi and SpA to serum IgGs from 
different species. The analysis of the sequences of the IgGs involved indicates that 
slight differences in these regions could play a role in the binding of IgG to its ligand. 
All studies, however, were carried out using SpA and Sbi genes cloned from S. aureus 
strains isolated from humans. It could therefore be that strains residing in other 
animals differ in the sequence of their Ig-binding proteins in order to improve the 
ability of the bacteria to specifically bind the host’s immune proteins.
Through the sequencing of the Ig-binding proteins SpA and Sbi from S. aureus strains 
isolated in different animals, the variation in sequence of these genes was examined. 
The results show that the variation in the Ig-binding regions in terms of substitutions 
at the genetic level and substitutions that appear in the protein are marginal. Those 
substitutions that do occur cannot easily explain the variation observed in the binding 
levels of IgG, especially in the binding of the Fc fragment and how it is overcome in 
different species through changes in the sequence of the Ig-binding proteins to 
produce higher affinity for the host’s serum IgGs.
The variation observed in SpA cannot fully explain the variation in IgG binding via 
the Fc region. Of those residues in SpA identified to be involved in binding Fc by 
NMR (Gouda et al 1998), only the residue N i l  is substituted in any of the SpA Ig- 
binding domains. This substitution is at a position that shows variation between the
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SpA domains (Figure 46). As all SpA domains bind IgG via its Fc domain (Jansson, 
Uhlen, Nygren 1998), this change is unlikely to greatly affect its Fc binding ability.
What is of possible interest is the variation that does occur in SpA’s Fab-binding 
sequences. Most of the variation observed in the Ig-binding domains is in the protein 
sequence for the third helix (Figure 46). From structural analysis, it is known that 
helices 2 and 3 are responsible for Fab binding (Graille et al 2000, Meininger et al 
2000). As there is some variation in this region, it is possible that it does have some 
effect on Fab binding, however some of these changes normally occur in the other 
domains at the corresponding positions. It is therefore difficult to know exactly what, 
if any, effect these changes will have on functionality without assessing the effects of 
the substitutions in direct binding studies.
The only other region in SpA which showed variation was the number of proline 
repeats in the octapeptide repeat region. This region of SpA has been implicated in 
cell-wall binding (Zhang et al 2000) and has been suggested as a marker for 
phenotyping S. aureus strains (Koreen et al 2004), however how the variation of the 
number of repeats affects the cell-wall binding is unknown. The C-terminal region of 
SpA after the octapeptide repeat is conserved in all strains sequenced.
Sbi is generally much more conserved, with little variation in sequence in most of the 
protein (Figure 47). However, like SpA, Sbi also shows variation in the C-terminal 
region. The first 36 residues after the polyproline region, like the rest of the protein, 
are highly conserved. This region contains a large number of tyrosines. As mentioned 
before, tyrosines are known to be sites of phosphorylation (Zhang et al 2000), and this 
region has been suggested to play a role in regulating the expression of the protein.
It is the most C-terminal part of the protein that shows the most variability, in the last 
105 residues of the protein, there are 47 amino acids substitutions. However this 
variability is not spread over the entire sequence, it tends to cluster into regions. One 
hypothesis that can explain this clustering is the presence of loop regions in the 
proteins’ tertiary structure. One of these regions of high variability is near the end of 
the polypeptide (Figure 47), a region that is often flexible in proteins.
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The sequence alignments of SpA and Sbi (Chapter 2) showed some homology in the 
N-terminal region of Sbi up to the polyproline repeat region. The highest level of 
sequence similarity is found in the Ig-binding domains, but in both the f^GPl -binding 
region and the region flanked by the ffeGPl -binding sequence and the second Ig- 
binding domain (domain 3) we have also found similarity with SpA (Figure 12). The 
main difference in the alignment is that SpA has five N-terminal Ig-binding domains, 
while Sbi can be divided into four N-terminal domains. The similarities in sequence 
of the SpA and Sbi Ig-binding domains suggest that these could have evolved from a 
gene duplication event. W e have found in this chapter that several of the SpA genes 
only have four N-terminal domains. Is it possible that SpA and Sbi have evolved from 
a common ancestor gene, that all the domains in Sbi could once have resembled the 
sequence of the SpA domains more closely, and that in some SpA strains, they have 
gained an extra domain, or the Sbi ancestor gene and some SpA genes have lost a 
domain. If the two genes have evolved from a common ancestor, it is likely the 
structure in this region is conserved. We have been able to predict the structure of the 
Sbi Ig-binding domains with a high degree of confidence, but not the other domains 




10.1 Analysis of the Sbi domain structure by small-angle X-ray 
scattering
10.1.1 Introduction
There is evidence to suggest that the Sbi and SpA genes are related. The N-terminal 
immunoglobulin-binding domains of both show high levels of sequence similarity 
(chapter 1) and there are similarities in sequence for the region including the (32GP1- 
binding domain of Sbi with SpA’s Ig-binding domains. Sequence analysis of the SpA 
gene revealed that in several strains this protein consists of only 4 Ig-binding domains 
(chapter 5). We have proposed (chapter 2) that Sbi consists of 4 domains, the 2 Ig- 
binding domains, the (32GP1 -binding domain, and a putative third domain. Since this 
region of the Sbi gene is also of the same length as the 4 SpA Ig-binding domains, 
could it be that the structure of this portion of the two proteins is conserved as well? 
Our structural prediction for the N-terminal domains of Sbi is that all 4 domains adopt 
a three-helix bundle fold, as is predicted for SpA. This prediction is based on the three 
domains of SpA, for which three-dimensional structures have been determined by 
both NMR and X-ray crystallography (SpA domains B, D, and E; SCOP database 
http://scop.mrc-lmb.cam.ac.Uk/scop/data/scop.b.b.bd.b.b.A.html, Murzin e ta l  1995).
Although no structure exists of multiple Ig-binding domain constructs of SpA, it is 
assumed that the molecule is composed of an elongated chain of four (or five) three- 
helix bundles linked together (chapter 4). To investigate whether Sbi adopts a similar 
domain arrangement we attempted to determine the three-dimensional structure of 
Sbi’s N-terminal region comprising the Ig-binding domains and the (S2GP1 -binding 
domain. Incessant attempts to crystallise Sbi-e and Sbi-S failed, likely due to the 
multi-domain structure and flexibility of these polypeptides. Structural analysis of 
these constructs by NMR proved unsuccessful as the large Sbi-e construct is close to 
the upper size-limit for this technique. The tendency of the smaller Sbi constructs to 
form multimers at high protein concentrations was also made them unsuitable for this 




Figure 48 shows X-ray solution 
scattering curves for 25 different 
proteins. The scattering intensities 
are plotted on a log scale, the 
upper axis displays the spatial 
resolution (A=27t/s). At low 
resolution angles of 2 to 3nm, the 
rapidly decaying curves are 
determined by the particle shape.
At medium resolution (2 to 
0.5nm), the curve is defined by 
the overall fold of the protein, 
while at low resolution (above 
0.5nm) the curves are all simaler, 
and defined by the molecule’s 
atomic structure. SAXS is only 
suitable for determining 
information on molecule shape, 
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This technique, like X-ray crystallography is suitable for proteins with a high 
molecular weight, and like NMR, it is a solution technique and does not require the 
production of crystals. SAXS has been shown to be well suited to studying flexible, 
low compactness or even unfolded macromolecules in solution. In SAXS, a solution 
of macromolecules is exposed to X-rays, and the scattered intensity is measured. The 
random positions and orientations of particles result in an isotopic intensity 
distribution, which, for monodisperse solutions of noninteracting particles, is 
proportional to the scattering from a single particle over all orientations. At low 
resolution, the scattering curves of proteins with different structures are very different, 
determined by the shape of the particle. As the resolution increases, the curves 
become more similar. SAXS thus provides information on the shape, and quaternary 
and tertiary structure, but it is not suitable for the analysis of atomic detail (Svergun 
and Koch 2002). Refer to Figure 48 for an example of SAXS scattering curves.
Our aim with this technique is to gain such structure information that we can then fit 
the Sbi models to, to improve the reliability of these.
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10.1.2 Methods
Expression of the Sbi constructs Sbi-e, Sbi-S and Sbi-1 was described in Chapter 3, as 
was the purification of Sbi-e and Sbi-1. Methods for SE chromatography were also 
described in Chapter 3.
10.1.2.1 Affinity purification of Sbi-S
Sbi-S was purified by affinity chromatography with a chelating HiTrap column 
(Amersham Biosciences) connected to the AKTA purification system. The column 
was loaded according to the column instructions with nickel sulphate and equilibrated 
in binding buffer (lOmM Tris-HCl pH8, 300mM NaCl, 0.005% Tween 20). The 
sample was loaded with the soluble protein fraction and washed. The protein was 
eluted with elution buffer (lOmM Tris-HCl pH8, 300mM NaCl, 0.005% Tween 20, 
1M Imidazole) on a 0% to 15% gradient over 60min at a flow rate of 0.5ml/min. This 
gave pure protein (>90%), eluted at about 15% imidazole. The imidazole was 
removed using a PD-10 column (Amersham Biosciences) to leave the proteins in 
binding buffer.
10.1.2.2 Trypsin digests
Sbi-e was prepared in a solution of 2mg/ml as determined by UV absorption (see 
below) in lOmM Tris-HCl pH7 buffer. l |il  of prepared trypsin was added (lOmg/ml 
in PBS prepared from a dry protein power -  Sigma). The reaction was carried out on 
ice and samples removed to determine the apparent level of degradation at different 
time points. The digestions were analysed by electron spray mass spectrometry by 
Andrew Gill at the Institute for Animal Health, Compton.
10.1.2.3 TEV digest
A 2ml fraction of purified protein was collected from the affinity column elute for 
both Sbi-S and Sbi-1. To this 40U of TEV protease (Invitrogen) was added, and the 
reaction was allowed to occur overnight at room temperature. The digested protein 
was analysed by light scattering to examine protein molecule size.
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10.1.2.4 Dynamic light scattering experiments
Dynamic light scattering measures fluctuations about the average intensity of light 
scattered by a protein solution of defined concentration in excess of that scattered by 
background sources. The scattered intensity fluctuations are primarily due to the 
random diffusive motion of the protein molecules into and out of a focused laser 
beam. (Wilson 2003) The size of particles in solution can be measured. This is 
because globular proteins are assumed to be spherical in shape. Therefore the Stokes- 
Einstein relation can be used to estimate the apparent hydrodynamic radius of the 
protein. From this, the apparent size of the protein can be estimated (Wilson 2003).
In light scattering and SAXS, it is important to have a monodisperse protein solution, 
this occurs when all molecules in a system are of a uniform molecular weight 
(http://composite.about.eom/library/glossary/m/bldef-m3514.htm). Polydispersity 
occurs when the size of molecules in a system is not uniform 
(http://composite.about.eom/library/glossary/p/bldef-p4086.htm).
The Sbi constructs were measured by light scattering immediately after purification to 
determine the effect of different components in the buffers, and to determine whether 
the oligomerisation of the Sbi proteins had been reduced. Proteins Sbi-e, Sbi-S, Sbi-1 
and Sbi-2 were analysed in the purification buffer eluted from the column (containing 
Imidazole), and after a PD-10 de-salting step to exchange and remove certain 
components of the buffer (i.e. Imidazole). The samples analysed did not have their 
concentration determined. 0.5M EDTA was added to some samples to absorb any 
nickel released from the chelating column. Sbi-S and Sbi-1 were also subjected to 
TEV digestion, to remove the His-tag. The dynamic light scattering apparatus 
machine used was the Malvern Zetasizer (Nano S, Malvern Instruments, Malvern, 
UK), and all experiments carried out measured the sizes of the particles present and 
the estimated protein size in kDa by the crystallography screen function.
Of the data obtained for the Sbi constructs by this method, the estimated size of the 
molecule is larger in all cases than the theoretical size of the constructs. This can be 
partly explained by errors caused by the assumptions about the spherical shape of the 
proteins, as we know Sbi-e in particular is expected to be an elongated molecule. This 
can lead to errors in the results of the measurements of the molecules in solution,
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however as all techniques show variability and differences to theoretical molecular 
sizes, it suggests that the errors that occur in light scattering data is of limited 
importance in this case.
10.1.2.5 Preparation of samples for small-angle X-ray scattering (SAXS)
Samples for SAXS were in lOmM Tris-HCl pH8, 300mM NaCl, 0.005% Tween 20, 
and stored at the concentration they were in after buffer exchange. Samples were only 
concentrated shortly prior to the SAXS experiment to reduce aggregation and 
precipitation. Protein concentrations were determined by UV absorption. The 
extinction coefficients at A 2 8 0nm are as follows: Sbi-e 20400 (Abs 0.1% (=1 g/1) 0.6), 
Sbi-S 18910 (Abs 0.1% (=1 g/1) 1.031), Sbi-1 10430 (Abs 0.1% (=1 g/1) 1.095).
10.1.2.6 SAXS experiments and data analysis
Synchrotron radiation X-ray scattering data was collected on the X33 beam line 
(Boulin et al., 1988; Koch and Bordas, 1983) at the Hamburg EMBL Outstation (on 
the DORIS III storage ring, at DESY). Solutions of Sbi-e were measured on a 
MAR345 image plate detector at protein concentrations of 2.8, 8.4 and 16.7 mg/ml 
and sample-detector distance of 2.4m and wavelength X = 1.5A, covering the 
momentum transfer range 0.013 < s  < 0.45 A ' 1 (s = 4 k  sin(B)/X where 2 9  is the 
scattering angle). To check for radiation damage, two 2-minute exposures were 
compared; no radiation effects were observed. The data was averaged after 
normalization to the intensity of the incident beam, corrected for the detector 
response, and the scattering of the buffer was subtracted. The difference data was 
extrapolated to zero solute concentration following standard procedures, and, for the 
gas detector, the curves measured in different angular intervals were merged. All data 
manipulations were performed using the program package PRIMUS (Konarev et a l ,  
2003).
The forward scattering 1(0) and the radius of gyration Rg were evaluated using the 
Guinier approximation (Guinier, 1939) assuming that at very small angles (s < 1.3/Rg) 
the intensity is represented as I(s) = 1(0) exp(-(sRg)2/3). These parameters were also 
computed from the entire scattering patterns using the indirect transform package 
GNOM (Svergun, 1992), which also provided the maximum particle dimension Dmax.
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The molecular mass (MW) of the solute was evaluated by comparison of the forward 
scattering with that from reference solutions of bovine serum albumin (MW = 6 6  
kDa). The excluded volume of the hydrated particle (the Porod volume) was 
computed using the equation (Porod, 1982):
eo
V  = 2k 2I(Q)I  Js2/ exp( i)&  (i)
0
Prior to this analysis an appropriate constant was subtracted from each data point to 
force the sA decay of the intensity at higher angles following the Porod’s law (Porod, 
1982) for homogeneous particles. This “shape scattering” curve was further used to 
generate low resolution ab initio models of Sbi-e using the program DAMMIN, 
(Svergun, 1999) which represents the protein by an assembly of densely packed 
beads. Simulated annealing was employed to build a compact interconnected 
configuration of beads inside a sphere with the diameter Dmax that fits the 
experimental data / exp(s) minimizing the discrepancy (x2  in SAXS indicates how well 
the scattering data fits the structure solution, a figure for x2  of around 1 indicates a 
correct solution):
x2=— TN - \ y
where N  is the number of experimental points, c is a scaling factor and ICaiAsj) and 
o(Sj) are the calculated intensity and the experimental error at the momentum transfer 
Sj, respectively.
The refinement of the Sbi structure was performed with the program BUNCH 
(Petoukhov and Svergun, 2005). This algorithm uses three-dimensional structures or 
homology models for the folded domains, and adds interdomain linkers and terminal 
loops represented as dummy residues chains (Petoukhov et al., 2002). A simulated 
annealing algorithm implemented in BUNCH optimises an energy function containing 
the discrepancy (2) to the experimental SAXS profile and force field terms to avoid 
steric clashes and ensure native-like conformations for the added chains.
The possibility of interdomain dynamics in Sbi-e was further explored using a new 
program based on a genetic algorithm. The experimental scattering profile is fitted by 
a combination of scattering patterns computed from an ensemble of conformations
(2)
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adopted by potentially flexible protein in solution. To generate a representative 
ensemble, 5,000 conformers of Sbi-e were constructed using the program BUNCH 
without using the experimental data in the energy term. In addition, 150 
conformations were generated using the initial part of the SAXS profile in order to 
have certain population of structures with the Rg close to the experimental one. For 
each of the 5,150 conformers the theoretical scattering curve was calculated with the 
program CRYSOL (Svergun et al., 1995). The genetic algorithm aims to select an 
ensemble of K models such the scattering pattern from their equimolar mixture that 
best fits the experimental data (Bemado, Petoukhov, Mylonas, Blackledge & Svergun, 
in preparation). The program was run for different K values to identify the minimum 
number of conformers in the sub-population still compatible with the experimental 
data. It was found that the runs with K>5 yielded a good agreement with experimental 
SAXS curve.
10.1.2.7 Sbi homology modelling
In Chapter 2, homology models were generated of both the Ig-binding domains and 
the P2GP1 -binding domain (see Figure 13 and Figure 15). The Ig-binding region of 
Sbi (composed of two three-helix bundles) and the P2GP1-binding domain (also
Table 22 Sizes o f the Sbi constructs, determined by SE chromatography.
















composed of two three-helix bundles) were linked together in O. This generated a 
model of the N-terminal region of the Sbi protein. This could be used in the 
refinement of the SAXS data.
10.1.3 Results
10.1.3.1 Size exclusion analysis of Sbi and SpA
Three Sbi constructs were analysed by SE chromatography: Sbi-e, Sbi-S, and Sbi-1, 
in addition to the commercial SpA. Theoretical masses for each are 30.9kDa (Sbi-e), 
18.3kDa (Sbi-S), 9.7kDa (Sbi-1) and 46.7kDa (SpA). However the measured size of 
each protein in the SE chromatography analysis did not agree with these theoretical 
sizes. In solution, all proteins constructs behaved as particles with larger masses 
(Table 22), suggesting that all exist as multimers in solution. The SE chromatography 
of Sbi-e shows the different profiles obtained with different protein concentrations, 
suggesting that the size of the Sbi-e particle increases as a function of the protein 
concentration (see Figure 49).
3 5 0  t—
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Figure 49 SE chromatography profiles of Sbi-e, with undetermined start concentrations for Sbi-e
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Table 23 Sizes o f Sbi constructs, determined by Light Scattering measurements, including the
polydispersity index (PSI).
Sbi construct Diam. (nm) PSI Est. MW
Sbi-e 8.63 0.592 351.5
Sbi-S 5.67 0.651 48.2 TEV digested de-salted&
Sbi-1 3.68 0.302 18.4 TEV digested
Sbi-2 4.32 0.491 2 1 . 1 TEV digested de-salted&
10.1.3.2 Dynamic light scattering analysis of Sbi
The dynamic light scattering properties of the Sbi constructs were analysed by 
determining which was the most populous peak in the scattering data, using intensity 
polydispersity (PSM) measurements. The peak nearest to the most populous peak in 
size in the crystallisation screen analysis (volume PSM) was than taken to give an 
estimated size of the component of the peak. This data is shown in Table 23. 
Comparisons of the estimated MW to the theoretical MW of the constructs show that 
all the protein sizes are much greater than would be expected for the Sbi protein 
monomers. Sbi-S and Sbi-1 (TEV digested) appear to exist as a dimer, while Sbi-2 
behaves as a tetramer. Sbi-e and Sbi-1 (EDTA present) in solution form multimers of 
approximately ten times the expected size. As all samples were filtered prior to the 
experiment, it is unlikely to be due to aggregation or dust in the samples.
10.1.3.3 Molecular size determined by small-angle X-ray scattering
Small-angle scattering was used to measure the size and effective molecular weight of 









Sbi-1 0 . 6 5 16 90 9.7
Sbi-S
2.4 5.6 17 1 0 0
18.3
0.28 3.0 17 28
Sbi-e 8.4 4.5 15 36 30.9
Table 24 The sizes o f Sbi constructs determined by SAXS. Protein concentrations were determined at 
280nm (extinction coefficients are given in methods). Rg is the radius o f gyration, and Dmax is the 
maximum paritcule diameter
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Figure 50 (a) Experimental scattering (a )
curve of Sbi-e (open circles) and the 
scattering from the model obtained with 
DAMMIN (solid line) and BUNCH 
(dashed line). The plot displays the 
logarithm of the scattering intensity as a 
function of momentum transfer s = 4n 
sin(Q)A where 0 is the scattering angle 
and X = 0.15 nm is the X-ray wavelength.
(b) Two different orientations of the 
structural models of Sbi-e. Beads show 
the ab initio shape obtained by DAMMIN, 
which is superposed to the trace 
representation of a BUNCH structural (b)
model (in blue). The bottom view is 
rotated by 90 degrees counterclockwise 




Sbi-S was measured at two concentrations; at the lower concentration, Sbi-S appears 
to dimerise while at the higher concentration it appears to form a pentamer. Sbi-1 was 
measured at a single concentration, and its complex appears to contain nine 
monomers.
10.1.3.4 SAXS analysis of Sbi-e
The X-ray scattering curve in Figure 50a yields a MW estimate of 33+3kDa indicating 
that the protein is monomeric in solution. The experimental radius of gyration Rg and 
the maximum size, Dmx, were 46+1A and 160+10A, respectively. These results 
indicate that Sbi is a highly elongated molecule in solution. The low resolution shape 
of Sbi reconstructed ab initio using the bead modelling program DAMMIN (Svergun, 
1999) neatly fits the experimental data with x=l-2 (Figure 50a). A typical
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F igure 51 (a) Experimental scattering curve of Sbi-e (open dots) and reconstructed model
the scattering obtained using the genetic algorithm protocol (solid displayed in Figure 50b is 
line), (b) Backbone trace representation o f the five conformers 
ensem ble obtained with the genetic algorithm.




indeed very elongated 
(155 A diameter) and 
depicts four bead domains 
connected by thinner 
loops. This appearance is 
compatible with four 
structural domains of Sbi 
joined by flexible linkers. 
The high resolution and 
homology models of the 
N-terminal domains of Sbi 
were employed to further 
model the structure of Sbi 
using the program 
BUNCH (Petoukhov and 
Svergun, 2005) as 
described in the methods. 
The model was 
represented using the 
folded domains connected 
by dummy residue linkers, 
and additional chains were 
introduced to model the N 
and C-terminal tails. 
Different runs of BUNCH 
yielded reproducible 
results displaying similar 
domain organizations and 
fitting the experimental 
data with x=1.7 (Figure 
50a). A typical BUNCH 
result superimposed with
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Figure 52 (a) Density obtained from SAXS density and (b) with the homology model fitted.
the ab initio shape in Figure 50b reveals a very good overlap between the two 
independently derived models from different programs. The overall shape of Sbi is 
rather extended but somewhat bent so that the C-terminal domains of the BUNCH 
model display some side contacts. Interestingly, the long N-terminal loop of Sbi, 
although extended, appears to be folded back and becomes not completely accessible 
to the solvent (this feature is typical for BUNCH reconstructions).
Multidomain proteins often reveal interdomain dynamics depending on the length of 
the linkers connecting the folded entities (Yuan et al., 2002). To account for the 
possible dynamic effects, an alternative interpretation was used allowing for the data 
fitting by a mixture of conformers. Using the genetic algorithm as described in the 
methods, it was found that selection of a five conformer ensemble from a 
representative set of randomly generated structures was sufficient to fit the 
experimental data. A typical set of structures provided by the genetic algorithm
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Figure 53 The 4-domain density structure of Sbi (a) by homology modelling and (b) the most probable 
structure predicted by SAXS. (b) contains longer N- and C-terminal peptides as DAMMIN is able to 
predict the structure of these long flexible peptides, such as the His-tag of Sbi-e, which is not possible 
to do by homology modelling without a suitable template to build the structure on. (a) therefore lacks 
the N-terminal His-tag and has a truncated C-terminal.
displayed in Figure 51a yields the fit with x=2-0. Interestingly, the individual structures 
in the set appear rather similar, suggesting that only limited conformational space is 
sampled by Sbi in solution. Simultaneously, the results point to a larger conformational 
freedom in the C-terminal domain of Sbi compared with the rest of the protein. The 
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Figure 54 The Verify 3D plots for the structures in Figure 53. The regions for the Sbi-e models in the 
upper portion of the plot suggest that the N-terminal regions (excluding the His-tagged modelled in the 
SAXS structure) are correctly modelled. The C-terminal region is less accurate; with the Verify 3D 
result suggesting the model produced by SAXS is more accurate in this region.
with the ab initio and BUNCH reconstruction. Moreover, the N-terminal loops in the 
genetic algorithm models displays a folded back conformation, as already observed in 
the BUNCH solution (Figure 50b).
10.1.3.5 A model for the domain organisation of Sbi
Using the ab initio density model derived from the SAXS data, we manually fitted the 
Sbi models generated in Chapter 2 to construct a three-dimensional model of Sbi’s 
predicted N-terminal region. The three-helix bundle motif units fit very well with the 
observed density of the first three domains of Sbi-e, suggesting that all four domains 
possibly adopt a similar structural fold. This homology model is shown in Figure 52.
The homology model of Sbi was compared to the SAXS structure. The homology 
model and SAXS structure are both shown in Figure 53. The Verify 3D plots for the 
two structures are overlaid in Figure 54; this shows the SAXS structure appears to be 
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Figure 55 Ramachandran plots for the structures shown in Figure 53 determined by Procheck, (a) The 
homology model and (b) the model based on the SAXS structure
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Table 25 Trypsin cleavage sites in the Sbi protein Sbi-e. Residues l*and 263* are the N- and C- 
terminal residues in the molecule.
Sbi trypsin digestion sites Point in Sbi-e sequence
1 * N-terminal residue
4 His-tag
37 Prior to helix 1
79 Between helix 1 and helix 2
97 Between 1st and 2nd Ig-binding domains
149 End of 2nd Ig-binding domain
186 (52GP1 binding domain
191 (32GP1 binding domain
2 0 0 P2GP1 binding domain
204 (32GP1 binding domain
263* C-terminal residue
in the Ramachandran plots (Figure 55) shows that the SAXS structure contains more 
residues in disallowed regions than the homology model.
10.1.3.6 Mapping of trypsin sites on Sbi-e
Digestion of protein molecules by trypsin results in the cleavage of the peptide chain 
in regions not folded into tertiary structures, i.e. between domains, as trypsin can 
generally not cleave at its cleavage site if the protein backbone is folded into a 
globular structure. Therefore trypsin digestion of a protein can be used to reveal the 
domain boundaries of any domains in the protein’s structure.
A trypsin digestion was carried out on the Sbi-e protein; the determined cleavage sites 
are shown in Table 25. When the cleavage sites were mapped onto both the Sbi 
models (Figure 56) the results generally support the proposed domain models. The 
first two sites detected do not appear on the homology model as it was not possible to 
model the N-terminal tag of Sbi-e (Y4 and K37), however as the N-terminal of the 
SAXS model is mainly unstructured, these two trypsin digestion sites do not cleave in 
a region that is expected to be structured. The first cleavage site mapped onto both Sbi 
structures (E79, Figure 56) is located between helices 2 and 3. The next two cleavage 
sites (R97 and R149) are located between domains 1 and 2, and domain 2 and 3
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Figure 56 The secondary structure of the structural models shown in Figure 53 as determined by 
Procheck (Laskowski et al 1993), with the experimentally determined trypsin digestion sites marked 
(red arrow heads), (a) The Homology model and (b) the SAXS structure
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respectively. This suggests that the predicted domain and helix boundaries in this part 
of the molecule are in good agreement, as trypsin is expected to cleave at sites that are 
accessible and not part of the core three-dimensional structure. The remaining 
restriction sites detected are R186, R191, K200 and R204. R191 cleaves the end of N- 
terminal helix 9 in both the homology model and SAXS structure, while K200 in the 
homology model cleaves the C-terminal end of this helix (see Figure 56 for the 
trypsin digestion sites on the secondary structure of the two models).
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10.1.4 Discussion
SAXS revealed the N-terminal region of Sbi (Sbi-e) to be an elongated molecule 
composed of four domains all of similar size. For the first time, this provides insights 
into the three-dimensional domain arrangement of a bacterial immunoglobulin 
binding protein. The similarity with the domain structure of SpA may suggest that this 
region of the Sbi protein is composed of 4 three-helix bundles as predicted in Chapter 
2. This would also support the prediction in Chapter 5 that Sbi and SpA have an 
evolutionary relationship, and that the j32GPl -binding domain and domain 3 of Sbi 
share an ancestral domain or gene with the Ig-binding domains of Sbi and SpA. 
Possible mechanisms by which the evolution of these two proteins occurred is 
discussed further in Chapter 7.
The sizes of the Sbi constructs were determined by three different methods. There are 
three sets of SE chromatography data for Sbi-e. The three elution profiles are very 
different (Figure 49), and suggest that an increase in the protein concentration results 
in an increase in the size of the Sbi-e particles, indicating the formation of large 
complexes. There are also two data sets for Sbi-S from the SAXS analysis; this also 
shows an increase in particle size with an increase in protein concentration (Table 24). 
This suggests that the Sbi constructs have the tendency to form large complexes 
composed of the Sbi monomers. This tendency could explain the ability of Sbi-1 to 
form insoluble complexes with Guinea pig serum IgG.
The SE chromatography results were carried out with the aim of increasing the purity 
of Sbi-e, while the DLS results were to analyse protein samples of Sbi-1, Sbi-2 and 
Sbi-S under different conditions in an attempt to reducing aggregation of the protein 
particle sizes, and improve the quality of the protein for the SAXS experiments and 
the possibility of NMR experiments. These experiments did show that the size of the 
protein particles does appear to be affected by the protein concentration, while the 
particle sizes for Sbi-1, Sbi-2 and Sbi-S also appear to be influenced by the presence 
or absence of the N-terminal His-tag. This is an area where further work is needed to 
gain a better understanding of the relationships between protein concentration, the 
presence of the His-tag on the protein and the particle size for the different Sbi 
constructs.
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Trypsin digestion analysis of the Sbi-e construct revealed the presence of 9 cleavage 
sites (Table 25). Trypsin cleaves preferentially at lysine and arginine residues on 
exposed peptide chains (http://www.expasy.ch/tools/peptidecutter/peptidecutter 
_special_enzymes.html). Mapping these sites onto the homology model and the 
SAXS structure shows that most of the detected trypsin digestion sites in Sbi are on 
loops in the structure, indicating that the allocation o f secondary structure in these 
regions is in good agreement with the predicted three-dimensional models (Figure 
56). The only cleavage sites located on secondary structure elements are R191 and 
K200 are located on helix 9 for the homology model and R191 in the SAXS structure.
The trypsin digest results in combination with the other structure validation results 
suggests that the SAXS model of Sbi can be used to improve homology models for 
proteins whose structure cannot be solved by other structural techniques, such as x- 
ray crystallography. In addition, circular dichroism studies on the P2GPI-binding 
domain (see Chapter 2) confirmed that this region of Sbi is a-helical, thereby also 
supporting the SAXS model. In light of the SAXS data showing that the Sbi protein is 
composed of four domains, we are confident that the model proposed is reliable.
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11 Chapter 7
11.1 Reflections and perspectives
Sbi is an S. aureus cell surface protein. Zhang et al (1998, 1999) identified the 
presence of an N-terminal Ig-binding domain, followed by a second proposed Ig- 
binding domain, and a domain capable of binding the serum protein (32GP1. 
Comparison of the Sbi sequence to the SpA sequence revealed high homology in the 
part of Sbi located N-terminally from the proline rich region (see Figure 8  for the 
structure of the Sbi gene) with the Ig-binding domains of SpA. We therefore predicted 
that this region of Sbi is composed of domains with a structural fold similar to the 
SpA Ig-binding domains. We also predicted that Sbi contains four such domains.
Sbi also contains a proline-rich region between the N- and C-terminal regions. The 
length of the repeat unit matches the motif found in the proline pipe helix (Butcher et 
al 1996). Therefore a proline pipe helix was built for this region of the structure. We 
proposed that the proline pipe helix interacts with the bacterial cell wall in a similar 
fashion as the MSCRAMM proteins, which also contain proline rich sequences in the 
regions identified to be cell wall binding (see Chapter 2 for more details). The 
mechanism of cell wall anchoring by these sequence motifs still remains unclear.
It was not possible to identify any sequences or protein structures homologous to the 
C-terminal region of Sbi. This part of the protein therefore either has a novel function 
and fold or it shares its fold with a previously identified fold, but the sequence 
homology is too low for identification.
Homology modelling of the Sbi Ig-binding domains, using three-dimensional 
structures of SpA domains B and D, revealed that the amino acids on the face of the 
three-helix bundle structure of the Ig-binding domain, responsible for binding to IgG 
via the Fc fragment, are all conserved in both Ig-binding domains of Sbi (see Figure 
14b & c). Residues on the face involved in Fab binding are not conserved in Sbi’s Ig- 
binding domains (see Figure 14d). We predicted that Sbi could only bind IgG via the 
Fc binding site (se Chapter 2).
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Binding studies with Sbi revealed that while both Sbi and SpA form insoluble 
complexes in the presence of intact serum IgGs, only Sbi precipitates in complex with 
IgG Fc fragments. This showed that although both Ig-binding proteins bind to the Fc 
fragment of IgG, SpA also requires Fab binding for precipitation. This observation 
supports the prediction in Chapter 2, based on sequence homology, that Sbi only 
binds to the Fc region of immunoglobulins.
We also examined a possible mechanism of complex formation by both SpA and Sbi. 
Hanson and Schumaker (1984) predicted that SpA in the presence of rabbit IgG forms 
a complex of IgG models stacked on top of each other with SpA Ig-binding molecules 
down each side (Figure 35). To investigate if such a model was possible we generated 
a model composed of two SpA domains, connected by a linker in complex with two 
Fc fragments. A similar model was created for both Sbi Ig-binding domains (see 
Figure 42 for the models of the SpA and Sbi complex with IgG). Interestingly, this 
revealed that while it is possible to fit two Fc molecules along in the SpA ladder 
model, it is not possible to do so for Sbi, because the shorter linker between the Ig- 
binding domains in Sbi causes steric clashes between the two Fc fragments. Our 
ladder model implies that, in the case of Sbi, Fc binding by both domains is more 
likely to cause cross-linking rather than stacking, seen in SpA. With this model we 
now can explain the formation of insoluble complexes between Sbi and Fc fragments, 
while the stacked complexes formed with SpA remain soluble in the absence of Fab.
Comparison of the binding patterns for the formation and size of soluble and insoluble 
complexes with both Sbi and SpA (in Chapter 3) reveals that each share their 
preferences in binding the different human IgG subclasses: both bind IgG l, IgG2, and 
IgG4 and show either weak or no binding to IgG3. Significant differences are 
observed in the presence of serum IgGs from different species: Sbi precipitates 
human, rabbit, mouse and Guinea pig serum IgGs while SpA precipitates human, pig 
and Guinea pig serum IgG, although Guinea pig IgG produces more precipitation in 
the presence of Sbi than with SpA. In the measurement of soluble complex sizes, SpA 
produces larger complexes in the presence of pig and cow serum IgGs than Sbi does. 
Sbi and SpA both appear to form 1:1 complexes in the presence of goat, horse, and 
sheep serum IgGs while Sbi also forms 1:1 complexes with pig and cow serum IgGs.
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Interestingly, single Sbi Ig-binding domains are still capable of forming large 
complexes with human (soluble) and Guinea pig (insoluble) serum IgGs.
Determination of affinity constants for Sbi in the presence of the different serum 
IgGs, using SPR, reveals that Sbi binds mouse serum IgG most strongly, closely 
followed by human and Guinea pig. The weakest binding was found with sheep and 
pig IgGs. Both Sbi Ig-binding domains bind human IgGl subclass strongly and also 
show similar affinity for IgG4. The binding of IgG2 revealed an order of magnitude 
difference in the affinity for IgG2 between the two domains (see Figure 33). Neither 
Sbi domains have any affinity for IgG3.
The differences found in complex formation between SpA and Sbi and the various 
serum IgGs was further analysed using homology modelling in Chapter 4. Models of 
SpA-Fc and Sbi-Fc complexes were generated using a crystal structure of SpA in 
complex with a human Fc fragment (see Chapter 4).
Analysis of the homology models of these complexes pointed to a number of 
substitutions in the Fc sequence that could affect the interaction and orientation 
between the C h2 and C h3 domains of the IgGs. The gain or loss of a large side chain 
at the Ch2-Ch3 domain interface in the Fc molecule could affect the elbow-angle 
between the two domains. Since the SpA binding site on the Fc molecule comprises 
residues on both C h2 and C h3, changes in the elbow-angle between the two domains 
are very likely to affect the binding of SpA (or Sbi) by changing the distance between 
the residues on the two C h domains required to bind SpA (or Sbi). Thereby binding 
could be affected without changing the residues in the binding site itself.
In most cases it is not completely clear what effect, if any, the substitution may cause 
on binding. We were able to identify two substitutions that we believe may play an 
important role in the binding between the two Ig-binding proteins and the IgGs. In 
chicken and sheep IgG we found a substitution (H435R and D376Y, respectively) that 
could affect the elbow angle of the Fc molecule. The chicken substitution (H435R) 
and a neighbouring substitution (Y436F) also occur in the sequence for human IgG3, 
the only IgG subclass that does not bind SpA or Sbi. The H435R and Y436F 
substitutions appear to be able to eliminate Fc binding completely, as shown by
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Jendeberg et al (1997). The Sheep IgG substitution introduces a large side chain at 
this position thereby possibly affecting the spacing and orientation between the two 
Ch domains.
Of the residues identified to be involved in the interaction between the C h domains, 
most are well conserved. A few amino acids are less conserved; these include residues 
315, 339, 375, and 378. Of these amino acids 315 is also involved in the interaction 
with the Ig-binding domain. For residues 339, 375 and 378, there is no apparent 
correlation between the substitution and the affinity of the IgG for SpA and Sbi.
Analysis of the interactions between the IgGs and the Sbi and SpA models identified a 
single site where a correlation between binding levels and the residue present could be 
determined. This is residue 315. Low binding species have a small uncharged or polar 
side chain at position 315, while the presence of large charged or polar side chains 
results in higher binding levels. Site directed mutagenesis of the IgGs at this position 
is needed to determine whether the substitutions really affect the ligand binding as 
proposed.
S. aureus infects a range of species; it is of economical importance in cattle where it 
causes mastitis, affecting milk production. However, our binding studies revealed that 
Sbi and SpA bind cow serum IgGs relativity poorly, as is the case for the IgGs from 
other farm animal species such as horse, sheep and goat. The Ig-binding proteins used 
in this study were both cloned from strains of S. aureus isolated from humans. To 
investigate whether the Ig-binding proteins of S. aureus strains isolated from human 
hosts have adapted to human proteins, we sequenced the SpA and Sbi genes from 
strains isolated from other species (see Chapter 5). The sequence analysis of the spa 
and sbi genes, however, showed no significant changes in the sequences of the Ig- 
binding regions of both genes that could account for the differences in IgG binding in 
the different host species; all sequences of the Ig-binding domains were essentially 
conserved in the different strains. This suggests that there is no tendency for acquiring 
host specific immunoglobulin binding in these strains. Since these animals are in 
regular contact with the human host future experiments should also include strains 
isolated from animals in the wild.
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All attempts to crystallise the Sbi-e region of Sbi for structural studies have so far 
been unsuccessful. We believe this is inherent to the predicted multi-domain structure 
of this construct. We therefore attempted to determine the structure in solution. NMR 
is unsuitable because of the size-limitations of this technique, therefore we tried 
small-angle X-ray scattering. From X-ray scattering analysis it can be concluded that 
the Sbi-e has an elongated molecular shape and is monomeric in solution. An ab initio 
model derived from the scattering data reveals an elongated protein composed of 4 
domains (see Figure 52), which neatly fits the models predicted in Chapter 2.
11.1.1 Implications for the evolutionary origin of Sbi and SpA
The structure determined by SAXS clearly shows Sbi contains 4 domains. The first 
three of these all appear to be the same fold, suggesting that domain 3 is similar to the 
two Ig-binding domains. The structure of the (52GP1 -binding domain is harder to 
predict than the others, as the model is less well refined in this region, however we are 
not able to rule out the possibility of it also being a three-helix bundle, although in the 
most probable model, based on the SAXS ab initio structure shown in Figure 53b, the 
3-helices are in a more open arrangement to the other domains.
W e discussed in Chapter 5 the possibility that there is an evolutionary relationship 
between Sbi and SpA. The high similarity of the Ig-binding domains would suggest 
that they might originate from one ancestral domain, which has been duplicated. In 
Figure 57 I propose several possible routes of this evolution. The structural model for 
Sbi presented in Chapter 6 fits well with the scattering data and suggests a structural 
similarity between the Ig-binding domains of both Sbi and SpA and domain 3 and the 
P2GP1-binding domain of Sbi. This suggests that all five domains in SpA and all four 
domains in Sbi could be descended from a single Ig-binding domain type protein. We 
suggest that the ancestor had the function of Ig-binding, as it is more likely that the 
two C-terminal domains in Sbi have lost this function. This is more likely than the 
independent evolution of the Ig-binding domains in the two proteins. Therefore one of 
three possible routes for the evolution of the two proteins is the evolution of a protein 
containing either four or five similar Ig-binding type domains. This protein was than 
duplicated, one evolved into SpA with five domains, the other acquired mutations in 
its third and fourth domains resulting in a change of function and evolved into Sbi
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Figure 57 Possible mechanisms for the evolution of the Ig-binding proteins SpA and Sbi. (a) The 
ancestor gene (I) consists of a single Ig-binding domain. This domain is duplicated (II) in a single gene 
until the gene consists of five domains. The gene is then duplicated (III) and one copy forms SpA. The 
other copy loses one domain while the other two undergo mutation to form Sbi. (b) The ancestor 
domain (I) is duplicated. The gene is than further duplicated (II). One copy undergoes further 
duplication of domains, while maintaining the Ig-binding function to form SpA (III). T he other copy 
also duplicates its domains, but some of the domains undergo mutation, and this results in Sbi. (c) 
Duplication of the ancestral Ig-binding domain occurs at an early stage (I). One copy retains its 
function, and after undergoing duplication of the Ig-binding domain forms SpA (II). The other copy is 
only duplicated until it has two Ig-binding domains, but in this case they suffer mutations and develop 














A / \t 11  1i i
/ \  
f t  f t I






l  \ i
SpA Sbi S p A Sbi
- 152-
with four domains. In the second method a single or double Ig-binding domain 
ancestor split into two genes. Both underwent subsequent duplication of domains, 
with one acquiring mutations in some of its domains giving rise to Sbi, while the other 
formed SpA. A third method can be based on this. The ancestor consisted of a single 
Ig-binding domain. This was duplicated, and one took the route where it acquired 
mutations in its two Ig-binding domains, to later form domain 3 and |32GPl-binding 
domain of Sbi. Meanwhile the ancestor gene on the other route will have undergone 
little or no change in its double domain form. Then at some point in time a copy of 
this gene is inserted into the gene of the other protein containing the mutations to 
form the modem day Sbi. The original copy of the Ig-binding domains was duplicated 
in its gene to form today’s SpA. One other piece of evidence to support the gain 
and/or loss of Ig-binding domains in the evolution of the Sbi and SpA genes is in our 
sequencing of the different SpA and Sbi genes (Chapter 5). We discovered several 
SpA genes containing only four Ig-binding domains rather than the more normal five. 
As the missing domains cover several different SpA domains it suggests that there is a 
mechanism that results in the loss of the Ig-binding domains under unknown 
conditions. An analysis of the linker sequences between the Ig-binding domains will 
provide evidence about the most likely evolutionary route. As the linkers between the 
Ig-binding domains in Sbi are different to those in SpA, it suggests that the molecules 
have evolved separately from an ancestral domain.
11.1.2 Remaining questions
11.1.2.1 Does Sbi bind other ligands?
SpA is known to bind several ligands other than Igs. These include gClqR/p33, von 
Willebrand factor and the tumour necrosis factor-a receptor. The interactions with 
these ligands are not as well characterised as the interaction with IgG. However one 
of these appears to share the Ig-binding site. Romagnani et al (1982) showed that 
iodination of SpA eliminates IgG binding via its Fc region, while Nygren, 
Ghebrehiwet, and Peerschke (2000) showed that the same method also eliminates 
binding of gClqR/p33. In Chapter 2 I have shown that the Ig-binding site is well 
conserved in Sbi as are the tyrosine residues targeted by the iodination of SpA. This 
suggests the possibility that Sbi, like SpA, binds gClqR/p33. Perhaps Sbi also binds 
other SpA ligands?
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Sbi binds the serum protein (52GP1 as well as IgG. (32GP1 is composed of short 
consensus repeat domains (Bouma et al 1999). Recent studies in our lab have shown 
that Sbi also binds to complement protein C3 (Burman et al submitted for 
publication). Does Sbi bind to any other host proteins? The C3 protein was detected 
by use of a pull down assay. While this method can be used to detect serum proteins 
bound by Sbi, it will not detect any ligands attached to host cells, and not present in 
the serum.
11.1.2.2 How is the expression of Sbi regulated?
Zhang et al (2000) discovered that when S. aureus is cultured in the presence of IgG, 
the expression of Sbi is up-regulated. However, how this occurs is unknown. The C- 
terminal region of Sbi, adjacent to the proline repeat region, is rich in tyrosine and 
threonine residues. Both residues are known to be involved in protein activation via 
the phosphorylation of these residues. However such activation sites are intracellular. 
Sbi does not contain any typical transmembrane region nor does it have any 
hydrophobic regions that could be expected to cross the membrane. Zhang et al 
(2000) showed that Sbi is located on the cell surface, but its mechanism of attachment 
is unknown, as Sbi lacks the LTXPG motif found in other adhesion proteins required 
for anchoring in the cell membrane. It is therefore unclear how it is attached to the 
cell and whether the tyrosine rich region is located intracellularly.
There are many unanswered questions remaining about Sbi. Future studies on this 
protein could reveal its role in S. aureus infections and whether it plays a greater role 
than the other Ig-binding protein SpA. Other areas of interest would include the 
function of individual ligands in infection and virulence for both Sbi and SpA, 
determined by the elimination of specific functional regions in addition to knocking 
out the entire gene. Also of interest is whether other S. aureus adhesion proteins show 
the same preference for ligands from a particular host, i.e. SpA appears to favour 
porcine IgGs. There is also further work needed to understand how the substitutions 
observed in Chapter 4 in the different IgG models affect binding and interactions with 
the Ig-binding proteins SpA and Sbi.
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11.1.2.3 What is the effect of functional elimination of S. aureus Ig-binding 
proteins?
In vivo, proteins generally interact with several others operating in the same pathway. 
However knockout studies generally remove the entire protein, or render it inactive. 
However, as we discussed above, SpA and Sbi interact with a number of known 
ligands in vivo. Most of the binding sites in SpA are restricted to a single domain. 
What effect would the elimination of a single binding site have on the in vivo 
virulence of the bacteria?
The use of targeted mutagenesis in the gene to eliminate a function has the advantage 
that it only affects a single site and will only affect the interactions of ligands that 
bind to that site. This means all other interactions can still occur, and can tell us how 
important one function is compared to another in virulence. For example, could the 
elimination of the Fab binding site on SpA result in a lack of generation of B-cell 
superantigens and thereby decrease the virulence of S. aureus1}
11.1.2.4 What is the role of the poly-proline repeat regions in SpA?
Unlike the number of polyproline repeats in Sbi, which is the same in all sequenced 
Sbi genes, the number of repeats in SpA varies from four to sixteen (see Chapter 5). 
Does this variation have any function? There is no apparent relationship between the 
number of repeats and the species from which the S. aureus strain was isolated. 
However, could there be a relationship between the number of repeats and the 
virulence of the strain?
11.1.2.5 Does S. aureus virulence vary from species to species?
The virulence studies discussed in Chapter 1 were all carried out on lab animals 
(mice, rats, rabbits). This could be important to consider as our binding studies 
(chapter 3) showed marked differences between the IgGs of mouse and rabbit (rat 
serum IgGs were not tested) with both Sbi and SpA. Sbi causes precipitation in the 
presence of these IgGs, while SpA forms large soluble complexes. This suggests these 
serum IgGs bind better to Sbi than SpA. Could this mean that Sbi plays a larger role 
in virulence in these species than does SpA?
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11.1.2.6 Does the specificity of S. aureus adhesion proteins differ from species to 
species?
Regarding the relative binding of these Ig-binding proteins, SpA appears to bind best 
to human and porcine serum IgG while Sbi binds best to human and rodent serum 
IgGs (of those tested in Chapter 3). Other studies have characterised the binding of S. 
aureus proteins to ligands such as fibrinogen and fibronectin, but these adhesion 
proteins have not been characterised binding to the same ligand but produced by 
different mammalian species (Chapter 3, Kronvall et al 1970). Zhang et al (1999) 
identified (32GP1 as a ligand for Sbi, used newborn calf serum. However, recent 
studies in our lab used human serum and identify a novel Sbi ligand, complement 
component C3. No (32GP1 was identified in these affinity pull-down experiments. 
This suggests that Sbi (and perhaps also SpA) does indeed bind different ligands in 
different hosts.
We have determined that Sbi and SpA genes show very little variation between strains 
of S. aureus isolated in different species. Is this the same for other adhesion proteins, 
or do they show greater variability in protein sequence and how does this affect 
virulence of S. aureus in different species? If the S. aureus adhesion proteins 
including SpA and Sbi bind poorly to the serum and ECM proteins of an animal 
species, does it make S. aureus a poor pathogen in those species or is there 
compensation (for example, IgG could be bound weakly, while fibrinogen is bound 
strongly)? One way to investigate this would be comparing binding data with 
infection and virulence data for different species. Unfortunately, these data are not 
available: while the U.K. Department of Agriculture and Rural Development website 
(http://www.dardni.gov.uk/) lists infection data for Brucellosis and Tuberculosis, it 
does not have information published on S. aureus infection rates.
11.1.2.7 The role of SpA from earlier virulence studies
As well as virulence studies with the adhesion proteins such as ClfA and FnBPA, 
virulence studies have also been carried out with SpA (Callegan et al 1994, Gomez et 
al 2004, Jonsson et al 1985, Palmqvist et al 2002, Palmqvist et al 2005). This has also 
been recently classified as an adhesion protein as it has been discovered that it binds a 
component of the ECM: the von Willebrand factor (Foster and Hook 1998, Hartlieb et
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al 2000) in addition to IgG. In the early virulence studies on SpA as well as other 
mutagenesis studies with SpA (for example: Jonsson et al 1985), SpA mutants were 
generated by chemical mutagenesis. Later studies used strains known to be defective 
in SpA. In all cases a small reduction in virulence was observed. The question is 
whether these strains had only the SpA gene eliminated or whether others were also 
affected such as Sbi. Testing for a reaction with IgG was used in determining the 
presence or activity of SpA. However we now know S. aureus contains two Ig- 
binding proteins SpA and Sbi. What we do not know is if they show different 
properties on the surface of S. aureus and whether all studies with S. aureus strains 
into the effect of SpA had functional Sbi or in effect they were studying the effect of a 
double mutant with the S. aureus strain also containing non-functional Sbi. Where 
detection of S. aureus mutants lacking IgG binding ability occurs, it would suggest 
the possible elimination of both genes, while when the presence of low-binding 
mutants is detected, it suggests that these strains could have only one or the other of 
the two Ig-binding genes active. The only way to answer this question would be to use 
S. aureus mutants of both SpA and Sbi generated by molecular biology, where it can 
be confirmed that only a single gene has been affected, and compare the action of the 
S. aureus mutants in vitro to both wild type S. aureus and a double knockout of both 
genes. Virulence studies with such S. aureus mutants would show whether one protein 
has a larger effect on virulence than the other.
11.1.2.8 Reflections on the role of S. aureus and its adhesion proteins in infection 
and future directions
Most virulence studies with S. aureus adhesion proteins (Moreillon et al 1995, Flock 
et al 1998, Jonsson et al 1985, Patel et al 1987, Callagen et al 1994, Palmqvist et al 
2002) have shown that the loss of an adhesion protein results in some reduction in 
virulence (chapter 1). Interestingly, in studies where the loss of an adhesion protein is 
compared to the loss of a toxin such as a-haemolysin, the strain with the a- 
haemolysin mutation shows a much greater reduction in virulence (Callegan et al 
1994, Jonsson et al 1985, Patel et al 1987). Unlike adhesion proteins a-haemolysin is 
a toxin secreted by S. aureus that is part of a group of channel forming toxins. These 
form channels in the membranes of the host cells, resulting in disruption of membrane 
potential and can cause cell death (Wilson, McNab, and Henderson 2002 Ch9). No
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single adhesion protein knockout has the same level of effect as a knockout of a -  
haemolysin. This could be due to the differences in their individual roles in infections. 
W hat is unknown though, is how multiple knockouts of adhesion proteins affect 
virulence in vivo. We have not been able to find any studies with strains of S. aureus 
carrying more than a single gene knockout in an animal disease model. We do know 
from the work of O ’Brien et al (2002) that multiple knockouts of adhesion proteins 
cause further increases in the lag time for platelet aggregation in vitro. In this work, 
using S. aureus knockout mutants of the ClfA, SdrE, and SpA genes, only the single 
ClfA knockout mutant had an increased lag time for aggregation compared to the use 
of wild type strains. However, double knockout mutants of SdrE or SpA and ClfA 
gave a further increase in lag time compared to the wild type, while the triple mutant 
recorded the longest lag time. This clearly shows that all 3 proteins appear to be 
required in an in vitro setting and the loss of the additional genes of SdrE and SpA 
increase the effect of the single ClfA mutation. The effect of these multiple knockout 
mutations on virulence in vivo is unknown. Perhaps the development of a drug 
therapy that targets multiple adhesion proteins would provide an effective way to treat 
and control S. aureus infections.
11.1.3 Conclusion
Sbi is an Ig-binding binding protein with high affinity for human, rabbit, Guinea pig 
and mouse serum IgGs, while SpA shows high affinity for human and pig serum 
IgGs. The N-terminal region of Sbi is predicted to be composed of 4 domains, all of 
the three-helix bundles typical of the SpA Ig-binding domains. Sbi contains two 
functional Ig-binding domains at its N-terminal, while the fourth predicted domain 
binds (32GP1 and domain three and the P2GPI-binding domain together have recently 
been shown to be involved in the binding of complement component C3 (Zhang et al 
1999, Burman et al submitted for publication). Comparison of the IgG sequences 
through homology modelling suggested that the IgG Fc residue 315 plays a role in 
determining affinity for Sbi and SpA, while the sequencing o f the Sbi and SpA genes 
from strains isolated in different hosts revealed that the sequence of the Ig-binding 
domain is conserved across all the hosts.
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Future directions for studies on Sbi should include virulence studies to determine its 
role in infection. Such a study would determine the role of Sbi by the generation of 
sbi strains, the introduction of Sbi into a non-virulent organism such as L. lactis, and 
the generation of Sbi mutants that lack the ability to bind one of its ligands (possibly 
more if it is determined that two or more different ligands share a binding site). The 
generation of such mutants would give a greater understanding of the role of Sbi in 
addition to an sbi' mutant, as it would provide specific information about the role of 
the binding of individual ligands on the virulence of S. aureus. Another direction of 
research would be the generation of S. aureus mutants lacking more than one 
adhesion protein. In vivo virulence studies with strains carrying multiple knockouts 
would give a greater understanding of the roles the proteins play in virulence with 
respect to each other.
There is currently little known about the C-terminal regions of Sbi. We predict that 
Sbi is anchored in the cell wall by its proline rich region. More studies on this part of 
the protein are needed. In addition the function of the tyrosine-rich C-terminal region 
needs addressing. Structural studies on these parts of the protein could reveal if it has 
any structural homology to other known proteins, while the production of soluble 
protein of both the C-terminal region and the proline rich region could be used to 
determine if and how they interact with for instance S. aureus signalling proteins. 
This could be of particular interest as the C-terminal region has been suggested to be 
involved in regulation of the expression of Sbi.
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12 Appendix 1
Table of S. aureus surface proteins, their ligands, and role in infectious diseases.
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Species of Serum IgG Concentration (M) ks (s’1) Chi squared (%2)
6.37E-05 3.13E-03 645
Chicken 3.19E-05 2.01E-03 97
2.12E-05 1.63E-03 11
1.26E-06 7.43E-03 9,240
Cow 6.29E-07 4.31E-03 2,630
3.15E-07 3.83E-03 11
1.07E-05 4.17E-03 68,200
Goat 5.33E-06 2.71E-03 21,500
2.66E-06 7.45E-04 3,230
9.84E-06 2.17E-03 772








Guinea Pig 1.34E-07 1.22E-02 10,200
6.70E-08 8.92E-03 1,890
3.51E-07 3.73E-02 65,800
Mouse 2.63E-07 3.19E-02 25,400
1.76E-07 2.00E-02 4,580
7.83E-07 8.23E-03 68,100
Pig 3.13E-07 6.77E-03 5,770
1.57E-07 6.29E-03 14,100
8.67E-07 1.34E-02 10,800
Rabbit 4.33E-07 7.53E-03 1,810
1.73E-07 6.05E-03 1,280





Interaction patterns between the Ch2 and Ch3 domains of the IgG models. 
CONTACT was used to calculate residues within 5.2A of a residue in the other Ch 
domain. Residues in the Ch2 domain (244 to 342) interacting with a residue in the 
Ch3 domain (343 to 438) are marked with a green square.
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Summary of the interactions between the C h2 and C h3. The number indicates the 
number of times an interaction between two residues is detected. Residue numbers in 
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Summary of interactions observed above between the IgG Ch2 and Ch3 domains. The 
numbered squared refer to the interactions listed in Table 9. Interactions detected in 
all models are marked in black. Changed interaction pattern: marked in red do not 
correspond to changes in sequence; blue corresponds to changes in the Ch2 domain; 
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1 1FC2 P P K P K D T L M H W L  D S K A K G Q P R G  Y P S D 1 A  E p p D G  S F S M H E A L N H Y T Q
2  Chicken_lgG_clone36 P P S P - G E L Y T W L  S Y R N T  G  P 1 T G  R P R D 1 E R p A G D T  F M V H E A L M R F S Q
3  Cow_lgG2 P P K P K D T L M H W T  G S R S K G P A R G Y P E D V D E s P D G S Y V M H E A L N H Y M Q
4  Guinea_Pig_lgG2 P P K P K D T L M H W L  R S K T K G A P R N F P A  D 1 H E s P D G S Y S M H E A L N H V T Q
5  Horse_lgG4 P P K P K D V L M H W L  S S K P T G Q P R D Y  P T  D 1 D E p P D G S  Y A M H E A L N H Y T E
6  Horse_lgG6 P P K P K D T L M H W R  R T K A K G E  L Q D Y P P D 1 N E p P D G  S Y V M H  E A  I H T Y R Q
7 Mouse_lgG1 P P K P K D V L T H W L  N S K T K G R P K D F P E D 1 T E p Q D G T  Y S L H E G L N H H T E
8  Pig_lgG4 P P K P K D T L M H W L  N S K A K G Q T R G Y P P D 1 D E p P D G T  Y A M H E A L N H Y T Q
9 RabbitJgG P P K P K D T L M H W L  R S K A R G Q P  L G  Y P S D 1 S E A P D G S Y S M H E A L N H Y T Q
10 Sheep_lgG1 P P K P K D T L T H W T  G S R T K G Q A R G Y P D Y 1 A  E s T D G S Y V M H E A L N H Y T Q
Sequence of the IgG models in the regions identified to be involved in interacting 
with the other domain. Conserved residues are highlighted in yellow. Residues 
conserved in all sequences have a black mark under them.
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15 Appendix 4
Interaction patterns for SpA with the IgG models. CONTACT was used to calculate 
residues between 1.8 A and 5.2A of a residue in the other half of the complex. 
Residues in the SpA domain (1 to 31) interacting with a residue in the IgGmodel (248 
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SpA interactions with Rabbit IgG
a  a s
interactions with Sheep lgG1
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Summary of the interactions between SpA and the IgG models. The number indicates 
the number of times an interaction between two residues is detected. Residue numbers 
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9 0 8 9 10 10 0 0 0 0 0 10 10 1 4 0 0 0 0 0 0 0 1 9 0 0 0
10 0 0 0 0 \ 0 0 0 0 0 0 0 0 1 0 0 0 0 9 7 10 10 10 10 0 0 0
1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 1 0 0 0
1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
1 3 0 0 0 0 0 0 0 0 0 0 7 10 1 10 2 0 0 1 0 0 0 0 7 0 0 0
1 4 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 0 0 10 0 1 0 0 8 0 0 0
1 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
20 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0 0 0 0 0 0 0 0
2 3 0 0 0 0 0 0 0 0 0 0 0 7 0 1 2 0 0 0 0 0 0 0 0 0 0 0
2 4 0 0 0 0 0 0 0 0 0 7 0 1 u 4 1 2 0 0 0 0 0 0 0 0 0 0 0
2 7 0 0 0 0 I T 0 0 0 0 0 4 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2 8 0 0 0 0 0 0 0 0 0 7 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
3 1 0 0 0 0 9 0 0 0 0 6 10 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0
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Summary of interactions observed above between SpA and the IgG models. The 
numbered squared refer to the interactions listed in Table 10. Interactions detected in 
all models are marked in black. Changed interaction pattern: marked in red do not 
correspond to changes in sequence; green indicates where a substitution occurs in the 
IgG sequences. The sequence for SpA is given.
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Sequence of the IgG models in the regions identified to be involved in interacting 
with SpA. Conserved residues are highlighted in yellow. Residues conserved in all 
sequences have a black mark under them.
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16 Appendix 5
Interaction patterns for Sbi-1 with the IgG models. CONTACT was used to calculate 
residues between 1.8 A and 5.2A of a residue in the other half of the complex. 
Residues in the SpA domain (1 to 31) interacting with a residue in the IgGmodel (248 
to 438) are marked with a green square.
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Summary of the interactions between Sbi-1 and IgG models. The number indicates 
the number of times an interaction between two residues is detected. Residue numbers 
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24 0 0 0 0 0
“ 9
0 0 0 0 7 0 1 0 3 0 3 0 0 0 0 0 0 0 0 0 0 0
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28 0 0 0 0 1
w
0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
30 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
31 0 0 0 3 1 0 0 6 8 3 7 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0
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Summary of interactions observed above between Sbi-1 and the IgG models. The 
numbered squared refer to the interactions listed in Table 11. Interactions detected in 
all models are marked in black. Changed interaction pattern: marked in red do not 
correspond to changes in sequence; green indicates where a substitution occurs in the 
IgG sequences. The sequence for Sbi-1 is given.
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Sequence of the IgG models in the regions identified to be involved in interacting 
with the other domain. Conserved residues are highlighted in yellow. Residues 
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Interaction patterns for Sbi-2 with the IgG models. CONTACT was used to calculate 
residues between 1.8 A and 5.2A of a residue in the other half of the complex. 
Residues in the Sbi-2 domain (1 to 31) interacting with a residue in the IgGmodel 
(248 to 438) are marked with a green square.
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Summary of the interactions between Sbi-2 and the IgG models. The number 
indicates the number of times an interaction between two residues is detected. 
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Summary of interactions observed above between Sbi-2 and the IgG models. The 
numbered squared refer to the interactions listed in Table 12. Interactions detected in 
all models are marked in black. Changed interaction pattern: marked in red do not 
correspond to changes in sequence; green indicates where a substitution occurs in the 
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Sequence of the IgG models in the regions identified to be involved in interacting 
with the other domain. Conserved residues are highlighted in yellow. Residues 
conserved in all sequences have a black mark under them.
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